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SUMMARY
Ogawa and Inaba are the two main serotypes of 
V. cholerae 01, the etiologic agent of the severe diarrhoeal 
disease, cholera. In the gut of human hosts, the vibrios produce 
a cholera toxin which causes rapid dehydration. Various field 
and volunteer studies ( Levine et a^, 1979, 1981; Cash e£ al,
1974 ) have indicated that antibacterial activity is more 
important than antitoxin activity in protection against 
subsequent challenge infection.
V. cholerae antigens have been classified by conventional 
serology into three groups. The A antigen is common to Inaba and 
Ogawa, the B is specific to Ogawa and the C specific to Inaba.
The structural analysis of V_^  cholerae LPS has received 
very limited attention and hence the antigens responsible for 
homologous and heterologous vibriocidal activity are not well 
understood. Recent chemical analyses of the cholerae LPS have, 
however, suggested that the group antigen is a repeat of 
perosaminyl residues whose amino functions are acylated by 
L-glycero-tetronic acid ( Redmond, 1979; Kenne e^ aL, 1982 ). 
However, the type specific antigens of Ogawa and Inaba are still 
obscure.
The objective of the present study was to investigate the 
shared and unique epitopes of Ogawa and Inaba serotypes with 
MCAbs. A panel of six MCAbs was produced and assessed for 
specificity to the two serotypes and other potentially cross 
reacting bacteria. All were directed primarily to the LPS rather 
than membrane protein. The specificity profile of each antibody 
was heavily dependent on the assay system employed and the 
antibodies could be classified into three groups. Three could be 
demonstrated to be totally specific to Inaba LPS on some assay 
systems but to show extensive cross reaction with Ogawa vibrios 
on other assay systems. Two antibodies were totally specific to 
Ogawa vibrios on all assay systems. A sixth antibody could be 
shown to be totally specific on Ogawa vibrios in some assay 
systems and to be totally specific to Inaba on other assay 
systems. The dual specificity of the four cross reactive 
antibodies could be related to the use of washing as opposed to 
nonwashing assays, the concentration and method of presentation 
of antigen and antibody, and the density, accessibility and 
geometry of the antigen on the bacterial surface.
These results indicate that the conventional 
classification of cholerae antigens does not take into account 
more subtle interactions between antigen and antibody. In 
addition, they emphasise the point that emerging hybridomas must 
be screened under the exact conditions of final use of the 
antibody to be generated. Finally, they indicate that a single 
antibody may be employed in a dual capacity, detecting different 
serotypes in two different assay systems.
The interaction of the antibodies with the vibrio LPS 
molecules meant that it was necessary to resolve these molecules 
in order to analyse the interaction. High resolution 
electrophoresis was necessary to do this as the size of the 
repeating unit was discovered to be exceedingly small (less than 
300 daltons) compared to that observed for Salmonella tvphimurium 
and ^  coli 0111:B6. Most interestingly, no differences in the 
mobility, number of side chains or the density of the 0-chains 
were detected on SDS-PAGE for the two serotypes. Thus, the 
difference in serotype cannot be related to difference in
electrophoretic mobility even at this fine resolution.
Nonetheless, the MCAbs were able to make clear distinctions
between the two serotypes on immunoblotting, emphasising their
considerable power as a specific detection system. The results 
suggest that the difference between Ogawa and Inaba must 
therefore be interpreted in terms of LPS molecules which have 
0-side chains with very small repeating units identical in size 
and electrophoretic mobility but containing enough structural 
differences to allow them to react differentially with serotype 
specific monoclonal antibodies.
INTR0D13CTII0N
1.1 General Introduction
Cholera-llke diseases have been common on the Indian 
subcontinent for many centuries and are reported in some of the 
earliest medical records. Susrata-samhita, a treatise on Indian 
medicine, written around the seventh century A.D. has 
descriptions of illness and death due to dehydrating diarrhoea 
and vomiting. It is likely that no long-distance spread of 
cholera took place before the nineteenth century despite clear 
descriptions of epidemics on the Indian subcontinent from the 
late fifteenth century onwards in the journals of Portuguese 
explorers. The first of the seven cholera pandemics erupted from 
India in 1817 but did not travel very far into Western countries. 
The second pandemic reached Moscow, Great Britain and America 
killing thousands of people between 1831-1849. The fifth pandemic 
in 1881 was studied by the French and German cholera 
commissions under Isadora Straus and Robert Koch in Egypt and 
later by Koch in Calcutta. Koch identified cholerae as the 
causative agent of cholera and in 1887, proposed that the disease 
was toxin mediated. It was only after De (1959) and Dutta (1959) 
reported their studies from India that the existence of cholera
toxin was finally established. De (1959) injected cholera 
culture filtrate into ligated loops of rabbit small intestine and 
showed that a few hours after the injection, the loops swelled up 
with rice-water fluid characteristic of cholera stools. Ten years 
later, methods for the preparation and purification of cholera 
toxin were established by Finkelstein and Lo Spalluto ( 1969 ) 
and its effect on the adenylate cyclase-cyclic AMP system was 
soon established. Since then, activation of adenylate cyclase by 
cholera toxin has been shown to occur in most mammalian cell 
types, the stucture-function relationship of the toxin has been 
defined, the cell receptor identified and most recently, the mode 
of action of the toxin on adenylate cyclase explained in 
considerable detail. Studies on cholera, the etiological agent 
of cholera, however, have lagged behind.
1.2 Epidemiology of cholera
Epidemic and pandemic cholera is caused by cholerae 01 
of which two biotypes exist, classical and El Tor. The first 
El Tor vibrios were isolated by Gotschlich in 1905 at the El Tor 
quarantine station in the Sinai peninsula. The vibrios isolated 
were agglutinated with cholera antiserum and resembled cholera 
vibrios described earlier by Koch but the organisms produced 
haemolysin which was not observed with the classical strain of 
cholera. It was not until 1961 when the El Tor variant produced 
an epidemic of major proportions in the Philippines that there 
was general agreement that the haemolytic cholerae could be 
responsible for severe epidemic human disease. Between early
1960s and 1980 the El Tor biotype spread throughout the world to 
the virtual exclusion of classical biotype organisms. However, in 
1982 diarrhoea due to the classical biotype reappeared in 
epidemic form in Bangladesh ( Saraadi et 1983 ) and it remains
to be seen whether classical cholera will again predominate in 
the Gangetic delta and whether it will spread elsewhere in Asia 
or Africa as the seventh pandemic is still with us.
1.2.1 Toxin genes of classical and El Tor biotypes
The analysis of cholera toxin gene stucture has shown that 
V. cholerae strains of the classical biotype contain a 
nontandem, chromosomal duplication of the ctx operon that is 
structurally identical in all strains ( Mekalanos e^ al, 1983 ). 
In contrast, about 70% of El Tor strains have only a single copy 
of ctx, while the remaining strains have two or more ctx copies 
present on a tandemly repeated genetic element. This duplication 
and amplification of the toxin operon may be related to the 
virulence of the serotypes.
1.2.2 Association of cholera with ABO blood group
Many diseases are associated with ABO blood group 
classification. Most of them occur in adults after their 
reproductive age and are not fatal, so they have been considered 
to be of little evolutionary consequence ( Mourant and Kopec, 
1978 ). Associations of ABO grouping with susceptibiltiy to major 
epidemic diseases such as plague and smallpox might account for 
greater genetic selection but these suggested relationships have
only been based upon known or supported molecular similarities 
between the etiological agent and blood group antigens and have 
not been identified in population-based studies ( Springer, 
1971 ). Barua and Paguio ( 1977 ) and Chaudhuri, 1977 observed 
that in endemic areas patients hospitalised with cholera were 
more likely to be of blood group 0 than the control population. 
Levine e^ a^, ( 1979 ) had also reported that US volunteers of 0 
blood group who were challenged with cholerae 01 tended to 
have more severe purging than non-0 group volunteers.
Glass et ( 1985 ) examined the blood groups of
patients hospitalised for diarrhoeal disease due to a variety of 
bacterial and viral agents. The authors identified a significant 
association only with the disease cholera, in which cholera 
patients were twice as likely to have blood group AB as community 
controls. Family contacts of cholera patients indicated that 
blood group did not affect an individual's risk of having a 
culture-proven infection with cholerae 01 but was directly 
related to the severity of disease. Individuals with the most 
severe diarrhoea were more often of blood group 0 and less often 
of AB compared with those with asymptomatic infection. Patients 
infected with enterotoxigenic coli. which expresses a 
heat-labile toxin similar to cholera toxin, did not show a 
similar distribution of blood group antigens. In addition, 0 
blood group patients were at no increased risk of infection with 
V. cholerae non 01 which is genetically related to ^  cholerae 01 
but does not normally produce cholera toxin.
While the authors were not able to identify the molecular
basis for this apparently genetically related protection, they 
have suggested that the constant selective pressure of cholera 
against people of 0 blood group may account in part for the 
extremely low prevalence of O group genes and the high prevalence 
of B group genes found among the people living in the Gangetic 
Delta.
1.3 Morphological characteristics of V. cholerae
V. cholera is a gram-negative bacterium. The bacteria are 
short and curved and have a single polar flagellum. Motility 
provided by the vibrio’s unipolar flagellum is important for its 
virulence ( Schrank and Verwey, 1976 ).
1.4 Cholera Infection
Humans are the only known natural hosts of cholerae 01 
infection and in nature they usually ingest these organisms by 
means of contaminated water ( Levine and Nalin, 1976 ) or food, 
typically sea food ( Dutta et 1971 ). The probable inoculum
size in nature is believed to be 10. to 10 organisms and this is 
corroborated by volunteer studies in which ingestion of 10^ 
classical Ogawa 395 organisms with 2.0g of sodium bicarbonate by 
North American volunteers resulted in diarrhoeal illness ( Levine 
et al. 1979 ). Gastric acid in normochlorhydric persons serves as 
a very competent nonspecific defence barrier ( Levine e^ al, 
1981 ).
When cholerae 01 organisms successfully pass through 
the pylorus in viable state, they reach the critical anatomic
site of host-bacterium interaction, the proximal intestine. Here 
a complex series of events occurs as the vibrio, using an array 
of virulence mechanisms, attempts to overcome a number of 
nonspecific defence systems employed by the host. Two 
nonspecific defence mechanisms work in unison, the small 
intestine peristalsis and a mucus layer coating the small 
intestine. cholerae organisms penetrate the mucus layer and 
rapidly reach the enterocytes of the small intestine to which 
they attach themselves. In this manner they overcome the normal 
defences and colonize the small intestinal mucosa ( Levine et al, 
1983 ) and elaborate the enterotoxin, cholera toxin. The vibrios 
can secrete a potent mucinase which is believed to assist their 
entrance into the mucus gel covering the mucosa ( Lam e^ al, 
1955 ).
1.5 Cholera toxin and its mode of action
Like many other bacterial diseases, cholera may range from 
a symptomless infection to a severe attack rapidly proving fatal. 
In its most characteristic clinical form it starts abruptly with 
diarrhoea, soon marked by the passage of rice-water stools and 
precipitating vomiting. Several litres of body fluid may be lost 
within a few hours which leads to shock and death if the fluids 
are not replaced. The diarrhoea is caused by the bacterial toxin 
rather than by a direct action of the bacteria themselves.
Cholera toxin is a protein of 87K which consists of 
an Aj peptide linked by a disulphide bond to an A^ peptide and 
five B peptides. The B subunits are responsible for cell binding
and the A subunits for the direct toxin activity.
The first event in the action of cholera toxin on cells
is the rapid and tight binding to receptors on the cell surface.
The membrane receptor for cholera toxin is a G„, gangliosideMl
( Holmgren e^ 1973; King and Heyningen, 1973; Cuatrecasas,
1973 ). This carbohydrate-rich sphingolipid is recognised by the 
B chains of the toxin. The cell penetration by the toxin is as 
yet poorly understood. After gaining entry into the cell the A^  ^
subunit catalyses the transfer of an ADP-ribose unit from NAD to 
the guanosine nucleotide-binding component of the membrane bound 
adenylate cyclase ( Moss e^ 1976 ). Adenylate cyclase is
active while GTP is bound to the GTP-binding component but 
reverts to an inactive state as GTP is hydrolysed to GDP by 
GTPase ( Cassel and Selinger, 1977 ). Cholera toxin blocks the 
GTPase action thus stabilising the active conformation of 
adenylate cyclase. Altenatively, cholera toxin may stimulate 
adenylate cyclase by enhancing an exchange reaction in which 
stimulatory GTP replaces inhibitory GDP at a rate higher than 
that of hydrolysis of GTP to GDP ( Lad et a^, 1980 ). The
increase in the adenylate cyclase activity of the mucosa of the 
small intestine raises the level of cAMP in these cells. The 
abnormally high level of cAMP stimulates active transport of ions 
by the intestinal epithelial cells, which results in a large 
efflux of Na^ and water into the gut.
1.6 Prevention and therapy of cholera
1.6.1 Rehydration therapy
Bacteriophage or serum treatment have not proved to be of 
any therapeutic value but chemotherapy provides an useful 
complement to the main purpose of treatment, which is the 
replacement of the lost fluid and electrolytes ( Chaudhuri, 1971; 
Pierce et 1970 ). The amount and composition of the blood
plasma has to be restored as rapidly as possible by a suitable 
fluid which contains almost exactly the electrolyte content of 
the stools. During the past decade, oral rehydration therapy by 
means of appropriate glucose—electrolyte solutions has simplified 
the treatment of dehydrating diarrhoea, making effective therapy 
feasible in places where intravenous treatment facilities are 
limited or unavailable. This treatment takes advantage of the 
presence of an uptake mechanism for sodium in conjunction with 
certain organic solutes, including glucose, which is not 
regulated by cyclic nucleotides and thus is unaffected in cholera 
and other forms of enterotoxic diarrhoea. However, in severely 
affected patients purging often occurs at such a high rate that 
balance cannot be maintained by oral fluid only and intravenous 
replacement of fluid is essential for survival.
1.6.2 Prevention of the disease
Cholera can be controlled by good sanitation and personal 
hygiene. The preventive measures required are similar to those 
taken against other infections of the enteric type, except that
no provision is needed against chronic carriers because these 
rarely occur in cholera. Clean water supplies and safe disposal 
of human sewage can dramatically reduce the number of clinical 
cases of cholera.
1.7. Immunity against cholera
1.7.1 Immunity following infection
In endemic areas the incidence of cholera is highest in 
children 2 to 4 years of age and incidence rates diminish 
thereafter with increasing age ( Glass et al,1982 ). At the same 
time the prevalence of vibriocidal antibody in serum increases 
with age ( Mosely et 1973; Mosely et a^, 1968). These
epidemiological observations point to the development of acquired 
immunity from clinical and subclinical infection. On the other 
hand, repeated Infections in endemic areas, usually not attended 
by clinical symptoms, have been reported. Genuine second attacks 
occurring within a few weeks of the first were observed by 
Woodward ( 1971 ).
The majority of the analyses on the quality and duration 
of infection—derived immunity have been conducted on healthy 
adult volunteers ( Clements et 1982; Levine e^ 1981 ),
who were not very representative of the undernourished population 
of the third world, the centre of endemic areas. However, such 
studies do throw some light on the knowledge of acquired 
immunity. Cash e^ ( 1974 ) showed that an initial clinical
10
cholera infection due to classical Inaba vibrios confers immunity 
to rechallenge with the homologous organism. Levine et al, 
( 1979 ) subsequently showed that an initial clinical infection 
due to classical vibrios of either serotype led to complete 
protection upon subsequent challenge with classical vibrios of 
the heterologous as well as the homologous serotypes. Not only 
were the rechallenged volunteers clinically protected but also 
classical vibrios were never recovered by direct culture of 
stools. The immunity was also shown to last for three years, the 
longest interval tested.
Levine et ( 1981 ) also undertook to examine the
immunity conferred by clinical infection with El Tor vibrios. An 
initial infection due to cholerae El Tor was found to provide 
significant protection against rechallenge with El Tor vibrios of 
either homologous or heterologous serotype. In contrast to the 
experience with classical vibrios in volunteers, individuals 
rechallenged with El Tor vibrios often had positive direct 
coprocultures. It was not established whether this was due to an 
enhanced capacity of El Tor vibrios to survive in nondiarrhoeal 
stool or whether El Tor vibrios stimulate less potent intestinal 
immunity than the classical vibrios.
1.7.2 Antigen-stimulated immunity in humans
Multiple antigens are elaborated by cholerae, among 
them are lipopolysaccharides ( LPS ), flagellar sheath proteins, 
various haemagglutinins and outer membrane proteins. Each of 
these antigens may play a critical role in pathogenesis.
11
Presumably, the host immune responses directed against these 
antigens serve as mediators of the potent immunity observed in 
volunteer studies. Information on the immune response is crucial 
to vaccine development to help determine what antigens are 
particularly desirable for inclusion in immunising agents.
1.7.2.1 Anti-LPS antibodies
After cholera infection, serum and intestinal or milk 
secretory immunoglobulin A ( SIg A ) antibody responses can be 
demonstrated by ELISA against purified LPS antigen ( Majumdar and 
Ghose, 1981; Majumdar et 1981). Serum vibriocidal antibody
assayed against live cholerae in the presence of complement is 
directed mainly, but not entirely, against the LPS antigen. Serum 
vibriocidal antibody levels rose significantly in more than 90% 
of North American volunteers who participated in cholera 
challenges ( Clements e^ 1982 ).
1.7.2.2 Antibodies to flagellar sheath protein
There have been no reports to date of the serum or local 
intestinal antibody response to flagellar sheath protein in man.
1.7.2.3 Antibodies against cholera haemagglutinins
The detection of human response against cholera 
haemagglutinins has also not been reported to date.
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1.7.2.6 Expression of outer membrane protein directed antibodies 
Sears e^ al, ( 1984 ) have characterised the frequency, 
magnitude and kinetics of the serum antibody response of humans 
to the major outer membrane proteins of cholerae after 
experimental cholera infection in challenge volunteers. 50% of 79 
volunteers challenged with the El Tor biotype and 54% of 35 
volunteers challenged with the classical biotype had 
significantly increased levels of IgG anti-outer membrane protein 
antibodies. Sera from paired volunteers showed significant rise 
of antibody as measured on ELISA when tested against outer 
membrane protein of either serotype. However, vibriocidal 
activity of the anti-outer membrane protein antibodies was not 
tested. Absorption of antisera with LPS resulted in only 12% 
decrease in anti-outer membrane protein activity on ELISA.
1.7.2.5 Anti-toxin antibodies
Cholera toxin is a potent antigen, the resultant immune 
response being directed entirely against the B subunit ( Holmgren 
et al. 1981; Peterson et aT, 1979 ). All neutralizing activity of 
cholera antitoxin can be absorbed with a purified B subunit.
More than 90% of North American volunteers who ingested 
V. cholerae while serving as controls in challenge studies to 
assess vaccine efficiency developed rises in serum antitoxin 
which was measurable in either toxin-neutralizing assays or as 
IgG on ELISA ( Robins-Browne et ^,1980 ). Serum IgG antitoxin is 
long lived, elevated levels being demonstratable in most North
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Americans at least two years after experimental cholera infection 
( Levine et 1977 ).
Approximately 60% of volunteers who participated in 
experimental cholera studies manifested increased levels of SIgA 
antitoxin in intestinal fluid measured before and 9 days after 
challenge ( Levine et 1981 ). The local antitoxin response
tends to be relatively short-lived, with antibody levels usually 
dropping by one month post challenge. Levine ^  ( 1979 )
demonstrated that purified cholera toxoid is antigenic in man 
when given enterally or orally, but fails to provide protection 
against experimental challenge.
1.8 Local immune defences
Since cholera is entirely a topical Infection it would seem 
most likely that topical defences would be the main determinant 
of protection against infection by cholerae. Recurrent 
infections are rare in cholera and the incidence of disease 
decreases rapidly with age ( Gangarosa and Mosely, 1975 ). Thus 
an effective immunity does seem to occur in cholera. This has 
been further documented by volunteer studies in which subjects 
who had previously been challenged with cholerae and had 
contracted the classical illness were rechallenged after a period 
of 3-6 months. Such people proved highly resistant to rechallenge 
despite rather low circulating antibody titres ( Cash e^ al, 
1974 ). Early work recognising local antibody in contrast to 
serum antibody as a potentially important protective defence 
against experimental cholera has been reviewed ( Pollitzer,
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1959 ). From this awareness has evolved a more detailed knowledge 
of how local immune mechanisms in the intestine function. 
Antigens are detected by Peyer's patch lymphocytes. These 
immature cells then migrate through the lymphatics to the 
circulation and are 'processed' at a site that has not been fully 
clarified as yet. The 'processed' lymphocytes then return to the 
gut, and perhaps to other tissues and tend to locate themselves 
in areas where antigen is present. Their product once back in the 
gut mucosa is secretory IgA. Studies using cholera toxin as a 
probe have led to a description of this immunocyte traffic as it 
pertains to cholera ( Pierce and Cowans, 1975 ).
The question of how local secretion of IgA or the 
presence by exudation from the serum of IgG or IgM can mediate 
destruction of vibrios in an environment where complement does 
not function has challenged the ingenuity of investigators. There 
is no such problem with respect to how antitoxic antibodies may 
work. If there is a layer of antibodies adjacent to the 
epithelium that will bind and deactivate toxin before it attaches 
to the cells, this will prevent all the disease manifestations. 
Thus in the surface of the intestine such antibodies may play an 
important role in defence against clinical illness if not against 
the infection itself. It is possible that failure by the upper 
intestine to secrete fluid in response to toxin limits the growth 
medium available for the multiplication of cholerae and so in 
fact antitoxin antibodies may at least limit the numbers of 
vibrios in an important way ( Levine et 1979 ). Several
mechanisms by which the growth of ^  cholerae can be inhibited
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are likely to operate within the host. The process by which the 
vibrios attach themselves to the gut epithelium is highly 
specific ( Jones and Freter, 1976 ) and antibodies against whole 
vibrios interfere with this process. Motility is important in the 
pathogenesis and antibodies against whole vibrios or specific 
0-antigen will cause clumping and arrested motion. It is unlikely 
that phagocytosis or vibriolysis is important in the gut.
1.9 Vaccines against cholera
The various forms of vaccines that have been tested against 
cholera were reviewed by Levine et al, ( 1983 ) and their 
relative efficiency is discussed below.
1.9.1 Toxoid vaccines
These are immunising agents intended to prevent cholera by 
means of stimulating antitoxic immunity. Various forms of the 
vaccine have been tried. They are, formaldehyde treated cholera 
toxin, glutaraldehyde treated cholera toxin, the purified B 
subunit and the procholeragenoid.
Toxoid vaccines stimulate purely antitoxic immunity and 
have not been shown to be efficacious in protecting humans 
against cholera ( Levine et 1979 ), although they may protect
animal models ( Pujita and Finkelstein, 1972; Holmgren and 
Svennerholm, 1977; Pierce e^ al, 1983 ).
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1.9.2 Killed whole cell vaccines
1.9.2.1 Parenteral whole-cell vaccines
In field trials, parenteral killed whole-cell vaccines 
have been shown to confer significant protection against the 
homologous 2^ cholerae serotype, usually for a period of less 
than one year. There is some evidence to suggest that parenteral 
whole—cell Inaba vaccine provides good short-term protection 
against Ogawa as well as Inaba cholera ( Mosley et 1973 )
where as Ogawa vaccine is effective only against Ogawa 
( Phillipines Cholera Committee, 1973 ). The whole cell vaccine 
probably fails because it lacks any toxin-derived antigen and 
because the injection route may be relatively inefficient in 
stimulating local immunity in the gut mucosa ( Pierce, 1978 ).
1.9.2.2 Oral whole cell vaccines
Killed vibrios have also been used as oral vaccines and 
have been shown to stimulate the appearance of local intestinal 
antivibrio antibody ( Freter and Gangarosa, 1963; Ganguly e^ al. 
1975 ), for a short period of time.
1.9.3 Combination vaccines
Combinations of antigens such as toxin plus LPS that 
stimulate both antitoxic and antibacterial immunity give 
synergistic protection over that provided by each antigen alone 
( Holmgren and Svennerholm, 1977). However, the protective 
vaccine has only moderate efficacy, 27-67% and multiple doses
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are required to Induce the protection.
1.9.4 Attenuated V. cholerae vaccines
The observation that both classical and El Tor clinical 
cholera infections in North American volunteers stimulated a high 
degree of protective immunity for at least 3 years ( Cash et al, 
1974; Levine et al, 1981) intensified research on the development 
of new cholera vaccines. As a result of these observations, the 
most promising approach would seem to be toward immunological 
control of cholera by means of attenuated non-enterotoxigenic 
V. cholerae strains used as oral vaccines.
1.9.4.1 Chemically mutagenised attenuated strains
Honda and Finkelstein ( 1979 ) mutagenised El Tor Ogawa 
3083 with nitrosguanidine and produced Texas Star-SR strain. This 
strain produces normal or increased amounts of B subunit but is 
negative in assays for holotoxin activity or A subunit activity. 
Texas Star-SR strain has been evaluated as a live oral vaccine in 
humans ( Levine et 1984 ). The clinical studies demonstrated
that mild diarrhoea occurred in one-fourth of the recipients of 
Texas Star-SR, although it does not elaborate holotoxin. The 
strain was able to colonise the duodenum and stimulate local and 
circulating antibody responses. Finally, one or two doses of 
vaccine provided a moderate degree of protection ( 61% vaccine 
efficiency ) against experimental challenge with high inocula of 
V. cholerae El Tor of either serotype which caused cholera in 
70-80% of control volunteers. However, the Texas Star strain
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itself suffers from certain drawbacks. Firstly, the method of 
attenuation, mutagenesis with nitrosguanidine, induces multiple 
mutations, not all of which are recognised. Secondly, the precise 
lesion presumed to be responsible for the attenuation of Texas 
Star is not known and consequently, until this is clarified there 
always remains the theoretical possibility of reversion to 
virulence.
1.9.4.2 Genetically engineered mutants
Recombinant DMA techniques have recently been applied to 
develop attenuated cholerae oral vaccine with none of the 
above mentioned ( Section 1.9.4.1 ) drawbacks ( Kaper and Levine, 
1981; Mekalanos et ^,1983; Kaper et 1983 ). Precise
deletions of the genes encoding the cholera toxin or the A 
subunit have been achieved in strains whose pathogenicity and 
ability to confer protection were demonstrated in volunteer 
studies. These recombinant DNA techniques can predictably and 
repeatedly yield non-enterotoxigenic variants for use as 
potential live oral vaccines. Field studies have to be conducted 
to evaluate the safety and efficacy of vaccine candidates 
produced by this method.
1.10 The antigenic structure of V. cholerae
Gardner and Venkatraman ( 1935 ) subdivided vibrios into 
six groups, each with a different 0 antigen. The 01 antigen, the 
specific antigen of the cholera vibrio is not shared by any other 
serotypes. All the serotypes of cholerae share a heat labile
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flagellar H antigen. An H antiserum can agglutinate all motile 
strains of the cholera group. It is possible that more than one H 
antigen exists although, the major H antigen is common to all 
members of the cholera group of vibrios.
The O antigen is a heat stable antigen. Kauffmann 
( 1930 ) examined the classification on the basis of agglutinaton 
and agglutinin absorption tests and concluded that the cholera 
vibrios of Gardner and Venkatraman 0 group 1 are Inaba and Ogawa. 
Inaba vibrios are with antigens A and C and Ogawa or 
Ogawa-Hikojlma with antigens A, B and ( C ). Formerly, Ogawa 
strains had been regarded as having A and B antigens and Hikojima
strains as having A, B and C antigens but Kauffmann observed that
Ogawa strains grown at 20^C, could totally absorb anti-Inaba 
sera, as could Hikojima strains and the difference between Ogawa 
and Hikojima forms appeared to be largely of a phenotypic and 
quantitative nature. In practice he noticed that the antigens of 
Inaba could be reduced to A and for Ogawa to B. Sakazaki and 
Tamura ( 1971 ) confirmed and extended these findings and 
concluded that the differences between the Ogawa and Hikojima 
forms were largely quatitative and dependent on the proportion of 
B and C antigens present in addition to the common A antigen.
They also suggested that the Inaba form was derived from Ogawa by
the loss of somatic antigen B. Inaba, Hikojima and rough variants 
were readily recovered from Ogawa strains. El Tor serotypes 
Inaba, Ogawa and Hikojima are serologically identical to the 
respective serotypes of classical biotype.
Serotypic conversions also occur in nature. It has
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frequently been observed that the heterologous serotype may be 
isolated, usually late, in the course of an outbreak originally 
caused by the other serotype ( Finkelstein,1973 ). Samadi et al, 
( 1983 ) have suggested that there may be more crucial biological 
characteristics other than the taxonomic traits used to identify 
the classical and El Tor strains, which gives new strains an 
advantage over the existing ones.
The current classification of such vibrios is therefore that 
the Ogawa serotype has antigens A and B and the Inaba has 
antigens A and C with Hikojima, should it exist having all three.
1.11 Reference sera for identification of V. cholerae serotypes
Sera raised against cholerae 01 represents the group 
serum and by the use of absorbed sera, the cholera vibrios are 
divided into serotypes. By absorption of 01 antiserum with Ogawa 
organisms a serum is prepared that agglutinates Inaba but not 
Ogawa. Similarly if the 01 antiserum is absorbed with Inaba 
organisms, the serum agglutinates Ogawa organisms but not Inaba. 
The recognition of these serotypes depends on the quality of the 
sera and the completeness of the absorption.
1.12 The chemical nature of somatic antigens
Watanabe and Verwey ( 1965 ) and Watanabe £t ( 1965 )
reported the isolation of a biochemically and immunologically 
homogenous, large ( lOOS ) LPS antigen, from culture supernatants 
of an Ogawa serotype El Tor vibrio, and shown this to be highly
21
protective in mice against intraperitoneal challenge with live 
vibrios suspended in mucin. Antisera produced against the antigen 
were mouse protective, vibriocidal and precipitating but had 
little agglutinating activity although the antigen absorbed all 
these activities from sera prepared with whole bacterial cells. 
There was essentially no cross-reaction or cross-reactivity with 
Inaba vibrios or antigens. The antigen was low in nitrogen 
content and was approximately 60% carbohydrate. The antigen was 
isolated by ammonium sulphate precipitation followed by 
deproteinisation by phenol extraction, lipid removal with 
chloroform-methanol and controlled cold ethanol fractionation.
A mouse protective antigen was also isolated from an Inaba 
serotype by the same group ( Verwey et a^, 1965 ). The Inaba LPS 
exhibited full activity in mouse protection tests and the heated 
antigen was fully capable of inhibiting vibriocidal antibody in 
the vibriocidal antibody inhibition test. In contrast to the 
Ogawa LPS, the Inaba antigen protected against both challenges, 
Inaba and Ogawa equally well.
Kaur and Shrivastava ( 1965 ) have also reported on LPS 
protective antigens from both Inaba and Ogawa serotype vibrios 
which elicited high titres of vibriocidal antibodies.
Such studies indicate that LPS is at least one of the 
protective antigens and that the Ogawa serotype appears to have a 
protective component, not shared with the Inaba.
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1.13 The structure of V.cholerae LPS
Jackson and Redmond ( 1971 ) performed immunochemical 
studies on the LPS from strain Inaba 569B. The major components 
they identified in the LPS were heptose, glucose, glucosamine, 
mannose and glycerol. Lipid A accounted for 30% of the weight of 
LPS. The authors were unable to account for 30% of the weight of 
the LPS. Galactose and 2-keto-3-deoxyoctonate ( KDO ) which 
typically links lipid A and the polysaccharide moieties were not 
detectable and it was suggested that the structure of the "core” 
LPS of cholerae may be fundamentally different from that of 
the Salmonella species.
Jann et al, ( 1973 ) also reported the absence of KDO in 
V. cholerae LPS and extended their study to confirm that KDO is 
not present in any of the cholerae strains they tested namely, 
S-forms of Inaba and Ogawa, El Tor and Hikojima, R-forms of Inaba 
and Ogawa. However, they detected fructose in all these LPS 
molecules and suggested that KDO may be replaced by fructose. 
They were also successful in isolating 2-amino-2-6-dideoxyglucose 
( quinovosamine ). The role of this amino sugar in the 
serological specificity was not defined.
Redmond ( 1975 ) detected an oligosaccharide in addition
to monosaccharides in the hydrolysed product of Inaba 569B LPS.
This oligosaccharide required harsher conditions of hydrolysis to
yield monosaccharides and was identified as
134-amino-4,6-dideoxy-D-mannose ( perosamine ) by C NMR studies. 
The perosaminyl oligomer was thought to represent the main sugar
23
component of cholerae LPS. On further anlaysis of vibrio LPS 
the presence of another highly unstable sugar,
4-amino-4-deoxy-L-arabinose was detected ( Redmond, 1978 ). The 
sugar was present only in Ogawa LPS and not in Inaba LPS.
Raziuddln and Kawasaki ( 1976 ) analysed LPS extracted 
from cell walls of Inaba 569B and El Tor Inaba. They found that 
among the characteristic components of gram-negative bacterial 
LPS, heptose phosphate was present but galactose and KDO were not 
detected. On the other hand, fructose was present.
1.13.1 The lipid A component of V.cholerae LPS
In enterobacterial LPS, glucosamine represents the 
backbone of lipid A, carrying the long chain hydroxy acids in 
ester or amide linkages ( Hammond et a^, 1984 ). The nature and 
distribution of fatty acids in the LPS of cholerae Inaba 569B 
and El Tor Inaba were of an identical pattern ( Raziuddin and 
Kawasaki, 1976 ). The most abundant fatty acid detected in the 
lipid A moiety was 3-hydroxy lauric acid. Further 
characterisation of the lipid A by Raziuddin ( 1977 ) indicated 
that approximately equal amounts of fatty acids and
3-hydroxy lauric acid were involved in ester linkages, but
3-hydroxy myristic acid was the only amide-linked fatty acid.
1.13.1.1 The toxic and immunological properties of
V. cholerae lipid A
The LPS and lipid A moieties prepared from cholerae 
El Tor exhibited almost equal endotoxic and anti-complementary
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activities ( Raziuddin, 1978 ). It was demonstrated that the 
lipid A representated the toxic centre of cholerae LPS as had 
been observed with other gram-negative bacterial LPS molecules 
( Peavy et aj^ , 1973; Rietschel et^  a^, 1975; Mansheim et al,
1978 ). The toxicity of lipid A from cholerae El Tor 
decreased following alkaline digestion which primarily hydrolyses 
the ester linked fatty acids of the lipid A portion of LPS. These 
results indicated that ester-linked fatty acids play a crucial 
role in toxicity. Luderitz et ( 1973 ) suggested that the
presence or absence of acylated hydroxy fatty acid esters may 
determine the endotoxicity of the LPS.
1.13.2 The polysaccharide portion of V. cholerae LPS
On mild hydrolysis of cholerae LPS Raziuddin and 
Kawasaki ( 1976 ) obtained a water soluble fraction of 
polysaccharides and a chloroform soluble fraction of lipid A. 
Raziuddin ( 1980 ) characterised the water soluble 
polysaccharides by fractionating them on a column of Sephadex 
G-50. The eluates were monitored for phosphorus and carbohydrate. 
Two main peaks differing in molecular size were obtained from all 
different strains of cholerae LPS tested. When each of these
peaks were rerun separately on the same column, both were 
observed to move in their original positions. Detailed analysis 
of the two peaks showed that high molecular weight fractions did 
not contain phosphorus and heptose whereas phosphorus and heptose 
were detected in the low molecular weight fractions. On the basis 
of haemagglutination assays the high molecular weight
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heptose-free fractions were identified as 0-specific side chain 
and low molecular weight heptose-containing fractions as core 
polysaccharide regions of the LPS. Glucose, heptose, fructose, 
phosphate and ethanolamine—phosphate were found to be 
concentrated in core polysaccharide, whereas mannose, rhamnose, 
glucosamine, D-quinovosamine and D-perosamine were concentrated 
in 0-specific side chains.
Hisatsune and Kondo ( 1980 ) compared the chemical and 
serological properties of LPS isolated from the smooth (S) and 
rough (R) forms of cholera vibrios. They observed that the S to R 
mutation of cholera vibrios involved the total elimination of two 
component amino sugars of S-form LPS, i.e. quinovosamine and 
perosamine. This elimination resulted in the loss of 
0-specificity of S-form LPS and concomitant appearance of 
serological cross-reactivity, in the passive-haemagglutination 
inhibition test, among R-form LPS molecules regardless of the 
serotypes, Inaba or Ogawa, of their S parents.
Kabir ( 1982 ) analysed V_^  cholerae 395 Ogawa LPS after 
splitting it into polysaccharide and lipid A moieties and 
detected glucose, heptose, fructose, glucosamine and 
quinovosamine in the polysaccharide portion. The presence of
4-amino-arabinose in only Ogawa LPS was confirmed by his 
findings. From gas-liquid chromatography and mass spectrometry on 
methylated polysaccharide the author was able to detect a 
branched structure with glucose and heptose residues primarily 
appearing at the nonreducing-end groups.
Sen et ( 1979 ), using méthylation studies, obtained
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results which indicated that the nonreducing ends of LPS 
extracted from Inaba 569B were occupied by glucopyranosyl and 
heptopyranosyl residues. They also observed the presence of two 
types of heptose residues, of which a large amount behaving like 
D-glycero-L-manno-heptose is located at the nonreducing end of 
the molecule. One or both heptose residues were thought to be 
located in the interior of the molecule. One of them had ( l->2 ) 
linkages and the other was branched. The 2-amino-2-deoxyglucose 
residue detected was also suggested to be present in the interior 
part of LPS as ( l->4 ) linked residues.
Sen et ( 1980 ) identified the two heptoses described
above with D-glycero-L-manno-heptose being the major one and 
D-glycero-L-gluco—heptose the other. The heptoses were assigned p 
anomerlc configurations from oxidation studies, though the 
presence of the »<-anomeric configuration of sugar residues was 
also indicated by the low specific rotation of LPS.
Majumdar et^  al, ( 1982 ) obtained a single precipitin line 
in the Ouchterlony double diffusion test with LPS from Ogawa 
G-2102 and rabbit antisera raised against whole organisms, 
indicating the LPS to be homogenous. The polysaccharide moiety 
obtained on acid hydrolysis of LPS was resolved into antigenic 
and core polysaccharides. Only the antigenic polysaccharide gave 
a single precipitin line in the ouchterlony gel-diffusion tests. 
These results corroborated the observations of Raziuddin ( 1978 ) 
and established the presence of both a core region and an 0-side 
chain which was responsible for the serologic specificity of 
V. cholerae LPS.
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The oligosaccharide obtained by Redmond ( 1978 ) from
13hydrolysis of Inaba 569B LPS was analysed by C NMR and chemical 
methods ( Redmond, 1979 ). It was found out to be a regular 
repeating structure of »<-(1^2> linked chain of D-perosamine 
units, with amino groups acylated with 3-hydroxypropionyl groups. 
Gel chromatography of the polymer suggested a molecular weight of
10,000 which according to the author was equivalent to an 
unbranched chain of about 60 perosamine residues. Trace amounts 
of other sugars in the polysaccharide were detected by NMR and 
these were were presumed to be present at the reducing terminal 
of the polymer.
Kenne et ( 1982 ) hydrolysed V_^ cholerae LPS into lipid
A and polysaccharide portions. The polysaccharide was further
separated into two fractions of 9000 ( major ) and 900
( minor ) by gel filtration. The main component of the
polysaccharide was identified as the unusually acid resistant
13 1oligosaccharide and its structure was elucidated by C and H 
NMR spectra as a homopolysaccharide composed of (l-»2)-linked
4-amlno-4,6-dideo%y^K-D-mannopyranosyl ( perosaminyl ) residues, 
the amino groups of which are acylated by 
3-deoxy-L-glycero-tetronic acid. The assignment of propionyl 
residues to the acyl groups by Redmond ( 1979 ) was not thought 
to be correct.
Kenne et ( 1982 ) found that 60% of saponified LPS and
70% of the polysaccharide consisted of the homopolysaccharide and 
hence they suggested that the main part of the 0-antigen of 
V. cholerae LPS is composed of simple repeating-units
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(perosaminyl) as observed for other gram-negative bacteria. 
According to the authors the N-acetylated perosaminyl polymer 
most probably represents the LPS antigenic determinant. A, common 
to Inaba and Ogawa and this was consistent with their results on 
haemagglutination-inhibition. No 0-antigen was present in the 
900 fraction. In conclusion the authors noted that the part 
connecting lipid A with the 0-antigen differed considerably from 
the cores observed in other gram-negative bacterial LPS 
molecules.
Brade ( 1985 ) reinvestigated the presence of KDO in both 
Ogawa and Inaba serotypes of cholerae because LPS from each 
serotype was found to be an active inhibitor of the serologic 
test system specific for the common LPS which consisted of KDO 
and at least one neutral sugar. KDO in V_^  cholerae LPS was 
identified by gas-liquid chromatography and mass spectrometry. 
From this recent study it was shown that KDO phosphate is a 
constituent of the LPS of ^  cholerae Ogawa and Inaba. This 
compound is liberated under harsh hydrolytic conditions and can 
be dephosphorylated subsequently by the action of alkaline 
phosphatase. The results indicated that at least two different 
KDO phosphates are present in the hydrolysate. One of them was 
identified as KDO-5-phosphate, the other as 7- or 8- phosphate. 
Whether the latter compound represents a constituent of LPS 
remains to be established. Thus the lack of KDO was shown not to 
be a taxonomical criterion for the members of Vibrionaceae.
It is clear from the data reviewed above that the structure 
of cholerae LPS is not yet fully understood and many features
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remain unresolved.
1.14 Antigenicity of core LPS
Anti-core antibodies have gained importance because of 
their potential to react with a broad spectrum of gram-negative 
bacteria, thus offering wide ranging protection for 
immunosuppressed patients ( Marks et 1982; Teng et 1985;
McCabe et 1977 ). Several research groups have now produced
MCAbs against some components of core LPS ( Nelles and 
Niswander, 1984; Mutharia et 1984; Lind et 1985 ). A new
type of common antigen located in the inner core region of LPS 
has been detected in a variety of gram-negative bacteria ( Brade 
and Galanos, 1983a ). Immunochemical investigations have shown 
the new antigen to be an *<-2-)4 interlinked
3-deoxy-D-manno-octulosonic acid ( dOclA ) disaccharide ( Brade 
and Galanos, 1983b; Brade and Rietschel, 1984 ), which has also 
been detected in the Ogawa and Inaba serotypes ( Section
1.13.2 ). Previous studies have indicated that production of 
antibodies against lipid A required immunisation of animals with 
bacteria coated with acid hydrolysed lipid A ( Bruins et al, 
1977; Galanos et 1971; Johns et 1977 ). However,
anti-lipid A MCAbs have been raised by Mutharia et ( 1984 )
by using whole heat-killed E_^  coli J5 cells for priming mice 
before removal of their spleens for fusion.
Gustafsson et al ( 1982 ) have produced a MCAb directed 
against the core region of cholerae LPS. These antibodies were 
inhibited by LPS preparations of both serotypes of 01 group of
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vibrios and some non—01 group of vibrios as detected on ELISA. 
Unrelated bacterial LPS molecules were unable to inhibit the 
MCAb. This according to the authors indicated that the MCAb was 
directed against an antigen present only in cholerae.
1.15 Bacteriocidal activity and LPS
Resistance to complement killing is an attribute of many 
gram-negative bacteria. The presence of the smooth phenotype, 
that is, LPS molecules containing long polysaccharide side chains 
( 0-antigen ), is the characteristic of the gram-negative cell 
envelope correlated with serum resistance. This conclusion has 
been based upon studies comparing rough isogenic mutants with 
smooth parental strains of coli and Salmonella species 
( Muschel and Larsen, 1970; Nelson and Roantree, 1967; Rowley,
1968 ). Cells lacking the 0-antigen are generally killed directly 
by complement in the absence of specific antibodies but become 
resistant to serum when 0-antigen is synthesised ( Dlabac,
1969 ). Studies conducted by Sansano et a^, ( 1985 ) with ^  coli 
suggest that the increased resistance to the lethal action of 
normal human serum shown by the smooth phenocopy may be due to 
the blocking of antibody binding sites by the 0-antigen of LPS, 
thereby preventing activation of the classical pathway of 
complement.
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1.16 Polyclonal effects of bacterial LPS on B-cells
It has been suggested that LPS treatment of B-cells might 
replace or mimick the enhancer in activating certain regions of 
immunoglobulin gene transcription ( Alt et^  ®i> 1982 ). LPS has 
also been thought to induce the synthesis of an enhancer binding 
protein required for the activation of kappa transcription 
( Nelson e^ 1984 ). A variety of studies have pointed to 
post-transcriptional effects of LPS treatment on immunoglobulin 
gene expression ( Yuan and Tucker, 1982; Mains and Sibbley, 1982; 
Yuan, 1984 ).
LPS molecules containing linear homopolysaccharides 
consisting of mannose as the 0-specific polysaccharide chains 
have been reported to have exceptionally strong adjuvant activity 
( Kido aJL, 1985; Kato e_t a^, 1985 ). The 0-specific chain of 
V. cholerae. B. abortus and ^  enterocolitica are also 
homopolysaccharides but of mannopyranosyl derivatives ( Section 
1.18 ). The adjuvant properties of such homopolymers have not 
been studied in isolation but are of interest in the context of 
this work.
1.17 Protein antigens of V. cholerae
Neoh and Rowley ( 1970 ), from their studies of antisera 
absorbed by LPS and outer membrane preparation, provided evidence 
that polysaccharide determinants may not be entirely responsible 
for the observed vibriocidal activity of antisera produced 
against V. cholerae. Kabir ( 1980 ) used several strains of both
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serotypes, Ogawa and Inaba and Kelly and Parker ( 1981 ) studied 
a wild—type strain, CA401 and each Isolated and characterised 
outer membrane preparations. Although they worked with different 
strains, each group consistently observed a major protein of
45,000 to 48,000. Manning et ( 1982 ) have analysed the
extent of variability of the major proteins in cholerae and 
showed considerable variation in the proteins by using a variety 
of detergents to solubilise the them, with the exception of a 
protein of 25K. Manning and Haynes ( 1984 ) identified a 
M^ 25K protein in the outer membrane of vibrio strains which was 
not present in a number of other organisms. The protein was shown 
to be very immunogenic. Stevenson et ( 1985 ) have purified
the 25K outer membrane protein of V^_ cholerae and cloned its 
structural gene with a view to generating a protein vaccine.
1.18 Cross-reactions of V. cholerae with bacteria of other 
genera
Many investigators have observed serologic cross-reactions 
between Brucella and cholerae ( Mathur, 1960; Eisele e^ al. 
1948 ). Eisele et al, ( 1946 ) and McCullough et ( 1948 )
attributed the cross-reaction to a flagellar H antigen of
V. cholera that is related to a somatic antigen in the three
species of Brucella. Gallut ( 1953 ) ascribed the cross-reaction 
to heat-stable somatic 0 rather than H antigens of 2t cholerae. 
Feeley ( 1969 ) examined the antigenic relationship between
Brucella species and V^ _ cholerae by agglutinin and 
agglutinin—absorption tests by using rabbit antisera. He observed
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that Brucella antisera agglutinated only the Inaba serotype of 
V. cholerae at low titres. The Inaba reactive antibody was 
absorbed by either heat-stable Ogawa or Inaba 0-antigens. Cholera 
antisera from rabbits immunised with either 0 or HO antigens of 
either Ogawa or Inaba contained Brucella agglutinins. This
I  activity! was absorbed completely from Ogawa antiserum by either 
Ogawa or Inaba 0 antigens but only partially from Inaba antisera 
by Ogawa 0 antigen. Thus the author concluded that the 
cross-reactive antigen is a heat-stable 0 antigen and is more 
dominant in the Inaba than in the Ogawa serotype of cholerae.
Barua and Watanabe ( 1972 ) described the production of 
vibriocidal antibody against cholerae. particularly the Inaba 
serotype, in ^  enterocolitica immunised rabbits or infected men. 
Y. enterocolitica serotype 0:9 has been regarded as strongly 
cross-reacting with Brucella species ( Ahvonen and Sievers, 
1969 ).
The serological cross-reactivity between ^  enterocolitica 
serotype 0:9 and the LPS of cholerae and Brucella species have 
now been related to the presence of N-acylated
4-amino-4,6—dideoxy-*4-D-mannopyranosyl residues in their
respective 0-antigenic chains ( Caroff et al, 1984a; Caroff 
et al, 1984b ). Bundle et al, ( 1984 ) confirmed the serological 
cross-reactions between ^  abortus and ^  enterocolitica with 
MCAbs. Since cholerae 01 shares a very similar O—chain 
structure with ^  abortus and enterocolitica 0:9 differing 
only in N-acyl grouping the anti-Y. enterocolitica and 
anti-B. abortus MCAbs were tested with Ogawa and Inaba LPS on
34
ELISA by the authors. Ascitic fluid derived from the MCAbs failed 
to reveal significant binding at dilutions of 1 in 100, whereas 
the binding to ^  abortus and ^  enterocolitica was to the order 
of 1 in 10,000. This contrasted with previous observations with 
polyclonal antisera ( Barua and Watanabe, 1972; Sandulche and 
Marx, 1978 ). The authors therefore concluded that although some 
vestige of recognition existed for the polysaccharide, the nature 
of the N—acyl group on the backbone sugar was crucial to the 
binding of these MCAbs.
1.19 Introduction to hybridoma technology
The theory of monoclonal antibody ( MCAb ) production is 
based on the clonal selection hypothesis of Macfarlane Burnet 
( Burnet, 1959 ). Each mammalian B lymphocyte has the potential 
to make a monospecific antibody. The constant region of the 
antibody chain may alter during the differentiation of the
lymphocyte clone but the variable region retains the singular 
specificity.
The first report of hybridoma production was in 1970 
( Sinkovirs et 1970 ) with virus specific lymphocytes
together with tumour cells and subsequently interspecies 
( Schwaber and Cohen, 1973 ) and human ( Bloom and Nakamura, 
1974 ) hybridoma products were reported before MCAb technology 
was established by Kohler and Milstein in 1975. Since then MCAb
production has grown exponentially to be utilised in a number of
different ways.
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The experimental problem encountered in monospecific 
antibody production relates to the fact that plasma cells which 
secrete antibody are terminally differentiated lymphocytes with a 
finite life span and cannot be normally grown in culture. 
However, tumours of such cells can be found in most animals and, 
in particular, can be readily induced in mice with the aid of 
mineral oils. The tumour cells secrete an antibody of single and 
unknown specificity but can be grown indefinitely in culture. If 
such tumour cells can be fused with a lymphocyte which makes 
antibody of the required specifity, the progeny may have the 
eternal growth capacity of one parent together with the specifity 
of the other ( Kohler and Milstein, 1975, 1976 ). The technique, 
however, involves the selection of a mutant strain of the tumour 
parent line which does not itself secrete antibody so that the 
production capacity of the progeny is directed to the specific 
antibody. A second and most important criterion is to select a 
tumour cell line as a fusion partner which is in some way 
vulnerable to the cell culture conditions so that it cannot 
survive unless it has participated in a fusion. The commonest way 
of achieving this is to use a parent tumour line which lacks 
either the enzyme thymidine kinase or hypoxanthine phosphoribosyl 
transferase ( HPRT ). These are enzymes of the salvage pathway of 
nucleic acid metabolism and are essential to cells growing in the 
presence of aminopterin which blocks the main pathways of 
nucleotide synthesis. After the fusion the cells are therefore 
usually grown on medium containing Hypoxanthine, Aminopterine and 
Thymidine ( HAT ) ( Littlefield, 1964 ) in which any parent
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tumour cells which have not participated in a fusion will die.
1.20 Comparison of MCAbs and conventional antiserum
The antigenic determinant is a particular site on an 
antigen responible for binding the antibody. This involves a few 
residues of amino acids and or sugars and in particular the 
specific conformation of the binding region. ( Amit ^  al, 
1985 ). Coventional polyclonal sera raised against an antigen 
have not only antibodies to several determinants on the antigen 
but also a family of antibodies of different structure and 
avidity which compete for each individual determinant. 
Consequently, extensive cross-reaction may occur between the 
antibodies and two antigens which have similar determinants 
( Campbell, 1984 ). This makes it difficult to analyse two 
different antigens sharing common determinants with polyclonal 
serum. On the other hand, identification of similar and 
dissimilar determinants on two antigens can be readily achieved 
by the use of MCAbs which can be selected for their ability to 
bind to a unique determinant or one shared by the required 
antigens. The fine specifity of a MCAb can be used in a variety 
of ways, like detecting small differences between two strains of 
bacteria and utilising these differences in specificities for 
diagnostic or preparative purposes.
Talmage (1959) pointed out that if it were possible for an 
antibody to bind two or more different antigens, then the great 
specificity of polyclonal sera could in effect be statistical. 
Thus one antibody could have the ability to react with eptopes A,
37
B and C, another with A,D and E and another with A,F and G, the 
specificity of the antiserum would then be observed as against A 
only since the varying cross reactions of the component 
antibodies would only give a minor background. However, a 
monoclonal antibody with cross reactive potential might show 
significant interactions with possibly unrelated antigens. Thus 
every cross-reaction observed with a MCAb must be analysed with 
care.
To achieve monospecifity of conventional antiserum, 
absorption by cross-reacting antigen is necessary. This procedure 
reduces the titre of the antiserum by removing all antibodies 
directed towards the target antigen but which also happen to 
cross-react with the absorbing antigen, as is the case with 
serologically related bacteria. Again, a hybridoma cell line can 
be selected for producing high affinity antibodies which exhibit 
significantly higher titres than polyclonal antiserum. Absorption 
procedures of antisera may vary from laboratory to laboratory, 
and are further complicated by the variability of each bleed from 
immunised animals. These factors make polyclonal antiserum 
unsuitable for the detection of specific cell surface molecules. 
Monoclonal antibodies do not have any of these drawbacks since 
they can be cultured when and where required and each time they 
will produce well characterised antibodies.
1.21 Monoclonal antibodies to bacteria
MCAbs have been used for studying bacterial antigens by 
various groups ( Nelles ^t 1984; Mutharia ^t ajL, 1984, Bundle
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et al, 1984; Gustafsson et al, 1983; Lind et 1985 ; Quinn
et 1984). They have largely been employed as superior
reagents for typing different strains of bacteria or for antigen 
identification and the information obtained has emphasised the 
considerable potential of MCAbs as general bacteriologicical 
reagents. Such antibodies have long term potential if it is 
possible to use them to develop good anti-idiotype vaccines 
( McNamara e^ 1984 ).
1.22 The objectives of this study
V. cholera, the etiological agent of cholera harbours a 
complex cell-surface LPS which determines its serological 
identity. Chemical analyses of the LPS have shed some light on 
the possible structures of the LPS antigens of these vibrios 
( Section 1.12 ), but the type-specific antigens remain poorly 
understood and the serological cross reactions among cholerae 
and other gram-negative bacteria ( Section 1.18 ) are difficult 
to explain.
The presence and absence of cross-reactions between two 
strains of bacteria may mean much more than just the sharing of 
chemical groups responsible for serological activity. The 
accessibility and geometry of the residues on the bacterial 
surface are also important and these can only be analysed by the 
use of antibodies, and preferably monoclonal ones.
The study was undertaken in order to try to better define 
at least some of the major cell surface antigens of ^  cholerae 
by means of hybridoma technology.
MATERIALS AND METHODS
2.1 Materials
The materials used during the course of this study are 
listed below with the names and addresses of their suppliers.
2.1.1 Cell Culture materials
RPMI-1640 and Aminopterine were supplied by Flow
Laboratories, Irvine, Scotland.
Foetal calf serum and Fungizone were obtained from Gibco 
Ltd., Falsely, U.K.
Penicillin and Streptomycin were obtained from Glaxo 
Pharmaceutical, London.
Hypothanthine was obtained from Sigma Chemical Co., Dorset,
U.K.
Thymidine was obtained from Boehringer-Mannheim, Sussex,
U.K.
2.1.2 Disposable Plasticware
Tissue Culture Flasks were supplied by Nunc, Trident House, 
Paisley, U.K.
Tissue Culture Plates were supplied by Costar Northumbria 
Biologicals Ltd., Northumbria, U.K.
MicroELISA plates were supplied by Dynatech Laboratories Ltd., 
Sussex, U.K. Sterile universals were obtained from Sterilln Ltd., 
Peltham, England, U.K.
2.1.3 Cell lines
Rat myeloma lines Y3.Ag.1.2.3 and YB2/0 were obtained from 
C.Milstein, MRC, Cambridge, U.K.
2.1.4 Vibrios
V. cholerae serotype Ogawa ( NIH 41 ) and Inaba( 35 A3 ) 
were obtained from The David Bruce Laboratories, Wiltshire, U.K.
2.1.5 'Animals
DA rats were obtained from OLAC (1976) Ltd., Blackthorn, 
Bicester, U.K. The rats were propagated by sibling mating and 
entered the study at 3-5 weeks of age.
Lou rats were obtained as a gift from Pathology Veterinary 
School, Glasgow University.
Lou X  DA FI hybrids were propagated in the animal house of 
Glasgow University.
2.1.6 Chemicals
Freund's complete adjuvant (H37 Ra) was obtained from DIFCO 
Laboratories Surrey, U.K. 2,6,10,14-Tetramethyl pentadecane 
( Pristane ) was obtained from Aldrich Chemical Co.Ltd.,
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Gillingham, Dorset, U.K. Hypoxanthine, 4-chloronaphthol, Periodic 
acid, Concanavalin A, Wheat germ agglutinin. Staphylococcus 
protein A ( Cowan strain >, Agarose, Polyoxyethylene sorbitan 
monolaurate( Tween 20 ), Phenylmethyl sulphonyl fluoride 
( PMSF ), Tris ( hydroxymethyl ) aminomethane ( Trizma Base ), 
Sodium azide and Dimethyl Sulphoxide ( DMSO } were obtained from 
Sigma Chem.Co.Ltd, Dorset, U.K.
Sodium chloride, ammonium chloride, ammonium sulphate, calcium 
chloride, citric acid and manganous chloride were all of 
analytical grade and were supplied by BDH Chemicals Ltd., Dorset, 
U.K.
Polyethylene glycol ( PEG ) 4000 was obtained from Merck,
Hydrogen peroxide was obtained from Fisons, England, U.K.
2.1.7 Electrophoretic Materials
Acrylamide, N,N,N'N*tetramethylene diamine ( TEMED ), 
N,N'-methylene bis acrylamide and ammonium persulphate were 
obtained from B.D.H. Chemicals Ltd., Poole, Dorset, U.K. 
2-mercaptoethanol and 2,5-diphenyl oxazole ( PPO ) were obtained 
from Koch Light Laboratories, England, U.K. Membrane Filters 
0.45um was supplied by Schleicher and Schull, Surrey, U.K.
Low molecular weight marker proteins was supplied by Phamacia 
Fine Chemicals, Hounslow, Middlesex, U.K.
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2.1.8 Stains
Coomassie Blue (R), Coomassie Blue (G) and Naphthol Blue 
Black were obtained from Sigma Chem.Co.Ltd., Dorset, U.K.
Silver nitrate was obtained from Jhonson Matthey Chemicals, U.K.
2.1.9 Radiochemicals
L-^^S- Methionine, specific activity 500Ci/mmole was supplied
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by Amersham, Bucks., England and I-Nal, specific activity 
200Ci/mmole was supplied by Western Infirmary, Glasgow 
University,Scotland.
2.1.10 Photographic Materials
X—ray films (Kodak X-Omat S), SX—80 developer and FX—40 X—ray 
liquid fixer were supplied by Kodak Ltd., Hemel Hampstead, U.K. 
400 ASA Photographic films (Kodak) were purchased from a 
photographic retailer, Glasgow, Scotland.
2.1.11 Serological Reagents
Rabbit anti-rat IgG ( H+L ), Rabbit anti-rat IgG ( H+L ) 
horse-radish peroxidase. Rabbit anti-rat IgG ( H+L ) conjugated
to iflupresceilf.. Sheep anti-rat IgGl, Goat anti-rat IgG2a, rabbit 
anti-rat IgG2b, goat anti-rat IgG2c were supplied by Miles 
Laboratories Ltd., Slough, U.K.
Normal goat serum, normal rabbit serum and donkey anti-rabbit 
precipitating serum were obtained from Scottish Antibody 
Production Unit, Wlshaw, Scotland, U.K.
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2.1.12 Enzymes
Ribonuclease A ( from bovine pancreas }, e^-Mannosldase(jack 
bean), P-Glucosidase (bitter almonds) Type I, «(-Glucosidase 
(yeast) Type VI, o(-Glucosidase (rice) Type V were obtained from 
Sigma Chemical Co. Ltd., Dorset, U.K.
Proteinase K was obtained from Boehringer-Mannheim, Sussex, U.K.
2.1.13 Miscellaneous
Lipopolysaccharides of Salmonella typhirourium,
E. coli 0111:B4, ^  coli 0127 B8 and bovine serum albumin was 
supplied by Sigma Chemical Ltd., Eppendorf tubes (1.5ml capacity) 
were obtained from Eppendorf, Geratebau, Netheler and Hinz, U.K. 
Suppliers Anderman and Co., Surrey, U.K. Dialysis tubing was 
obtained from Visking Tubing, Scientific Instruments Centre Ltd., 
London. Multichannel micro-pipettes were obtained from Flow 
Laboratories, Ayrshire, U.K. Micro-pipettes used during the 
course of this study were obtained from Gilson Anachem Ltd., 
Luton, U.K.
All other reagents were of analytical grade or of the highest 
available purity.
2.2 Standard Solutions and Buffers
2.2.1 Fusion and Cell Culture Media
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2.2.1.1 RPMI-1640 medium
This medium was supplied as a dry powder by Plow 
Laboratories. The medium was made up from the supplied powder by 
the cell culture unit of Glasgow University as instructed by the 
suppliers. Sterilisation was done by filtration and then 
allquoted and stored at 4^C.
The composition of RPMI-1640 medium is shown in Table 2.1.
2.2.1.2 Heat—Inactivation of foetal calf serum (PCS)
Foetal calf serum was inactivated at 56^C for 30 minutes 
and stored at -20^C. Frequent freeze-thawing was avoided.
2.2.1.3 HAT and HT media
The concentration of HAT and HT in medium was as
described by Litlefield (1964). Hundred fold concentrated HT
stock was prepared by dissolving 136.Img hypoxanthine, 36.7mg
thymidine and 2.25mg glycine in 100ml of distilled water.
Hypoxanthine was solubilised by stirring the mixture at 50^C for
60 minutes. The solution was then sterilised by filtration and
aliquoted and stored in dark at -20^C.
HT medium was made up by diluting 1.0ml of the
sterilised stock solution with 100ml of complete medium ( Section
2.2.1.5 ) to give a concentration of 3x10 M, 1x10 M and 
-5
1.6x10 M for glycine, hypoxanthine and thymidine respectively.
HAT medium was prepared with the addition of 0.4ml of 
stock aminopterin ( O.lmM ) to 100ml of HT medium to give a final
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Table 2.1 
Amino acids
Composition of RPMI 1640 medium
mg/litre
L-Arginine
L-Aspargine H20
L-aspartic acid
L-Cystine,disodium salt
L-Glutamic acid
L-glutamine
Glycine
L-Hlstidine
L-Hydroxyproline
L-Isoleucine
L-Leucine
L-LysineHCl
L-Methionlne
L-phenylalanine
L-Proline
L-Serine
L-Threonine
L-Tryptophan
L-Tyrosine
L-Valine
2 0 0 . 0 0
56.82
2 0 .0 0
59.15
20.00
300.00
10.00
15.00
2 0 .0 0
50.00
50.00
40.00
15.00
15.00
20.00
30.00
20.00 
5.00
20.00
20.00
Vitamins
Biotin
D-Calcium pantothenate
Choline chloride
Folic acid
i-Inositcl
Nicotinamide
p-aminobenzoic acid
PyridoxineHCl
Riboflavin
Thiamin.HCl
Vitamin B12
0 . 2 0
0.25
3.00
1.00 
35.00
1.00
1.00
1.00
0.20
1.00
0.005
Inorganic salts
Ca(N0 )
KCl
MgSO .7H 0 
NaCl 
NaHCO 
Na2HP0.
69.49
400.00
1 0 0 .0 0  
6000.00 
2000.00
800.7
Other Compounds
Glucose 
Glutathione 
Sodium phenol red
2000.00
1 .0 0
5.00
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concentration of 4x10 M.
2.2.1.4 Antibiotics
Penicillin 10^ I.U./L and streptomycin lOOmg/L were used 
in routine culture medium.
2.2.1.5 Complete Medium
This was made up with the addition of either 10% or 20% 
FCS ( v/v ) and fungizone (2.5pg/ml) to RPMI-1640 and referred to 
as 10% or 20% complete medium.
2.2.1.6 Trypan Blue Dye Solution
One part of 1% (w/v) trypan blue dye solution was mixed 
with four parts of 1% (w/v) NaCl. The mixture was then diluted 
with saline to give 0.1% solution immediately before use for the 
Trypan Blue exclusion test.
2.2.1.7 Polyethylene glycol (PEG) solution
40% (w/v) PEG was made up by adding 40g of PEG to 60ml
of RPMI. The mixture was solubilised and sterilised by 
autoclaving at 151b/sq.in. for 15 minutes. The mixture was 
aliquoted when hot and stored at -20^C.
2.2.1.8 Ammonium chloride solution
0.9g of ammonium chloride was dissolved in 100ml of 
distilled water to give 0.9% solution. This was then aliquoted in 
volumes of 300pl and stored at -20^C.
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2.2.2 Immunoassay Buffers 
Mcllvalne's Buffer 
Stock solutions 
Citric acid (O.IM)
NagHPO^.l&HgO (0.2M) 
Working diluent
17.9ml of citric acid and 32.1ml of Na^HPO^ were mixed 
and the volume made up to 100ml to give a solution of pH6.0.
2.2.3 Saline Buffers
2.2.3.1 Phosphate buffered saline (PBS) PH7.4 
NaCl (145mM)
Na^HPO^ (9mM) 
NaH^PO^ (1.3mM)
2.2.3.2 PBS-Tween
0.5ml of Tween 20 was added to every litre of PBS.
2.2.3.3 Trls-saline buffer pH7.2 
Trls-HCl (20mM)
NaCl (0.15M)
NaN^ (0.05%)
48
2.2.3.4 Tris-Tween buffer
5.0ml of Tween 20 was added to every litre of trls-saline
buffer.
2.3 Methods
2.3.1 Animal Handling
2.3.1.1 Immunisation of rats
DA rats were immunised with either Ogawa ( NIH 41 ) or
Inaba ( 35 A3 ) serotypes of Vibrio cholerae. The vibrios were
obtained as a suspension in 0.5% phenol-saline. The organisms
g
were washed in PBS and resuspended in PBS. 10 vibrios in 0.05ml 
of PBS were mixed with equal volume of complete Freund's adjuvant 
and vortexed to give a homogenous emulsion. This emulsion was 
injected subcutaneously at two sites into a DA rat. A week later 
the process was repeated. The rat serum was tested for antibodies 
against the respective vibrios 4-5 days after the second 
injection.
Any rat that had a high titre i.e. atleast a titre of 1 in
9
1000, was given an intraperitoneal boost of 5x10 vibrios in PBS 
4 days before the fusion.
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2.3.1.2 Collection of Blood from Rats
Immunised rats were bled by cutting the end of the tail by a 
sharp scalpel blade. A few drops of blood were collected by 
letting it drip from the cut end into an eppendorf tube and it 
was allowed to clot. The clot was centrifuged and serum obtained.
Rats used for the fusions were sacrificed in an ether jar. 
The blood was then immediately collected from the inferior vena 
cava using a G21 needle.
2.3.1.3 Pristane priming of rats
2ml of pristane were injected intraperitoneally into rats, 
7-10 days before injecting hybridoma cells into them.
2.3.1.4 Induction of ascites in rats
2-5x10^ hybridomas were washed several times in PBS to 
remove any traces of albumin carried over from the tissue culture 
medium. The cells were finally suspended In PBS and Injected 
intraperitoneally into a rat.
2.3.1.5 Collection of ascites fluid
The rats developed visible ascites tumours 3-5 weeks after 
injection with hybridomas. The ascitic fluid was collected by 
sacrificing the rat in an ether jar and withdrawing the fluid 
with a syringe fitted with a G21 needle.
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2.3.2 Production of rat—rat hybrid myelomas
2.3.2.1 Rat Myelomas used for Hybridoma production
The rat cell lines Y3.Ag 1.2.3 < Y3 ) and YB2/3AG20 
( YB2/0 ) described in Section 1.20.1 were used for the 
production of the B-cell hybridomas.
2.3.2.2 Culture of the Myeloma Lines
The myeloma cells to be used for a fusion were grown in a 
spinner culture flask in 10% complete medium at 37^C in a water 
bath equipped with a magnetic stirrer. The flasks were filled 
with 5% COg. The cells required for a fusion were collected from 
the spinner culture medium and examined for atleast 95% viability 
(described in Section 2.3.2.3).
2.3.2.3 Cell viability and cell count
Cell viability was determined by Trypan Blue exclusion 
test. An aliquot of cell suspension was mixed with an equal 
volume of dye solution. The number of live and dead cells were 
counted in a Neubauer Haemocytometer.
2.3.2.4 Preparation of spleen cell suspension
DA rats were sacrificed in an ether jar. The rats were 
then soaked in 70% propanol and dissected using sterile 
equipment. The blood was collected immediately as described in 
Section 2.3.1.2. The spleen was then removed and placed in a
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sterile universal. Further work with the spleen was carried out 
in a sterile hood.
The spleen was teased apart with two G21 needles in a 
petridish containing RPMI. The released spleen cells were passed 
through a G21 needle twice and twice through a G25 needle to give 
a single cell suspension. The cells were then washed and 
resuspended in RPMI and counted as described in Section 2.3.2.5.
2.3.2.5 Spleen cell count
50pl of spleen cell suspension was pipetted into an 
eppendorf tube containing 300pl of 0.9% ammonium chloride and 
incubated for 5 minutes at room temperature. The lymphocytes were 
counted in a Neubauer Haemocytometer.
2.3.2.6 Fusion Protocol
Fusion between spleen and myeloma cells was carried out 
essentially by the procedure of Kohler and Milstein (1975) with 
minor modifications (Campbell,A.M. 1984).
1ml of 20% complete medium was dispensed into each well 
of a 24-well costar plate. The number of costar plates used 
depended on the number of spleen cells obtained from a spleen. 
Usually 4 plates were set up for a single fusion.
Myeloma cells collected from a spinner culture were 
washed and resuspended in RPMI. A small aliquot of both spleen 
and myeloma suspension were kept aside to be used as controls. 
The remaining spleen and myeloma cells were mixed at a ratio of 
2:1 and centrifuged at 500/| for 5 minutes. The supernatant was
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discarded and the pellet was dispersed by gentle tapping. 2ml of 
40% w/v PEG was added to the pellet over a period of 30 seconds 
with gentle shaking. The pellet was then resuspended for 30 
seconds and incubated at room temperature for another 30 seconds.
5ml of RPMI was then added to the resuspended mixture over a
period of 90 seconds and a further 5ml of RPMI all at once. The
mixture was then incubated at room temperature for 2-3 minutes
and centrifuged at SOOxg for 5 minutes.
The cells were then suspended at a concentration of 2x10^ 
spleen cells/ml of complete medium containing 20% foetal calf 
serum. 50pl ( a drop ) of resuspended cells were dispensed into 
each well containing complete medium.
2.3.2.7 Spleen cell feeder layer
A spleen cell suspension was prepared as described in 
section 2.3.1.4 in complete medium containing 20% foetal calf 
serum at a concentration of 10^ cells/ml. lOOpl of this 
suspension was dispensed into each well of a 96-well costar 
plate.
2.3.2.8 Cloning by limiting dilution
2-4 weeks after the fusion hybrid clones emerged in some 
of the wells. When the clones were quite confluent the 
supernatant was tested for antibody secretion on an ELISA. The 
positive clones were then cloned by limiting dilution. This was 
carried out by suspending the hybrid cells at 10 cells/ml in 
complete medium containing 20% foetal calf and dispensing lOOpl
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into wells prelayered with feeder cells. The suspension of hybrid 
cells was then double diluted and lOOpl was again dispensed into 
each well. The doubling dilution was carried out once more so 
that finally 0.25 cells were dispensed into the wells.
Positive clones from the first cloning were cloned for 
the second and third time by the same procedure. Positive clones 
from the lowest dilution were expanded in flasks and some were 
frozen down.
2.3.2.9 Freezing and Thawing of cells
Cells were suspended in 1.0ml aliquots containing 2x10^ 
cells in RPMI supplmented with 20% foetal calf serum and 10% DMSG 
in 1.5ml capacity cryostat ampoules. The aliquots were frozen at 
-70^C overnight, then transferred to a gas-phase liquid nitrogen 
freezer.
Cells brought up from liquid nitrogen were quickly thawed 
in a 37^C water bath, washed twice with RPMI, suspended in 
complete medium containing 20% foetal calf serum and incubated at 
37^C in a humidified CO^ incubator.
2.3.2.10 Routine culture of hybridoma cells
All hybrid cells were cultured in complete medium 
containing 20% foetal calf at 37^C in a humidified CO^ incubator.
The clones established after the third cycle of limiting 
dilution cloning were regarded as monoclonals. The monoclonals 
were propagated either in spinner cultures or as ascitic fluid 
( Section 2.3.1.4 ).
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2.3.3 Iimnuno Assays
2.3.3.1 Enzyme Linked Immunoabsorbent Assay (ELISA)
Solutions 
DBlocking buffer 
2% Bovine Serum Albumin 
3% Normal goat serum in PBS
ii)Antiserum/Conjugate dilution buffer 
0.5% bovine serum albumin in PBS
iii)Substrate
0.4mg/ml o—phenylene diamine dissolved in Mcllvaines buffer 
containing 0.32pl/ml hydrogen peroxide(0.01%)
Routine Screening ELISA
96 well microtitre plates (Dynatech MicroELISA Systems) were 
first washed with distilled water and then coated with 10^ 
vibrios/lOOpl/well in PBS. The plates were centrifuged at BOOxg 
for 5 minutes at room temperature. The supernant was removed by 
flicking the plates which were then washed twice with PBS and 
incubated at room temperature for 30 minutes with blocking 
buffer to saturate the unreacted sites in the wells. The blocking 
buffer was removed and the plates were washed three times with 
PBS-Tween. lOOpl of hybridoma supernant or antiserum at the 
appropriate dilution were then added to each well and the plates 
were incubated for 2 hours at room temperature and then washed 3 
times with PBS-Tween. lOOpl of a 1 in 1000 dilution of horse
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radish peroxidase conjugated detection antibody ( Miles HRP 
conjugated anti-rat IgG (H+L) ) in conjugate dilution buffer were 
then added to each well and the plates were incubated for a 
further hour before being washed four times with PBS—Tween. lOOpl 
of substrate were then added and the plate was incubated at room 
temperature in the dark for 20 minutes. The reaction was stopped 
by the addition of 50pl of 4N H^SO^. The optical density of each 
well was measured with a titretrek Multiskan spectrophotometer 
at 492nm.
Assays were performed in duplicate. Controls were wells 
without vibrios to check for non-specific binding of the antibody 
to the plate and wells with pre-immune serum or negative tissue 
culture supernant to check for the non-specific binding of the 
second antibody to the vibrios. A positive sample was judged to 
be one 100% in excess of the average control reading.
2.3.3.2 Competition Assay ( ELISA )
The competition assay was carried out to confirm the 
specificity of the antibodies towards respective serotypes of 
V. cholerae.
The MCAbs were titred on serotypes of vibrios to which they 
exhibited an apparent specificity. The limiting concentration of 
antibody able to react with 10^ vibrios was determined. All six 
MCAbs were used at their respective limiting concentrations for 
the competition assays.
ELISA plates were coated with either serotype of
V. cholerae and blocked as described in Section 2.3.3.1. Crude
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LPS from either serotype or LPS obtained from Sigma or whole 
vibrios were used as competing antigens. In eppendorf tubes lOOpl 
of varying concentrations of LPS or vibrios were added. To each 
of these tubes was added 100^1 of twice the limiting 
concentration of a MCAb. The tubes were incubated overnight at 
4^C. lOOpl of this mixture was then added to wells of precoated 
and blocked ELISA plate and the plate was incubated for 2 hours 
at room temperature. At the end of the incubation period the 
plates were treated as for routine ELISA assay described in 
Section 2.3.3.1.
2.3.3.3 Immunofluorescence Assay
Multispot microscope slides were washed with methanol
Q
and air dried. lOpI of suspension at 10 organisms per ml in PBS 
were applied to each spot. The slides were allowed to dry at 65^C 
for 30 minutes. The vibrios were then fixed in alcohol for 2 
minutes. lOpl of MCAb in tissue culture supernatant were then 
applied to each spot. The control was negative tissue culture 
supernatant. The slides were incubated in a humidified atmosphere 
at room temperature for three hours, washed in PBS and reacted 
with lOpl of fluorescein conjugated rabbit anti-rat IgG ( H+L ) 
at a dilution of 1:28. After one hour of incubation in a 
humidified atmosphere at room temperature, the slides were washed 
in PBS and examined in a Leitz Orthoplan fluorescent microscope 
equipped with a Leitz MPV compact photometer.
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2.3.3.4 Agglutination Assay
2.3.3.4.1 Slide agglutination assay
lOpl of 1.6x10^^ vibrios per ml in PBS were dispensed 
on a slide and lOpl MCAb concentrated by ammonium sulphate 
fractionation ( Section 2.3.4.3 ) was added to it and mixed by 
gentle rocking of the slide.
2.3.3.4.2 Slide agglutination with S.aureus coated antibodies 
S. aureus cells were coated with MCAbs as described by
Kronvall, 1973. 10^/ml 5^ aureus organisms were washed three
times with PBS. 1ml of the washed suspension of cells were 
incubated with 1ml of ten times concentrated MCAb or 1ml of 
normal rat serum for one hour at room temperature. The incubated 
cells were washed again with PBS and used for slide agglutination 
as described in 2.3.3.4.1.
2.3.3.4.3 Agglutination in V-bottom plates
MCAb concentrated ten fold by ammonium sulphate 
fractionation was used for the assay. 20pl of a suspension of 
1.6x10^^ vibrios per ml in PBS were dispensed into each well of a 
V-shaped 96 well microtitre plate ( Costar ) and 20pl of MCAb 
were added to it. The plate was tapped gently to allow thorough 
mixing and incubated in a humidified atmosphere overnight at room 
temperature.
Secondary agglutination was accomplished by adding 
lOpl of rabbit anti-rat IgG ( H+L ) at a dilution of 1:10 to the
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above mixture.
2.3.3.4.4 Agglutinations at altered pH 
Buffers
Citrate Buffer pH6.0
9.5 ml of O.IM citric acid
41.5 ml of O.IM sodium citrate, total volume was made 
upto 100ml with distilled water.
Carbonate-Bicarbonate Buffer pH9.2 
4ml of 0.2M anhydrous carbonate
46ml of 0.2M of sodium bicarbonate, total volume was 
made upto 100ml with distilled water.
1.6x 10^^ vibrios/ml were washed five times with either
with citrate buffer or carbonate-bicarbonate buffer. Ten times
concentrated MCAbs were dialysed overnight at 4^C with either of 
the two buffers. The dialysed MCAbs and the equilibrated vibrios 
were used for agglutination tests as described in 2.3.3.4.3.
2.3.3.5 Complement fixation assay 
Stock Solution 
81.6g NaCl ( 1.4M )
12.Ig Tris ( O.IM )
33ml of 0.15M of MgSO^
15ml of O.IM CaClg 
The pH was adjusted with HCl to 7.4 and the final volume 
was made upto 1 litre.
Working Solution
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Ig of BSA was dissolved in 100ml stock solution and the 
final volume was made upto a litre.
Procedure
Tubes were set up with varying concentration of antibody
g
and 10 vibrios of either serotype. Controls consisted of
antibody at all concentrations with no antigen and antigen with 
no antibody. 0.6ml of guinea pig complement ( 1  in 600 ) were 
then added to each tube and the tubes were incubated at 4 C 
overnight.
The following day the sheep red blood cells ( 5RBC )
(0.1 packed volume ) were washed with working solution and
resuspended in 10ml of the same solution. lOpl of haemolysin were 
added to it, mixed well and incubated for 30 minutes at 37^C. 
0.2ml of this 5RBC preparation was added to each tube and
incubated for about 15-20 minutes watching 100% lysis control. 
When controls were all lysed, the tubes were cooled quickly and 
centrifuged lOOOxg for 10 minutes. The optical density of the 
supernatants were measured at 413nm using 0% lysis as blank.
2.3.3.6 Direct binding assay
Blocking Agent
Neat normal goat serum
Linbro multi—well plates were washed with PBS before 
g
adding 10 vibrios to each well. The plates were then centrifuged 
at 500xg for 15 minutes. The contents of the plates were 
discarded and the plates were washed twice more with PBS before 
adding blocking agent to it. After 30 minutes of incubation the
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plate was washed twice with PBS-Tween and 50pl of labelled 
antibodies along with SOpl of normal goat serum were added to the 
respective wells. The contents of the plate were discarded after 
two hours of incubation at room temperature, plates were washed 
5-6 times with PBS-Tween and the wells were cut out for being 
counted on LKB 1275 Minigamma counter.
No antigen in a well served as a control.
2.3.3.7 Inhibition radioimmunoassay 
Blocking Agent 
Neat normal goat serum
Linbro multi—well disposable trays were used for this assay.
9lOOpl of 10 vibrios per well in PBS were dispensed into each 
well of the plate and the plates were centrifuged at SOOxg for 15 
minutes. The contents of the wells were discarded with a flick 
and the wells were washed twice with PBS. Normal goat serum as 
blocking agent was added to fill up each well upto the brim and 
incubated for 30 minutes. The plates were washed twice with 
PBS-Tween. lOOul of cold antibody was added and incubated for two 
hours, plate was washed again and 50pl of normal goat serum was 
added before the addition of SOpl of hot antibody. The plate was 
incubated for another 2 hours at room-temperature. After the 
incubation the plates were washed 5-6 times with PBS-Tween. The 
wells were then cut out and counted in the LKB 1275 Minigamma 
counter.
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2.3.4 Immunological and Immunochemical Methods
2.3.4.1 Internal Labelling of Monoclonal Antibodies
Buffers and Solutions
lOxTKM Buffer
IN Tris-HCl pH8.2
IM KCl
50mM MgClg
3D-TKM Buffer
1ml TritonxlOO, Ig sodium deoxycholate, 0.5g SDS and 10ml lOxTKM 
buffer made upto 100ml with distilled water.
Primary Lysis Buffer
10ml of TritonxlOO and 10ml of lOxTKM made upto 100ml with 
distilled water.
Secondary Lysis Buffer
0.2g deoxycholate, O.lg of SDS and 2ml of lOxTKM made upto 20ml 
with distilled water.
Triton stock solution 
10% Triton in TKM
IM Sucrose solution in 3D-TKM buffer 
0.5M Sucrose solution in 3D-TKM buffer 
Immunoprecipitate Buffer
50mM Tris pH8.8, 1% w/v SDS and 0.01%w/v phenol red.
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2.3.4.1.1 Procedure
Cells to be labelled were grown at a logarithmic rate.
6
2-3x10 cells were pelleted and washed twice in serum free medium
and twice in labelling medium. The cells were then resuspended in
350.25-0.5ml of labelling medium and SOpCi of S-methionine were 
added to it. The cells were incubated at 37^C for 90 minutes. The 
cells were then centrifuged at 500xg and resuspended in 0.5ml of 
complete medium. The resuspended cells were divided into equal 
aliquots. One of the aliquots were incubated at 37^C for 4 hours 
to study the secretory immunoglobulins of the hybridomas. The 
other aliquot of cells were lysed to study the nascent 
intracellular immunoglobulins synthesised by the hybridomas.
2.3.4.1.2 Lysis of Cells
The aliquot of radio—labelled cells to be lysed were 
washed twice in ice-cold TKM buffer and resuspended in lOpl TKM 
buffer. The cells were solubilised with the addition of 0.45pl of 
primary lysis buffer. The mixture was left to stand on ice for 20 
minutes. The cells were centrifuged at 3000xg for 20 minutes to 
pellet the nuclei. The post-nuclear supernatant was transferred 
to fresh tubes containing 50pl of secondary lysis buffer. 
Insoluble debri was removed by high speed centrifugation 
(30,000xg for 30 minutes). The supernatant was collected and the 
intracellular immunoglobulins precipitated as described below.
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2.3.4.1.3 Immunoprécipitation of Monoclonal Antibodies
! 50ul of the intracellular extract was added to
lOpl of goat anti-rat anti-serum (1:10). The mixture was 
incubated for 1 hour at room-temperature and 50 pi of donkey 
anti-goat precipitating anti-serum was added to it and incubated 
overnight at room temperature.
2.3.4.1.4 Isolation of secreted Monoclonal Antibodies
The cells incubated for 4 hours were centrifuged in 
Sorvall at 15K rpm to pellet the cells. The supernatant was used 
to immunoprecipitate the monoclonal antibodies as described in 
Section 2.3.4.1.3.
2.3.4.1.5 Purification of Immunoprecipitates
The immunoprecipitates formed were pelleted at 3,000xg for 
30 minutes and resuspended in lOOpl of 3D-TKM buffer. Sucrose 
gradients were prepared by layering 0.5ml of IM sucrose at the 
bottom of an eppendorf and 0.5ml of 0.5M sucrose on top of the IM 
sucrose layer. lOOpl of the resuspended immunoprecipitates were 
carefully layered on top of the sucrose gradient and centrifuged 
at 3000xg for 30 minutes and the gradients rinsed with 
immuno-precipitate buffer. The precipitates were drained with a 
drawnout pasteur pipette and dissolved in lOOjjl of TKM buffer. 
The samples were then applied on 10% SDS-polyacrylamide gels.
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2.3.4.1.6 Analysis of the immunoprecipitated Monoclonal
Antibodies on SDS-PAGE
30|il of the immunoprecipitated monoclonal antibodies 
dissolved in TKM buffer were taken up in 30pl of SDS-PAGE sample 
buffer ( see Section 2.3.5.4 ) and applied on a 10%
SDS—polyacrylamide gel. The gel was run at 30mapms till the dye 
had reached the end of the gel.
2.3.4.1.7 Fluorography
The gel obtained from Section 2.3.4.1.6 was incubated in 
DMSG for 20 minutes. The process was repeated with fresh DM50. 
The gel was then placed in a solution of 60g of PPO dissolved in 
250 ml of DMSO and incubated for another 40 minutes. The gel was 
finally washed in water for 45 minutes and dried. The dried gel 
was exposed and developed as described in Section 2.3.4.5.2.
2.3.4.2 Ouchterlony 
Solutions 
1% w/v agar in PBS 
Glass slides were coated with 3.5ml of hot agar solution 
( 45^C ) and the agar was allowed to solidify. Templates were 
used to punch holes in the agar. The plugs of agar from the wells 
were removed using a Pasteur pipette attached to a vacuum line. 
lOul of antiserum, control serum and monoclonal antibodies at 
dilutions of neat, 1/2, 1/4, 1/8, 1/16 and 1/32 were pipetted
into the surrounding wells in order of concentration. Monoclonal
65
antibodies used as neat were 10 fold concentrated from culture 
supernatant by ammonium sulphate precipitation( Section
2.3.4.3 ). RatHmmunog 1 obu 1 in class specific antisera was pipetted 
as neat ( lOpl/well ) in the centre well. The slides were 
incubated in a humidified atmosphere overnight at room 
temperature and the precipitin lines were allowed to develop for
3-4 days in a humidified atmosphere at 4^C.
2.3.4.2.1 Staining precipitin lines 
Stain
0.025% w/v Coomassie brilliant blue R in methanol:water:acetic 
acid 50:45:5 by volume.
Destain
Water:acetic acid:methanol 87:8:5 by volume.
Wash solution 
5% sodium citrate 
Procedure
The slides were washed in 5 changes of wash solution over 
48 hours to solubilise any non-specific precipitates and 
carefully dried with a sheet of filter paper. Slides were stained 
by immersing them in the stain for 15-20 minutes. They were 
destained in the destain until the background was clear. The 
slides were dried by blotting with a filter paper.
2.3.4.3 Fractionation of Antibodies
Monoclonal antibodies were precipitated from the culture 
supernatant by using 40% saturated ammonium sulphate.
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Culture supernatant was cooled to 4^C in ice and half its 
volume of saturated ammonium sulphate was added dropwise with 
constant stirring at 4^C. The mixture was left on ice 30 minutes 
and then centrifuged at 500xg for 10 minutes. The pellet obtained 
was washed twice in 40% saturated ammonium sulphate solution 
before dissolving it in a small volume of PBS. The solution was 
dialysed against 100 volumes of PBS at 4^0 overnight to remove 
traces of ammonium sulphate. The buffer was changed the next day 
and the dialysis continued for another 2 hours. The sample was 
collected and stored at -20^0.
2.3.4.4.Purification of Monoclonal Antibodies from cell culture 
supernatant
2.3.4.4.1 Purification on DEAE Affi-gel Blue column 
Buffer A
0.02M K^HPO^, pH 8.0,0.02% NaN^
Monoclonal antibodies in cell culture supernatant were 
isolated from albumin in the medium by using a DEAE Affi-Gel Blue 
column.
A column of DEAE Affi-Gel Blue was prepared of 20ml bed 
volume. The column was washed with two bed volumes of buffer A. 
The monoclonal antibody in the culture supernatant was dialysed 
for 24 hours in buffer A at 4^C. 2ml of the dialysed neat culture 
supernatant was applied to the column. The IgG fraction was 
eluted with two volumes of Buffer A. Fractions of volume 1ml were 
collected and the protein peak was determined by absorbance
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280 nm. Each fraction was tested by ELISA and the activity peak 
determined. Fractions with the highest activity and the lowest 
protein content were pooled and lyophilised.
The proteins bound to the column were eluted with two bed 
volumes of 1.4M NaCl in buffer A. The activity and protein 
profile of these fractions were also recorded. The column was 
regenerated with two bed volumes of 6M guanidine hydrochloride, 
followed by two bed volumes of buffer A.
2.3.4.4.2 Purification of immunoglobulins on QAE-Sephadex 
Buffer
O.IM Tris-HCl pH 6.5 
QAE-Sephadex A50 was swollen for 3 days in O.IM 
Tris-HCl buffer and the suspension was degassed before pouring it 
into the column. A 10ml column was set up and equilibrated with 
buffer at a flow rate of Iml/min. 1ml of ten times concentrated 
immunoglobulin ( Section 2.3.4.3 ) was layered on top of the 
column and 4-5ml fractions were collected from the column at 
about Iml/min. The protein content of the fractions were measured 
by their absorbance at 280nm and fractions were collected till 
the absorbance reached a value of 0.01. Each fraction was tested 
for their antibody activity on ELISA. Fractions with the highest 
acitvlty were pooled and lyophilised. The sample was regenerated 
with distilled water and dialysed against O.IM Tri-HCl before 
further use.
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2.3.4.5 Immunoblotting
LPS or proteins transferred onto the nitrocellulose paper 
were detected by the anti-sera or monoclonal antibody either by 
enzyme system or protein A.
2.3.4.5.1 Immunoblotting ( Enzyme detection method )
The antigens transferred on the nitrocellulose paper 
were detected using enzyme-conjugated antisera as described by 
Towbin et al, ( 1979 ).
Solutions
Blocking buffer
5% normal goat serum in PBS
Substrate
Stock solution
0.3g of 4-chloro—1—naphthol dissolved in 100ml of methanol. 
Working solution
1 volume of stock chloronaphthol added to 5 vlumes of PBS and 
final concentration of hydrogen peroxide was 0.01%.
Procedure
After electroblotting the nitrocellulose paper was incubated in 
the blocking buffer overnight at 4^C or at 37^C for an hour to 
block the remaining reactive sites on the paper. The paper was 
then incubated with either anti-sera diluted in the blocking 
buffer or monoclonal antibody in cell culture medium for 1.5-2 
hours. The paper was washed after the incubation period with 5 
changes of PBS for 30 minutes. Rabbit anti-rat IgG ( H+L ) 
horse-radish peroxidase diluted in the blocking buffer (1 in
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1000) was applied to the nitrocellulose paper and incubated for 
another one hour. After the incubation the paper was again washed 
in PBS five times for 30 minutes. The substrate was then added to 
the paper and incubated for 2-5 minutes. The bands detected by 
the antibodies were stained purple. The stained paper was 
preserved by washing it thoroughly in distilled water and drying 
it between filter papers. The dried paper was photographed within 
a week.
2.3.4.5.2 Immunoblotting with Protein A
The procedure followed was that described by Batteiger 
et al (1962) with minor modifications developed in our 
laboratory.
Blocking Buffer
0.5% Tween-20 in Tris buffer
Procedure
After the electrophoretic transfer from a gel to 
nitrocellulose paper, the paper was incubated in the blocking 
buffer as described in Section 2.3.4.5.2. The anti-sera diluted 
in the blocking buffer or monoclonal antibody was applied to the 
paper and Incubated for 1.5-2 hours. After the incubation period 
the paper was washed in blocking buffer five times for 30 
minutes. The paper was then incubated with rabbit anti-rat IgG 
( H+L ) diluted 1 in 2000 in the blocking buffer for 1 hour. The 
paper was washed again in blocking buffer for 30 minutes with 5 
changes. lodinated protein A ( lO^cpm ) was applied to the paper 
and incubated for another hour. The unreacted protein A was then
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discarded and the paper was washed as described above and dried 
between filter papers. The dried paper was then exposed on an 
X-ray film. This was done by placing a film on an |ihtensifyingl 
screen in a cassette and then placing the paper over the film. 
The assembly in the cassette was wrapped in black bags and the 
film exposed at -70^C till it was ready to be developed. The film 
was developed and fixed in the dark according to the instructions 
of the suppliers for the developer.
2.3.4.6 lodination of Protein A. Immunoglobulins and Lectins
Img of iodogen was weighed into a vial and dissolved in
0.5ml of chloroform. The chloroform was allowed to vaporise
slowly so as to leave a thin coating of iodogen in the vial.
Img of protein A, 1-0.5mg purified immunoglobulin ( Section
2.3.4.4.2 ) or 0.5mg of lectin was disolved in 0.5 ml of the
buffer in which it would be finally used. The solution was
transferred to the vial containing the dried iodogen. 400-500pCi 
125of Na I were added to the vial and incubated at room
temperature for 15 minutes with intermittent shaking. After the
incubation period the mixture was removed and applied onto a 10ml
sephadex-G25M column equilibrated with the appropriate buffer.
1ml fractions were collected and lOul of each fraction was
counted on a LKB 1275 Minigamma counter. The frations with the 
125
peak I incorporation were pooled and aliquoted if necessary.
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2.3.4.7 Radlolabelled-Lectln Binding Studies 
Solutions 
50% methanol 
Fixing Solution
0.2ml of 25% glutaraldehyde in 50% methanol
Tris-KCl Buffer
20mM Tris pH 8.0
0.12MKC1
0.05% NaNg
Reducing Solution
15mg of NaBH^ in 150 ml of Tris-KCl buffer.
Reaction Buffer 
ImM MnCl^
ImM CaClg
0.1% haemoglobin and 1% Tween 20 in Tris-KCl buffer.
Sonicated organisms or crude LPS from cholerae were run
on SDS-polyacrylamide gels as described in Section 2.3.5. The
gels or the transfers on the nitrocellulose papers were reacted 
125with I-Lectins. The whole process was carried out at room 
temperature.
2.3.4.7.1 Lectin binding on Gels
125Gels to be reacted I-Lectin was incubated twice with 50%
methanol for 30 minutes and fixed with the fixing solution for 90
minutes. The fixing solution was replaced with reducing solution 
and incubated for 2 hours with two changes of the solution. The 
gel was then equilibrated with reaction buffer for 1 hour with 4
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7 125changes of the buffer. 10 cpm of I-lectin in the reaction
buffer was applied to the gel and shaken for 3 days. The gel was 
washed for 5 days with 3 changes of reaction buffer each day. The 
washings were monitored and the gel dried when the counts in the 
washings were that of the background. The gel was exposed as 
described in Section 2.3.4.5.2
2.3.4.7.2 Lectin binding on Nitrocellulose Papers
The method followed was identical to that described in 
Section 2.3,4.7.1 except that the nitrocellulose paper was not 
incubated in 50% methanol.
2.3.5 SDS-PAGE of sonicated bacteria and LPS
2.3.5.1 Sonication of vibrios
V. cholerae of either serotype were washed in water to 
remove any traces of phenol and then resuspended in water at a 
concentration of 8x10^^ organisms per ml. The suspension of 
vibrios were sonicated in an ice bath at 80 watts, three times 
for 10 second intervals. The sonicated samples were aliquoted and 
stored at -20^C.
2.3.5.2 Extraction of LPS
LPS from the Ogawa and Inaba serotypes were extracted 
essentially by the process of Westphal and Jann ( 1965 ).
Vibrios suspended in 0.5% phenol-saline at a 
concentration of 8x10^^ and 90% ( w/v ) phenol were separately
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heated to 65^C. Equal volumes of each were mixed thoroughly and 
the mixture was incubated for 15 minutes at 65^C. The mixture was 
then cooled to lO^C in ice and centrifuged at SOOOrpm for 45 
minutes. The aqueous phase was removed and the phenol phase was 
reextracted with water. The two aqueous phases were pooled and 
dialysed against water for 48 hours. The dialysed sample was 
centrifuged at 105,000xg at 4*^ C and the LPS was obtained as a 
gelatinous precipitate. The precipitate was dissolved in water 
and stored at 4^C. This crude LPS preparation was used throughout 
the study unless stated otherwise.
The yield of LPS was determined by the dry weight of the
LPS.
2.3.5.3 Protein estimation of sonicated extract and LPS
2.3.5.3.1 Protein estimation by Bradford's method
Bradford's reagent ( Bradford,1976 ) was prepared 
fresh before use by dissolving lOOmg of Coomassie Brilliant Blue 
G-250 in 50ml of 95% ethanol. 100ml of 85% w/v phoshporic acid 
were added to it and the volume was made upto a litre. The 
solution was filtered before use.
A duplicate series of tubes containing 10, 20, 30, 40 
and 50pg BSA per lOOpl ( from a stock solution of Img/ml ) were 
set up. The volume in the test tubes were kept constant at 100|il. 
0.3ml of Bradford's reagent was added to each to tube and mixed 
well and incubated for 10 minutes at room temperature. The 
optical density of the contents of the tubes were measured at 
595nm and a standard curve was drawn.
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LPS and sonicated samples of vibrios were treated in a 
similar fashion and their protein content was determined by 
reading the concentration from the standard corresponding to 
their optical densities.
2.3.5.3.2 Protein estimation by the method of Lowry
Solutions
A. 2% NaCOg in O.IN NaOH
B. 0.5% CuSO^.511^ 0 in 1% potassium tartarate
C. 1ml of solutin B mixed with 50ml of solution A. This 
solution was prepared fresh before use.
E. Folin's reagent
Standard BSA solution ( Img/ml )
Procedure
Test tubes were set up in duplicates with lO-lOOpg of BSA 
and samples whose protein content was to be determined. The 
volumes were kept constant at 100|il. 1ml of reagent C was added 
to each test tube and incubated for 10 ten minutes. 0.1ml of 
Folin's reagent was then added and mixed well. The tubes were 
incubated for another 30 minutes and the optical density was 
measured at 7S0nm. The standard graph was plotted and the 
concentrations of unknown samples were obtained from the graph.
2.3.5.4 Polyacrylamide Gel Electrophoresis
Molecular weight determination and blotting of LPS and 
protein molecules were carried out on denaturing gels. The gels
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were prepared and run as described by Laemmli ( 1970 ).
The stock solutions used were as described below:
Stock solutions
Acrylamide—bisacrylamide (30:0.8)
30g of acrylamide and 0.8g of bisacrylamide were dissolved in 
100ml of water. The solution was then filtered and stored in a 
dark bottle at 4^C.
Resolving gel buffer 
3M Tris-HCl pH 8.8 
Stacking gel buffer 
0.5M Tris-HCl pH 6.8 
Ammonium persulphate
15% w/v of ammonium persulphate was prepared in water just before 
use.
Reservoir buffer
The buffer consisted of 0.025M Tris base, 0.192M glycine and 0.1% 
SDS. The pH was adjusted to 8.3.
Sample buffer
The buffer consisted of Q.0625M Tris base, 2% SDS, 10% 
glycerol,5% 2-mercapto-ethanol and 0.001% bromophenol blue. The 
pH was adjusted to 6.8.
Coomassie Blue Stain
The stain was made up by dissolving Ig of |CoomassieiBlue G-250 in 
250ml of methanol and 100ml of acetic acid.
Destain for Coomassie Blue
The destain consisted of 40% methanol, 10% acetic acid in 
distilled water.
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2.3.5.6.1 Preparation of slab gels
Slab gels of varying l^gths] and concentrations of 
acrylamide were prepared as stated in the respective sections.
2.3.5.6.2 Electrophoresis of Sonicated Vibrios
Equal volumes of the sonicated suspension ( Section
2.3.5.1 ) and sample buffer were mixed and boiled at 100 C for 5 
minutes. An aliquot of this mixture was loaded on a 15% slab gel 
10cm long. The gels were run at 60 mamps till the bromophenol
blue had reached the end of the gel.
The gels were stained with Coomassie Blue for 2-4 hours or 
silver stained. A replica of the gel was used for electrophoretic 
transfer on nitrocellulose paper ( described in Section
2.3.5.10 ). The Coomassie blue stained gels were destained to
remove the backround colour and facilitate the examination of the
stained bands.
2.3.5.4.3 Electrophoresis of LPS
Crude and pure (Sigma) LPS were dissolved in water and 
suspended in equal volumes of sample buffer and boiled at 100 C 
for 5 minutes. Appropriate volumes of the mixture were then 
loaded on 15% or 20% gels.
2.3.5.5 Silver Stain for LPS
Sonicated vibrios or crude LPS extract on gels were 
silver stained by the method of (Tsai and Frasch 1982) to detect
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the LPS. All glassware and plastic containers to be used in this 
method were thoroughly cleaned and rinsed with double deionised 
water. Double deionised water was used throughout in this method.
Solutions for Silver Stain 
Solution for fixing Gels
40% ethanol and 10% acetic acid in water.
Oxidising Solution
0.7% periodic acid in fixing solution.
Silver Stain
28ml of O.IN NaOH, 2ml of concentrated ammonia, 5ml of 20% silver 
nitrate and 115ml of water.
Developer
0.005% citric acid and lOOul of 37% formaldehyde in a litre of 
water.
Solution for preserving the silver stain
3% acetic acid
Procedure
After the gel electropheresis was complete the gel was placed 
in the fixing solution overnight.
The following day the gel was incubated in the oxidising 
solution for 5 minutes with shaking. The gel was then washed for 
45 minutes with atleast 5 changes of water. After the last wash 
the silver stain was added and the gel incubated in it for 10
minutes with vigorous shaking. The stain was discarded and the
gel was washed again for 30 minutes with 4-5 changes of water.
The gel was then incubated in the developer until the bands
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appeared with the desired intensity. The gel was then washed in 
water and preserved in 3% acetic acid.
2.3.5.6 Resolution of V.cholerae LPS
2.3.5.6.1 Resolution on 20% acrylamide
2-20ng of LPS were loaded on 40-50cm long gels and the
samples were electrophoresed at SOmamps until the tracking dye
had reached the end of the gel and for further two hours at the
same current. The gel was then silver stained.
2.3.5.6.2 Resolution on 15% acrylamide
2-20ng of LPS were loaded on 40-50cm long gels and the 
samples were electrophoresed at SOmamps until the tracking dye 
had reached the end of the gel and for further two hours at the
same current. The gel was then silver stained.
2.3.5.6.3 Resolution of hiRh mobility band
20-60ng of LPS were loaded on 90cm long gels and
electrophoresed at SOmamps for 8 hours and at 20mamps for 16
hours and by then the dye had reached the end of the gel. The
current was then increased to SOmamps and the electrophoresis was 
continued for another 2-3 hours. The gel was then cut in two 
halves lengthwise and stained for LPS.
2.3.5.7. RNAse digest of crude LPS
Crude LPS from either serotype were digested with 
50pg/ml of RNAse in lOmM Tris pH7.2 and ImM EDTA for 30 minutes 
at 37^C. After the digestion was complete the RNAse was extracted
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from the solution by 90% phenol at 65^C. The LPS remaining in the 
aqueous phase was dialysed against water for 24 hours before 
being studied on SDS-PAGE by silver staining.
2.3.5.8 LPS digestion with »<-mannosidase.P- and o<-Rlucosidase
A time-course digest of the LPS with the respective 
enzymes was carried out to study the presence of any terminal 
mannose,?- or o i- glucose residues in the LPS molecule.
SOOng of LPS were digested with 10 units of o<-mannosidase,
10 units of P-giucosidase and 25 units ofo<-glucosidase 
for different lengths of time at 37^C. Equal volume of sample
buffer was added to each digested sample and boiled for 5 minutes
to stop the enzyme reaction. The samples were then ready for 
SDS-PAGE analysis.
2.3.5.9 Acid Hydrolysis of LPS
LPS was hydrolysed with 1% acetic acid at 100 C for 
different lengths of time. The hydrolysed samples were 
neutralised with O.IN NaOH and analysed on SDS-PAGE by silver 
staining. An aliquot of hydrolysed sample was extracted with 
ether. Ether was removed from the aqueous phase by blowing air 
and the ether phase was air dried.
2.3.5.10 Electroblotting 
Transfer buffer
The buffer contained 25mM Tris-base, 0.19M glycine, 20% v/v 
methanol and 0.02 % SDS. The pH was adjusted to 8.6.
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Proteins and LPS were electrophoretically transferred 
onto nitrocellulose paper to enable binding studies with 
antibodies. The transfer was carried out essentially by the 
method of Batteiger (1981). Briefly, a plastic grid followed by 
a buffer-soaked Scotch-Brite pad and then a soaked filter paper 
was placed under the piece of gel to be electrophoresed. A 
nitrocellulose paper also soaked in buffer was then carefully 
placed on the wet gel so as to exclude any air bubble between the 
gel and the nitrocellulose paper. This was followed by a wet 
filter paper and another pad and a plastic grid. The assembly was 
immersed with the nitrocellulose paper closest to the anode in a 
BIO-RAD tank for electroblotting filled with the transfer buffer. 
The electrophoretic transfer was carried on at 350-400mamps for 
2.5-3 hours.
PRODUCTION AND PRELIMINARY CHARACTERISATION OF MONOCLONAL 
ANTIBODIES TO V.CHOLERAE
3.1 Experimental approach
The rat system for the production of monoclonal
antibodies was selected in this study. The rat cell lines
Y3/Ag.l.2.3 and YB2/0 and the DA ratswere readily available.
Heat killed and phenol preserved vibrios were injected 
into animals. Heat killed vibrios were used as they corresponded 
most closely to the routine vaccines.
3.2 Specificity of Rat Anti-sera against V.cholerae
Normal rat serum and anti-Ogawa and anti-Inaba sera
obtained from several rats were tested against Ogawa and Inaba 
vibrios on ELISA ( Section 2.3.3.1 ). The optimum number of 
vibrios coated on ELISA plates were determined by performing a 
chequer-board ELISA with antl-Ogawa and anti-Inaba antisera and 
normal rat serum. Figure 3.1 Illustrates the reaction of antisera 
and normal rat sera against various amounts of vibrios. Antisera 
exhibited a very strong reaction against 1.2x10^ vibrios and the 
reaction of normal rat sera was low, so 10^ vibrios were selected 
as the optimum concentration of f^brios! for future assays on
Fig.3.1 Chequer-board ELISA
Various amounts of vibrios were coated on ELISA plate and sera 
from immunised and unimmunised rats were reacted with them. The 
assay was repeated three times. The bars represent the deviation 
between three assays.
Reaction of anti-Ogawa antiserum against Ogawa vibrios 
y\ Reaction of anti-Inaba antiserum against Inaba vibrios
I I ^ 2  Average reaction of unimmunised rat serum against Ogawa
and Inaba vibrios
Background reaction was below 0.1 O.D.
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ELISA. The ELISA reactions of antisera and normal sera on two 
serotypes of cholerae are illustrated in Figure 3.2. Normal 
rat sera had little activity against the two serotypes of
V. cholerae. Anti-Ogawa antisera reacted with both Ogawa and
Inaba and had high titres against both serotypes. Anti-Inaba 
antisera also reacted strongly with Inaba and Ogawa vibrios. 
However, the reaction of each type of antisera was stronger
against the immunising serotype, this is in agreement with the
results obtained by Cryz et^  ( 1982 ).
3.3 Presence of A.B and C Antigens on V.cholerae
Among the heat stable lipopolysaccharide antigens of
V. cholerae, serogroup 0:1, the group-specific antigen A, is
shared by Inaba and Ogawa serotypes. The type-specific antigen B 
is Ogawa specific and C is Inaba specific ( Kauffmann, 1950 ). 
The results of the activity of the polyclonal antisera ( Section
3.2 ) are In agreement with the conventional serological 
classification of cholerae. The anti-Ogawa sera may be
presumed to react with the A and B antigens, hence the
cross-reaction with Inaba vibrios. Similarly the anti-Inaba sera 
may be presumed to cross-react with the A antigens on Ogawa 
vibrios.
3.4 Myeloma Lines Used as Fusion Partners
3.4.1 Y3/A&.1.2.3 Myeloma Line
Y3 cell line was cultured in complete medium containing 
10% FCS.The cells could be grown in spinner or Nunc T-75 culture
Fig.3.2 a ELISA of antisera and unimmunised rat sera against 
Inaba vibrios
Reaction of anti-Ogawa antisera 
Reaction of anti-Inaba antusera 
Reaction of unimmunised rat sera 
—  —  —  —  Background reaction
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Fig.3.2 b ELISA of antisera and unimmunised rat sera against
Ogawa vibrios
Antisera from ten different rats were tested and the mean values
were plotted, the bars indicate the variation between each assay.
Q  Reaction of anti-Ogawa antisera
Reaction of anti-Inaba antisera 
I [ I I Reaction of unimmunised rat sera
Background reaction was below 0.1 O.D.
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flasks. The doubling time for the cells was 18-20 hours.
3.4.2 YB2/0 Myeloma Line
YB2/0 cells were cultured in complete medium containing 
10% PCS. The doubling time of the cells were about 30 hours.
3.5 Hybridomas Raised From Rat Myeloma Lines
3.5.1 Hybridomas derived from Y3/Ag.l.2.3 Myeloma Line
Ogawa or Inaba immunised rat spleen cells were fused with 
Y3/Ag.1.2.3 cells obtained from a spinner culture or a T-75 
culture flask. The Y3/Ag 1.2.3 cells from a spinner culture were 
superior fusion partners to Flask grown cells. When they were 
cultured in a Nunc flask, a high proportion of cells stuck to the 
surface of the flask and had to be shaken off before the fusion. 
Spleen cells fused with Y3/Ag.l.2.3 from a spinner culture gave a 
higher percentage of hybridomas than cells fused with Y3/Ag.1.2.3 
grown in a T-75 flask ( Table 3.1 ). The average time period for 
the hybridomas to be visible after a fusion was 8-15 days. 
Hybridomas derived from flask cultured Y3 cells usually took 
longer to emerge.
The emerging hybridomas were screened for secretion of 
antibodies reactive with Ogawa and Inaba on ELISA on the third or 
fourth week after fusion. The positive clones were expanded from 
the 2ml wells into 25ml culture flasks. The cells were then 
subcloned ( Section 2.4.8 ) and some were kept frozen in liquid 
nitrogen. Frozen primary clones could subsequently be recovered 
and cloned if necessary.
Ü6
Fusion No. Culture of Y3 Percentage of 
wells with 
hybridomas
Percentage of 
positive hybrids
1 T-5 Flask 2 100
2 T-5 Flask 6 50
3 T-5 Flask 20 60
4 Spinner Flask 80 60
5 Spinner Flask 65 -
6 Spinner Flask 45 —
Table 3.1 Effect of culture conditions of Y3 cells on yield of 
hybridomas
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3.5.2 Hybridomas derived from fusion with YB2/0 Myeloma Line 
Spleen cells from a rat hyper-immunised with Inaba vibrios
were fused with YB2/0 cells grown in a spinner culture. 10-15 
days after the fusion 70 out of 90 wells in the fusion plates had 
hybridoma growth in them. The hybridomas were then screened on 
ELISA. 50% of the clones secreted antibodies against Inaba
vibrios. The cells from the positive wells were expanded in
culture flasks. The cells grew at a very slow rate in the flask 
and most of them eventually died. This difficulty in expansion 
rendered the cells unsuitable for antibody production and the 
YB2/0 line was not pursued further.
3.5.3 Subclones Screened on ELISA
10-12 days after subcloning 90-95% of the wells 
subcloned at 0.5 cells per well had cells growing in them. About 
50% of the wells subcloned at 0.25 cells per well had cell 
growth, presumably due to slight inaccuracies in cell counting. 
The supernatants from the wells were assayed on ELISA. Almost 
every subclone secreted antibodies similar to that of the parent 
clone in the original fusion plate. This confirms the reports
from others on the early stability of the rat system (Clark
et al. 1982). Subcloning was performed three times at 0.25 
cells/well before a hybridoma was presumed to secrete monoclonal 
antibodies.
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3.6 Specificity of Monoclonal Antibodies
Monoclonal antibodies raised against the Ogawa serotype 
were 04A6, 03D1 and 0402, each derived from a separate fusion.
The monoclonal antibodies raised against Inaba serotype were 
I1A1,I4B1 and I4C3 all derived from the same fusion. The six 
established clones were reacted on ELISA with a panel of 
distantly related gram-negative bacteria to detect any 
cross-reactions between serotypes of 01 group and other unrelated 
0—antigens.
Figure 3.3a shows the reaction of 04A6, 0301 and 0402
against Ogawa, Inaba, E^ coll. B. abortus and ^  melitensis on 
ELISA. The monoclonal antibodies do not react with the Inaba 
serotype. None of the three monoclonal antibodies bound to any of 
the other gram-negative bacteria. Culture supernatants of 04A6 
and 0301 had a titre lower than 1 in 512 and 0402 had a titre of 
1 in 512 against the Ogawa serotype.
The reaction of IlAl, I4B1 and I4C3 is demonstrated in 
Fig.3.3b. The monoclonal antibodies reacted very strongly with 
Inaba vibrios. None of the three MCAbs appeared to react with 
the non-Ol group of antigens. The titre of IlAI was 1 in 256 and 
that of I4B1 and I4C3 were less than 1 in 512 against Inaba. It 
should be noted that while all three of these antibodies appear 
to react at background level with Ogawa vibrios, the background 
is slightly higher than that obtained with the Ogawa specific 
monoclonals on the Inaba vibrios.
MCAbs raised against A, B and C antigens by Gustafsson and
Fig.3.3 a Titration of rat MCAbs on various gram-negative
bacteria
Each MCAb was titred on 10^ bacteria. The values plotted are a 
mean of five asays.
I ]_ j I Reaction of 04A6 against Ogawa
yY Reaction of 03DI against Ogawa
Q  ^2^ Reaction of 04D2 against Ogawa
Average reaction of 04A6, 04D2 and 03D1 on Inaba,
B. abortus. B. melitensis and ^  coli ML 308 
_________ Background reaction
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Fig.3.3 b Titration of rat MCAbs on various gram-negative 
bacteria
Each MCAb was titred on 10^ bacteria. The values plotted are a 
mean of five asays.
Reaction of IlAl against Inaba 
Reaction of I4B1 against Inaba 
Reaction of I4C3 against Inaba
Average reaction of IlAl, I4B1 and I4C3 on Inaba,
B. abortus. B. melitensis and E^_ coli ML 308 
 —. —  Background reaction
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Fig.3.3 c Titration of anti-V. cholerae mouse MCAbs 
Mouse MCAbs as ascites were obtained from Sweden ( Section 3.6 ). 
The antibodies were titred on 10^ bacteria. The values plotted 
are a mean of two asays.
^ R e a c t i o n  of antl-A MCAb against Inaba
^ R e a c t i o n  of anti-A MCAb against Ogawa
y/y____Reaction of anti-B MCAb against Ogawa
^ ^  Reaction of anti-B MCAb against Inaba
^  Reaction of anti-C MCAb against Ogawa
^ R e a c t i o n  of anti-C MCAb against Inaba
--------- _  Background reaction
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Holme ( 1983 ) were received in exchange and tested on ELISA as 
with the other MCAbs with the exception of the blocking buffer. 
The MCAbs received as ascitic fluid reacted with BSA and hence 
the ELISA plates were blocked with 5% normal goat serum. On doing 
so, the MCAbs exhibited their respective specifities 
( Fig.3.3c ).
Consequently, primary screening of the MCAbs established in 
this study detected three monoclonal antibodies apparently 
specific to the B antigen of classical serology and three 
apparently specific to the C.
3.7 Class and Subclass Analysis of Monoclonal Antibodies
3.7,1 Immunoglobulin Class and Subclass determination by
Ouchterlonv
The method of Ouchterlony ( Ouchterlony and Nilsson, 
1978 ) involved precipitation of antibodies by a polyclonal 
antiserum in agar. Anti-rat IgG, IgM, IgGl, IgG2a, IgG2b and 
IgG2c were reacted with rat serum. Each of the anti-rat 
immunoglobulin class and subclass antisera reacted with the 
various subclasses of the immunoglobulins present in the rat 
serum. The major immunoglobulin component of the rat serum was 
IgG. The distribution of the subclasses of IgG in the serum were 
in the decreasing order of IgGl, IgG2a, IgG2c and IgG2b as judged 
by the intensity of the precipitin lines obtained with the 
reagents used ( Figure 3.4a ).
Immunoglobulins of all six hybridomas were precipitated 
only by anti-rat IgG2b ( Figure 3.4b ). It was necessary to
Fig.3.4 a Ouchterlonv of rat antisera
Polyclonal antiserum against rat IgGl, IgG2a, IgG2b and IgG2c 
were added in the centre wells of 1, 2, 3 and 4 respectively. Rat 
antiserum was added in doubling dilutions in the peripheral 
wells.
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Fig.3.4 b Ouchterlony of rat MCAbs
Polyclonal antiserum against rat IgG, IgM, IgGl, IgGZa, IgG2b and 
IgG2c were added in the centre wells of I, 2, 3, 4, 5 and 6 
respectively. Rat MCAb 04A6 was added in doubling dilutions in 
the peripheral wells.
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concentrate the tissue culture supernatant 10 fold with ammonium 
sulphate ( Section 2.3.4.3 ) to obtain any precipitation.
Attempts to confirm the subclass allocation by ELISA did 
not yield a clear picture because of the nature of the commercial 
antisubclass reagents. The four anti-rat Ig subclass reagents 
were available as antisera from three species of animals 
( Miles ), hence comparison of data was inconvenient. Moreover, 
the reagents reacted with light chains.
It is of interest to note that all six monoclonal 
antibodies are of the same subclass. Mouse monoclonal antibodies 
reactive with bacterial lipopolysaccharides and carbohydrates in 
general tend to be either IgMs or of the IgG3 subclass which is a 
minor serum component ( Section 6.4 ) and the data suggest that 
IgG2b may be the equivalent subclass in the rat.
3.7.2 SDS-PAGE Studies of MCAbs Precipitated with Second 
Antibody
The immunoglobulins secreted by the established
hybridomas were analysed on 10% SDS-PAGE by internal labelling of
35the hybridomas with 5-methionine ( Section 2.3.4.1 ). The 
Y3/Ag.l.2.3 cell line and mouse myeloma line, P3/X63 Ag.8 
( Kohler and Milstein, 1975 ) were also labelled for comparison.
The second antibodies used were goat anti-rat IgG and 
goat anti-rat IgM. The precipitating antiserum was donkey 
anti-goat. Both anti-rat IgG and anti-rat IgM precipitated the 
Y3/Ag 1.2.3 kappa light chain and the monoclonal antibodies, 
presumably due to reaction with their light chain as there were
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no heavy chains apparent on the gels or fluorographs 
( Figures.5b ). All the monoclonal antibodies made a heavy chain 
of molecular weight 50-51,000 and all but 04A6 made two light 
chainsC Figure 3.5a ). The two light chains may either represent 
the Y3 light chain together with that of the monoclonal antibody 
or differential glycosylation of a single light chain ( Kohler 
and Milstein, 1976 ).
Fig.3.5 a SDS-PAGE of MCAbs precipitated with polyclonal
antisera
MCAbs were internally labelled and precipitated as described in 
Section 2.3.4.1.
Lane 1 04A6 precipitated with anti-rat IgG
Lane 2 04A6 precipitated with normal goat serum
Lane 3 03D1 precipitated with anti-rat IgG
Lane 4 04D2 precipitated with anti-rat IgG
Lane 5 P3 precipitated with anti-mouse IgG
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Fig.3.5 b SDS-PAGE of MCAbs precipitated with polyclonal
antisera
MCAbs were internally labelled and precipitated as described in 
Section 2.3.4.1.
Lane 1 Y3 precipitated with anti-rat IgG
Lane 2 Y3 precipitated with anti-rat IgM
Lane 3 IlAl precipitated.with anti-rat IgG
Lane 4 IlAl precipitated with anti-rat IgM
Lane 5 Radioiodinated Protein molecular weight markers
Lane 6 I4C3 precipitated with anti-rat IgG
Lane 7 I4C3 precipitated with anti-rat IgM
Lane 8 I4B1 precipitated with anti-rat IgG
Lane 9 I4B1 precipitated with anti-rat IgM
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ANALYSIS OF V. CHOLERAE LPS ON SDS-PAGE
4.1 Outer membrane of V. cholerae
The V^ , cholerae outer membrane consists of
lipopolysaccharide and protein. The LPS is believed to be
responsible for the major host immune response ( Levine et al, 
1979; Majumdar and Ghose, 1981; Majumdar et 1981 ). Low
molecular weight outer membrane proteins have also been reported 
to be immunogenic ( Kabir, 1980; Stevenson et al, 1985 ). The
reaction of the six MCAbs raised in this study with these 
components was Investigated by Western blots of sonicated vibrios 
and LPS extracted from the vibrios.
4.2 Sonicated V. cholerae organisms
The protein content of the sonicated vibrios was
determined by both the method of Lowry et ^  ( 1951 ) and
Bradford ( 1976 ). 2x10^^ sonicated vibrios per ml had a protein 
content of 12.5 mg per ml by the Lowry method and 4.3 mg per ml 
by the Bradford method of protein estimation.
4.3 Extraction of LPS from the vibrios
V. cholerae LPS was extracted by the hot aqueous-phenol method 
described in Section 2.3.5.2. The aqueous phase was centrifuged
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to obtain the gelatinous precipitate of LPS. The crude LPS thus 
obtained was not purified any further. The protein contamination 
in the LPS was 1.2 mg/ml by the Lowry method and 0.2 mg/ml by 
Bradford method of protein estimation.
Carbohydrate components of LPS of some gram-negative 
bacteria have been reported to absorb light at specific 
wavelengths ( Afzal e^ al, 1984 ). Crude LPS obtained from the 
serotypes of cholerae were scanned over wavelengths 220-700nm 
to detect any absorption. The LPS absorbed to a small extent at 
wavelengths of 280-260nm ( Fig.4.1 ) which may have been
contributed by the contaminating proteins and nucleic acids but 
could also be accounted for by light scattering from such a large 
molecule. The LPS did not otherwise have any characteristic 
absorption at any wavelength examined. Ogawa and Inaba LPS gave 
identical results.
4.3.1 Storage of LPS
Crude LPS obtained from heat killed vibrios were dissolved 
in distilled water and stored at 4^C at a concentration of 
l|ig/ml. No visible aggregation was observed at these conditions 
of storage for a period of about three months. Aggregation was 
observed in samples stored for longer than three months.
4.4 V.cholerae proteins estimated by the Lowry's and the 
Bradford's methods
Many substances are known to interfere with the Lowry's 
method of protein estimation ( Peterson, 1979 ). The extensive
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Fig. 4.1 Absorption plot of LPS
LPS from Ogawa serotype at a concentration of Ipg/ml was scanned 
over wavelengths 220nm to 700nm
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list of substances reported by the author to interfere with the 
assay include lipids and glucosamines, both of which are present 
in high amounts in the cholerae LPS ( Raziuddin, 1980 ). The 
interference of these two substances may have been the reason for 
the high values of protein obtained in the sonicated vibrios and 
the crude LPS by the Lowry's method of estimation. The Bradford’s 
assay has not been reported to be affected by non-protein 
substances. The protein content as obtained by the Bradford's 
method of estimation has been taken as the value of protein in 
the sonicated and the LPS samples.
4.5 Silver stain of sonicated vibrios and LPS
10 pg of protein from the sonicated samples and 15 ng of 
LPS from each serotype were electrophoresed on 15% polyacrylamide 
gels ( Sections 2.3.5.4.2 and 2.3.5.4.3 ) and silver stained as 
described in Section 2.3.5.5. In the sonicated samples of the 
vibrios a prominent streak ( Fig.4.2a ) or bulge ( Fig.4.2b ) was 
stained at the region of 30K . A major band at about 14K
and two other bands in the region of 16K were present along 
with numerous other faintly stained bands. The pattern of bands 
for both serotypes were identical.
The LPS preparations from the Inaba 35 A3 and Ogawa 
NIH 41 serotypes consisted of two major band types, a slow moving 
band of 30K and a fast moving band of 14K. The low
molecular weight band formed a doublet. The Inaba 569B LPS 
obtained from Sigma showed bands in addition to that observed 
with Ogawa NIH 41 and Inaba 35 A3. However, the two most
Fig.4.2 a Silver stain of sonicated vibrios
Sonicated vibrios were electrophoresed on 15% acrylamide gel, 
10cm long.
Lane 1 Protein molecular weight markers ( Pharmacia )
Lane 2 lOpg protein from sonicated Ogawa vibrios
Lane 3 lOpg protein from sonicated Inaba vibrios
Lane 4 5pg protein from sonicated Ogawa vibrios
Lane 5 5pg protein from sonicated Inaba vibrios
Lane 6 20ng of Inaba 569 B LPS
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Fig.4.2 b Silver stain of sonicated vibrios and LPS
Sonicated vibrios and crude LPS from Ogawa NIH 41 and Inaba 35 A3
were electrophoresed on 15% acrylamide gel, 10cm long.
Lane 1 lOpg protein from Ogawa sonicated vibrios
Lane 2 lOpig protein from Inaba sonicated vibrios
Lane 3 15ng of Ogawa LPS
Lane 4 15ng of Inaba LPS
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prominent bands coincided with the two bands of Ogawa NIH 41 and 
Inaba 35 A3.
4.6 V. cholerae LPS on SDS-PAGE
The bands obtained with the crude LPS of both serotypes 
corresponded with the broad streak ofM^ 30K and the doublet of 
14K in the sonicated samples ( Fig. 4.2 ). This indicated that 
the LPS constituted a major portion of the vibrio outer membrane.
The crude LPS on electrophoresis formed a broad band and 
in the presence of proteins most frequently it streaked at the 
sides of the track ( Fig.4.2b ). Typical smooth LPS molecules 
from other gram negative bacteria separate on electrophoresis to 
give three components in the complex molecule. The fastest moving 
band is that of the lipid A. The core migrates just behind the 
lipid A and it is followed by several 0-side chains in the order 
of increasing molecular weight giving a "ladder" effect ( Palva 
and Makela, 1980; Goldman and Leive, 1980 ). In the Ogawa NIH 41 
and Inaba 35 A3 LPS the fast moving doublet may, by analogy, be 
tentatively identified as the lipid A and the core. The putative 
0-side chain did not separate into a "ladder" of units differing 
by increments in molecular weight but gave a diffuse band. This 
indicated an apparent lack of size differences in the side chains 
of the ^  cholerae LPS. The Inaba 569B LPS exhibited more than 
two diffused bands, presumably each one represents 0-chains of 
the particular strain. However, the diffused nature of the slow 
moving band indicated some heterogeneity which could not be 
resolved under the conditions employed.
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4.7 Coomassie blue stain of sonicated vibrios
lO^g of protein from the sonicated samples of the vibrios 
were electrophoresed on a 15% acrylamide gel and stained for 
proteins with coomassie blue. Numerous bands in the region of 
70-30K were stained but there was comparatively little 
staining below 30K ( Fig. 4.2 c ).
4.8 Western blot of sonicated vibrios and crude LPS
LPS and the sonicated vibrios were electrophoresed and 
blotted as described by ( Batteiger, 1982 ) ( Section 2.3.5.10 ). 
The blot of the sonicated vibrios was stained with amido black 
( Pig. 4.3a and b ). This reagent does not stain LPS. The LPS was 
immunoblotted with MCAbs 04A6, IlAl and I4B1 and detected with a 
second rabbit anti-rat antibody crosslinked to horseradish 
peroxidase ( Section 2.3.4.5.1 ).
The MCAbs 04A6 and IlAl reacted with either the Ogawa or
the Inaba serotype respectively ( Fig.4.3a ). I4B1 reacted with
LPS of not only the homologous strain but also with the Inaba
569B ( Fig.4.3b ), suggesting that the LPS of the two strains are
antigenically similar. The four other MCAbs also reacted only 
with the serotypes originally assigned to them by the ELISA assay 
( Section 3.6 ). All six MCAbs reacted only with the slow moving 
band or bands tentatively identified as the C-antigen, and not 
the faster moving putative core of the LPS. They did not react 
with any of the protein antigens in the sonicated samples.
Pig.4.2 c Coomassie blue stain of sonicated vibrios
Sonicated vibrios were electrophoresed on a 15% acrylamide gel,
10cm long.
Lane 1 Protein molecular weight markers ( Pharmacia )
Lane 2 lOpg protein from Ogawa sonicated vibrios
Lane 3 lOpg protein from Inaba sonicated vibrios
107
1 4 . 4K
1 2  3
Fig. 4.3 a Western blot of sonicated vibrios and LPS 
Sonicated vibrios and crude LPS were electrophoresed on 15% 
acrylamide gel, 10cm long. The gel was electrophoretically
blotted onto a nitrocellulose paper and the blots were either
stained with amido black or immunostained and developed by enzyme 
detection method ( Section 2.3.4.5.1 ).
Lanes 1-3 were stained with amido black
Lanes 4-7 were reacted with MCAb IlAl
Lanes 8-11 were reacted with MCAb 04A6
Lane 1 lOjjg protein from Ogawa sonicated vibrios
Lane 2 lOpgprotein from Inaba sonicated vibrios
Lane 3 Standard protein molecular weight markers
Lanes 4 and 8 lOpg protein from Ogawa sonicated vibrios
Lanes 5 and 9 lOjig protein from Inaba sonicated vibrios
Lanes 6 and 10 15ng of Ogawa LPS
Lanes 7 and 11 15ng of Inaba LPS
io8
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Fig.4.3 b Western blot of sonicated vibrios and LPS 
Samples were electrophoresed on 15% acrylamide gel, 10cm long and 
then electroblotted onto a nitrocellulose paper. Part of the blot 
was stained with amido black and the other part was 
immunostained ( Section 2.3.4.5.1 ).
Lanes 1-4 were stained with amido black
Lanes 5-7 were reacted with MCAb 14B1
Lane 1 Protein molecular weight markers ( Pharmacia )
Lanes 2 and 5 lOpg protein Inaba sonicated vibrios 
Lanes 3 and 6 15ng of Inaba 35 A3 LPS 
Lanes 4 and 7 5pg of Inaba 569 b LPS
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4.9 V.cholerae proteins on SDS-PAGE
The Ogawa and the Inaba serotypes did not differ in the 
protein patterns obtained by the silver stain, the coomassie blue 
or the the amido black stains ( Fig. 4.2b and c and 4.3 a ). Some 
low molecular weight protein bands were dominant in the silver 
stained gel and the high molecular weight proteins did not stain 
very well. In the coomassie blue stained gel and the amido black 
stained blot there was an abundance of high molecular proteins 
and the low molecular weight proteins were barely detectable.
The silver stain used in this study ( Section
2.3.5.5 ) stained both proteins and LPS. Glycoproteins have been 
reported to be most intensely stained by this method ( Tsai and 
Frasch, 1982 ). The differential staining of the proteins by the
three stains used may have been responsible for the different
protein profiles.
4.10 Western blot of enzyme digests of LPS
The diffuse band of the cholerae LPS observed in the
silver stained gels and the immunoblots raised the possibility of 
several related substances comigrating. Different glycosidases 
were used to study the effect on the migration of
glycosidase-digests of LPS.
The V\ cholerae LPS was digested with e<-mannosidase, 
0^ -glucosidase and P-glucosidase as described in Section 2.3.5.8. 
The digested LPS was elecrophoresed and immunoblotted. 
Differences between the digested and the undigested molecules
I l l
were observed on blotting ( Fig. 4.4a )i »<-inannosidase digest 
gave rise to two diffuse bands close to each other and in the 
same molecular weight range as that of the undigested molecule. 
In the P-glucosidase digest two bands were visible, one more 
dominant than the other. Digests from the »^-glucosidase did not 
produce any change in the blotting pattern. Both Ogawa and Inaba 
LPS gave rise to similar bands on digestion with the 
glycosidases. Silver staining showed complex patterns as the 
enzyme preparations stained extensively themselves ( Fig.4.4b ). 
All the MCAbs reacted in a similar fashion.
4.11 Action of exoglycosidases on LPS
The exoglycosidases used in this study did not yield very 
conclusive results. The enzymes on their own showed multiple 
bands over a wide range of molecular weights with silver stain 
( Fig.4.4b ). The presence of proteins affects the migration and 
staining of the LPS ( Fig. 4.2 ) and hence it was difficult to 
interpret the results obtained in Pig. 4.4a.
Exoglycosidases would hydrolyse only the terminal sugar 
residues. This would lead to the shortening of the sugar chains 
on the core or the 0-side chains. cholerae 0-antigen is 
predominantly made up of ( 1^2 ) linked 4-amino-4,6-dideoxy-«^-D
mannopyranosyl residues ( Redmond, 1979 ). The two diffused bands 
observed in the digest of #rmannosidase may have arisen from the 
partial digestion of the LPS molecule.
It was more difficult to interpret the results 
obtained from the digests of ^-glucosidase. Glucose has been
Fig.4.4 a Western blots of enzyme digests of LPS 
Inaba 35 A3 LPS digested with various enzymes ( Section 2.3.5.8 ) 
was blotted and immunostained with protein A ( Section
2.3.4.5.2 >.
Lane 1 Inaba LPS
lane 2 s^mannosidase digested Inaba LPS
Lane 3 «^-mannosidase enzyme
Lane 4 p-glucosidase digested Inaba LPS
Lane 5 |^glucosidase enzyme
Lane 6 «^glucosidase (yeast) digested Inaba LPS
Lane 7 a^-glucosidase (yeast) enzyme
Lane 8 e^^lucosidase (rice) digested Inaba LPS
Lane 9 «(-glucosidase (rice) enzyme
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Fig.4.4 b Silver stain of enzyme digests of LPS
Enzyme digested LPS and the enzymes on their own were 
electrophoresed on 15% acrylamide gel, 10cm long.
Lane I «(-glucosidase
Lane 2 [^glucosidase
Lane 3 Crude Inaba 35 A3 LPS
Lane 4 «(-glucosidase digested Inaba 35 A3 LPS
Lane 5 ]^-glucosidase digested Inaba 35 A3 LPS
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detected in the LPS of the cholerae ( Raziuddin, 1979; Kenne 
et al. 1982 ), but details about its conformation are not
available. The appearance of the two bands could be explained by 
partial hydrolysis of the LPS molecule, the substrate, 
|1-glucoside being provided presumably by the core. This
experimental approach is clearly severely hampered by two 
factors. The detailed structure of the LPS is not known and 
therefore the results are difficult to interpret. In addition, 
the enzymes employed were impure and any results obtained could 
be the result of the activity of unknown contaminants rather than 
the true enzyme. Consequently this line of investigation was not 
further pursued.
4.12 Analysis of LPS with lectins
Lectins are plant proteins which can bind to
carbohydrates with a high degree of specificity. They are 
generally used to study the presence of sugar residues or the 
conformation of oligosaccharides in glycoproteins ( Baenziger 
et al. 1979 ). Lectins have also been used in structural studies
of gram—negative bacterial LPS ( Kabir, 1982; Corbel et^ , ajl 
1984 ). The lectins, Concanavalin A ( ConA ) and wheat germ
agglutinin ( WGA ) were employed in this study.
4.12.1 Concanavalin A binding sites on V. cholerae LPS
V. cholerae LPS and the%r and f^glucosldase digests of
the LPS were Western blotted and the blot was reacted with 
125
I-Con A as described in Section 2.3.4.7.2. The film was
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125developed two days after exposure to the isotope. I-Con A did 
not bind to the LPS or the enzyme digests of the LPS ( Fig. 
4.5 ). The radioiodinated con A did however bind to two bands of 
the enzyme j^glucosidase.
4.12.2 Wheat germ agalutinin binding studies on LPS
Ogawa and Inaba LPS were electrophoresed on a 15%
polyacrylamide gel along with some molecular weight protein
125markers. The gel was overlaid with I-WGA as described in 
section 2.3.4.7.1. The film was developed 20 days after exposure 
to the radioisotope. The iodinated WGA bound to the 
glycoprotein, ovalbumin and also to phosphrylase b among the 
protein markers but not to the LPS ( Fig. 4.6 ). Phosphorylase b 
is not a glycoprotein but the product obtained from Pharmacia kit 
of protein markers may have some glucan residues as suggested by 
Dubray and Bezard ( 1982 ).
4.13 Lectin-LPS interaction
The work undertaken here with the lectins demonstrated 
that neither Con A nor WGA were capable of binding to vibrio LPS. 
Kabir ( 1982 ) had reported the precipitation of alkali-treated 
Ogawa LPS with Con A and N-acytelated LPS with WGA in capillary 
tubes. Two of the methods used in this study were, the treatment 
of a blot and a gel with lectins. To obtain a minimal amount of 
background the gel or the blot had to be washed several times 
with wash buffer containing Tween 20 ( Section2.3.4.7.1 ).
If the binding of the lectins to the bacterial LPS was of
Fig. 4.5 Concanavalin A binding sites on V.cholerae LPS 
LPS and enzyme digests of LPS were electrophoresed and blotted. 
The blot was treated with radioiodinated con A ( Section 
2.3.4.7.2 )
Lane 1 Ogawa LPS
Lane 2 «^-glucosidase digested Ogawa LPS
Lane 3 j^-glucosidase digested Ogawa LPS
Lane 4 o^-glucosidase enzyme
Lane 5 P-glucosidase enzyme
Lane 6 Inaba LPS
Lane 7 «(-glucosidase digested Inaba LPS
Lane 8 P-glucosidase digested Inaba LPS
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Fig. 4.6 Wheat germ agglutinin binding sites on V.cholerae LPS 
LPS from Ogawa and Inaba were electrophoresed and treated with 
radioiodinated WGA.
Lane 1 Standard protein molecular weight markers
Lane 2 Ogawa LPS
Lane 3 Inaba LPS
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low affinity the possibility of them being washed from the gel or 
the blot was high.
The observations from this work did not indicate any 
binding of the lectins to the LPS. The glucosamines residues 
detected by Kabir ( 1982 ) were the residues of the lipid A which 
the author had exposed by pretreating the LPS with alkali.
6.14 Resolution of V. cholerae LPS
In contrast to LPS preparations from other gram negative 
bacteria, resolution of the 0-antigen side chains of cholerae 
LPS was difficult to obtain under normal conditions of gel 
electrophoresis. The migration of the complex 0-side chain of the 
V. cholerae LPS gave a diffuse, but definitely not single band 
( Section 4.4, Fig. 4.2 ). It was clearly more homogenous than 
other gram-negative bacterial LPS molecules analysed on 
SDS-polyacrylamide gels ( Hitchcock and Brown, 1983, Schiller 
et al. 1984 ). However, the broad and diffuse band of the
0-antigen suggested the existence of heterogeneity at a finer 
level. Resolution of the microheterogeneity in the LPS molecule 
was undertaken by making some modifications in the conditions of 
SDS-PAGE.
4.14.1 Resolution of LPS at high percentage of acrylamide and 
a long electrophoresis time
E.coli ( serotype 0127 B8 ) LPS ( Sigma ) and crude 
V. cholerae LPS were electrophoresed on a 20% polyacrylamide gel
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of 20 cm length as described in Section 2.3.5.6.1. The gel was 
then stained for LPS.
E.coli ( 0127 B8 ) LPS resolved into numerous bands 
in the classical "ladder". From the lower end of the gel the 
different components of the LPS were the lipid A, the core and 
then the 0-side chains with increasing molecular weight as the 
number of repeating units attached to it increased ( Fig. 4.7 ). 
The cholerae LPS had again not been resolved with respect to 
the 0-side chain. It exhibited the lipid A and the core as a 
doublet which had the same mobility as the lipid A of coli. On 
careful examination of the stained 0-region of the LPS it was 
possible to detect a few bands at the trailing end.
It became apparent, after a large number of 
experiments, that it was not the use of a high percentage gel, 
but rather the long electrophoresis which allowed the LPS to be 
further resolved.
4.14.2 Resolution of LPS on a 15% gel with a long
electrophoresis time
V. cholerae LPS was electrophoresed on a 15% acrylamide gel as 
described in Section 2.3.5.6.2 to improve upon the resolution 
achieved so far. The gel was then silver stained as before. This 
resolved the cholerae 0-side chains and revealed the existence 
of at least 8-9 discrete bands ( Fig. 4.8 ). The lipid A 
component was allowed to run off the end of the gel. The 
separation of the complex 0-side chains was concentration 
dependent. At low concentrations the separated bands did not
Fig. 4.7 Silver stain of LPS on a 20cm long 20% 
SDS-polvacrylamide gel
E. coll ( 0127 B8 ), Ogawa NIH 41 and Inaba 35 A3 LPS were 
electrophoresed as described in Section 2.3.5.6.1.
Lane 1 lOpg coli LPS
Lane 2 7.5pg coli LPS
Lane 3 5jig ^  coli LPS
Lane 4 5ng Ogawa LPS
Lane 5 3.7ng Ogawa LPS
Lane 6 2.5ng Ogawa LPS
Lane 7 lOng Inaba LPS
Lane 8 7.5ng Inaba LPS
Lane 9 5ng Inaba LPS
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Fig. 4.8 Silver stain of LPS on a 20cm long 15% 
SDS-polvacrylamide ael
E. coli 0127 B8, Ogawa NIH 41 and Inaba 35 A3 LPS were 
electrophoresed on 15% gel as described in Section 2.3.5.6.2.
Lane 1 lOpg coli LPS 
Lane 2 7.5pg coli LPS
Lane 3 5pg ^  coli LPS
Lane 4 5ng Ogawa LPS
Lane 5 3.7ng Ogawa LPS
Lane 6 2.5ng Ogawa LPS
Lane 7 lOng Inaba LPS
Lane 8 7.5ng Inaba LPS
Lane 9 5ng Inaba LPS
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stain well ( Fig. 4.8, lane 6 ) and at high concentrations the 
slow moving bands were overstained and hence remained 
indistinguishable ( Pig. 4.8, lane 7 ). The best separation and 
staining of the LPS was obtained at concentrations of 10-13 ng
( Fig. 4.8, lanes 8 and 9 ).
The ^  coli LPS was less suited for this system as the
sharp bands obtained in the 20 % acrylamide gel ( Section
4.14.1 ) were diffuse, though each diffuse band showed little 
apparent microheterogeneity.
4.14.3 Electrophoresis of LPS on a DNA sequencing gel
On a gel system like that described in section 4.14.2, 
the 0-side chains of the cholerae LPS were resolved by 
allowing the high mobility band of lipid A to run off the gel. To 
achieve a good resolution and retain the lipid A band in the gel, 
a DNA sequencing gel of 42 cm length was employed. On a long gel 
greater amounts of LPS were needed for the optimum separation and 
staining of the LPS. The electrophoresis was carried out as
described in Section 2.3.3.6.3. The gel was cut in two halves 
before being stained for LPS. The upper half of the gel did not 
contain any stained material and the lower half had both the 
lipid A and the 0-region ( Fig. 4.9 ). Under these conditions of 
separation at least ten distinct bands were visible in the 
0-region. It was apparent that at low concentrations of LPS the 
high mobility bands of the 0-side chain were not detectable.
The lipid A part of the molecule was also resolved 
into three bands not observed before. The middle band of the
Fig. 4.9 Silver stain of V.cholerae LPS
Crude Inaba 35 A3 LPS was electrophoresed on a 15% 
SDS-polyacrylamide gel of length 42cm as described in Section 
2.3.5.6.3. The top 20cm of the gel which contained no material 
reacting with the stain have not been included in the photograph. 
Lane 1 15ng Inaba LPS
Lane 2 20ng Inaba LPS
Lane 3 22.5ng Inaba LPS
Lane 4 25ng Inaba LPS
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three was most intensely stained followed by the lower most band 
and then the top most band.
4.15 Immunoblots of resolved LPS
4.15.1 Enzyme detection of immunoblots
Immunoblots of gram-negative bacterial LPS molecules have 
been reported by various workers ( Sidberry et 1985; Poxton
et al, 1985; Sturm e^ 1984 ). The antibodies essentially
recognise all the polymeric bands of the 0-antigen. The MCAbs 
raised against V_^ cholerae were reacted with the resolved LPS to 
analyse their reactivity against the various 0-antigen bands. The 
crude LPS from either serotype of cholerae were resolved on 
15% acrylamide gels as described in Section 2.3.5.6.2 and 
blotted. The blots were reacted with MCAbs and developed by the 
ELISA technique using 4—chloronaphthol as insoluble substrate 
( Section 2.3.4.5.1 ).
A good immunoblot of the LPS was difficult to achieve 
because of the poor efficiency of blotting of the resolved 
0-antigens. The sites of the 0-antigen recognised by the MCAbs 
are seen in Fig. 4.10. All the samples were electrophoresed and 
blotted together. In Fig.4.10b, the stripes of the O-antigen can 
just be detected. In the rest of the blots the LPS appeared as a 
long streak with some portions of it more reactive than others. 
There clearly seemed to be two to three regions in the area of 
the 0-antigen which bound more antibody. The smearing of the 
0-antigen observed in Fig.4.10a, lane 3 was not uncommon. The 
enzyme linked detection system is one of limited sensitivity.
Fig. 4.10 a Immunoblot of V.cholerae LPS
Ogawa NIH 41 and Inaba 35 A3 LPS were electrophoresed ( Section
2.3.5.6.2 ) and blotted. The blots were reacted with six MCAbs
and stained with 4-chloronaphthol ( Section 2.3.4.5.1 ).
Lanes 1,3,5,7,9 and 11 15ng Ogawa LPS
Lanes 2,4,6,8,10 and 12 15ng Inaba LPS
Lanes 1 and 2 reacted with IlAl
Lanes 3 and 4 reacted with I4B1
Lanes 5 and 6 reacted with I4C3
Lanes 7 and 8 reacted with 04A6
Lanes 9 and 10 reacted with 03D1
Lanes 11 and 12 reacted with 04D2
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Fig. 4.10 b) Immunoblot of V.cholerae LPS
Magnified view of stained portion of Lane 2 of Pig.4.10 a).
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although good resolution and a higher sensitivity technique would 
be more suitable for the analysis of LPS which only resolves at 
low concentration.
1254.15.2 Immunoblots using I-Protein A
The method employed here involved the use of a double 
sandwich system ( Section 2.3.4.5.2 ) by using rabbit anti-rat 
specific antiserum followed by iodinated protein A after the blot 
was treated with the MCAbs. This method was employed in order to 
attempt to improve upon the immunoblots obtained by the enzyme 
detection technique. Various concentrations of the LPS were used. 
Low amounts resulted in faint streaks with no apparent signs of 
the ladder like appearance of the antigen. High amounts also did 
not show the stripes observed in a silver stained gel. In Fig. 
4.11 a and b, Inaba LPS was resolved on a gel ( Section
2.3.5.6.2 ) and transferred onto a nitrocellulose paper- The blot
was reacted with MCAb IlAl and detected using iodinated protein
A. Films were exposed to the blot for different time intervals. A
study of the blot from films developed after various exposure
times indicated regions of preferences on the antigen for
antibody binding. Two or three "hot spot" regions with inert
regions between them are apparent, confirming the results
obtained by enzyme blots ( Fig.4.10 ). The sensitivity of this
detection system was much greater and it could be used with
smaller amounts of antigen. However, the resolution was no finer,
125
presumably due to the path length of the gamma rays from the I 
isotope being too great and leading to blurring effects..
Fig. 4.11 Immunoblot of V.cholerae LPS
Inaba 35 A3 LPS was electrophoresed ( Section 2.3.5.6.2 ) and 
blotted. The blot was treated with MCAb I4C3 and developed with 
radioicdinated protein A ( Section 2.3.4.5.2 ).
a) Lane 1 Inaba LPS reacted with I4C3 and developed after 3 
days of exposure to the isotope.
b) Lane 1 Inaba LPS reacted with I4C3 and developed after 7 
days of exposure to the isotope.
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4.16 Serotype Specificity of MCAbs
The MCAbs raised in this study to cholerae did not
react with abortus or ^  coli ( strain ML 308 ) on ELISA
( Section 3.6 ). The antibodies were tested for cross-reactivity 
on blots of sonicated abortus organisms, ^  coli ( 0111 B4 ) 
LPS and S^ typhimurium LPS ( Fig. 4.12 ). None of the antibodies 
showed any cross reactivity with this diverse panel of antigens
on blotting.
4.17 Relative mobilities of LPS molecules on SDS-PAGE
Ogawa and Inaba LPS gave identical mobility with respect 
to lipid A, core and the 0-antigen on SDS-PAGE. S^ typhimurium
and E^ , coli ( 0111 B4 ) LPS have been very well characterised.
The mobilities of these two LPS molecules were therefore compared 
with that of Ogawa and Inaba LPS ( Fig. 4.13 ). The whole range 
of the cholerae LPS was within the space of five repeat units 
of S^ typhimurium.
4.18 Analysis of hydrolysed LPS on SDS-PAGE
The lipid A of LPS is linked to the terminal sugar of the 
core by a ketosidic bond which is acid labile. Most gram-negative 
bacterial LPS molecules ( Jann et 1975 ) including
V. cholerae LPS ( Kenne e^ al, 1982 ) have been dissected by a
preliminary acid hydrolysis. Crude Ogawa and Inaba LPS were 
hydrolysed as described in Section 2.3.5.9. The hydrolysed 
product was extracted with ether twice. The ether soluble product
Fig. 4.12 Serotype specificity of MCAbs as exhibited on 
Immunoblots
Sonicated bacteria or LPS were electrophoresed ( Section
2.3.5.6.2 ) and electroblotted. The blot was immunostained as 
described in Section 2.3.4.5.1.
Lanes 1-4 reacted with MCAb 03D1 
Lanes 5-9 reacted with MCAb I4B1
Lanes 1 and 5 lOpg protein of sonicated ^  abortus
Lanes 2 and 7 lOpg coli LPS
Lanes 3 and 4 15 and lOng Ogawa LPS
Lanes 6 and 8 7 and 15ng Inaba LPS
Lane 9 lOpg S^ typhymurium LPS
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Fig. 4.13 Silver stain of LPS
LPS from various bacteria were electrophoresed and silver 
stained.
Lane 1 5ng Ogawa LPS
Lane 2 Sng Inaba LPS
Lane 3 lOpg ^  typhimurium LPS
Lane 4 lOpg coli LPS
Lane 5 Acetic acid hydrolysed Ogawa LPS
Lane 6 Ether extracted aqueous phase of hydrolysed Ogawa LPS
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and the aqueous phase were electrophoresed. The ether phase 
obtained did not stain with silver nitrate ( not shown ). The 
aqueous phase before and after ether extraction was stained and 
showed no difference between serotype. However, the doublet of 
the lipid A-core region was reduced to a single band in both 
cases ( Fig.4.13 ). The Inaba LPS, not shown in the Figure, gave 
the same results. While the hydrolysed sample appeared in this 
case to be resolved with greater clarity, further experiments 
showed this to be due to the concentration effect ( Section
4.14.2 ) with the hydrolysed material being present in slightly 
lower amount.
4.19 Features of V. cholerae LPS
The resolution of the LPS obtained in this study
demonstrates that like other Gram-negative bacterial LPS 
molecules, V. cholerae LPS is also heterogenous, though the 
extent of heterogeneity observed is much smaller. Unlike ^  coli 
and typhimurium LPS, cholerae LPS has a restricted 
preferred range of repeating units, starting well above the one 
repeat unit shown by these molecules.
The cholerae 0-antigen is known to be composed of
perosaminyl residues, the amino groups of which are acylated by 
3-deoxy-L-glycero-tetronic acid ( Kenne et a^, 1982 ). The repeat 
unit, however has not been identified to date. The close 
similarities observed between the 0-chain bands on silver stained
gels ( Pig. 4.8 and 4.9 ) suggested very small differences in
molecular weight between them. Such differences on the DNA
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sequencing apparatus correspond to an increment of one base in 
the DNA molecule. By analogy, the difference between LPS bands 
was in the region of a single sugar residue.
The dependence on concentration of the resolution of the 
LPS ( Section 4.14.2 ) confirmed that the differences between the 
bands were very small. At low concentrations, resolution was good 
but only a small number of bands were visible. At higher 
concentrations, these original bands became blurred but further 
resolved bands could be identified below the original ( Pig. 
4.9 ). Consequently, it is difficult to place an estimate on the 
total number of bands present in any sample. If the increment 
between bands is taken as a single repeating unit, this suggests 
that, while a large number of repeating units is the favoured 
structure for most of the LPS molecules, there are also molecules 
present with a lower and possibly much lower, number of repeating 
units.
The immunoblots of the LPS ( Fig. 4.10 and 4.11 ) illustrate
a different pattern from that obtained in the silver stained
gels. Certain regions of the 0-antigen in the immunoblots bound 
more antibody than others. This might suggest that some bands are 
more antigenic than others. However, it is also possible that 
this result is essentially an experimental artefact due to some 
of the bands being less efficiently blotted on to the 
nitrocellulose paper.
The mobility of the lipid A-core complex of the
V. cholerae LPS was very similar to that of the ^  typhimurium
and the E. coli LPS ( Section 4.14.1 ).
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The disappearance of one band from the doublet of the 
lipid A-core of cholerae LPS on acid hydrolysis ( Section 
4.18 ) strengthens the tentative identification of the high 
mobility doublet as that of the lipid A-core complex. However, 
the reduction of the doublet to a single band was observed even 
before the ether extraction of the hydrolysed LPS. This could 
mean that the unbound lipid A was present in very small amounts 
after hydrolysis and was consequently not detected.
ANALYSIS OF THE SPECIFICITIES OF THE MONOCLONAL ANTIBODIES
The anti-V. cholerae MCAbs were shown to react with the 
side-chains of the 0-antigen of the respective serotypes only, in 
the Western blots ( Section 4.8 ). The specificity of the MCAbs 
was further analysed under various assay systems to yield more 
information about the LPS as antigen and the antigen-antibody 
binding.
5.1 Competition assay ( ELISA ) with vibrios and crude LPS
Crude LPS and vibrios were used as competing antigens in 
an attempt to block the binding sites of the antibodies to the 
whole vibrios coated on ELISA plates. Competing antigen was 
incubated with the MCAbs ( Section 2.3.3.2 ) and the mixture was 
added to the ELISA plates coated with either Ogawa or Inaba 
vibrios. The antibodies not bound to any of the competing 
antigens were free to react with the vibrios.
Fig. 5.1a illustrated that homologous serotype vibrios or 
LPS though from a different strain inhibited I4B1 from binding to 
the vibrios coated on ELISA plates. Fig.5.1 b and c demonstrated 
that the binding of the MCAbs, 04A6, 03D1 and 04D2 to the Ogawa
Fig.5.1 a Competition ELISA with vibrios and purified LPS 
Inhibition of binding of I4B1 and 0301 MCAbs to Inaba 35 A3 and 
Ogawa NIH 41 vibrios respectively were studied with homologous 
vibrios and Inaba 569 B LPS ( Sigma ). Each value plotted in the 
graph is a mean of three assays.
I4B1 competed with Inaba 35 A3 vibrios
I4B1 competed with Inaba 569 B LPS
0301 competed with Ogawa NIH 41 vibrios
0301 competed with Inaba 569 B LPS
Background reaction was below 0.1 0.0.
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Fig.5.1 b Competition ELISA with crude V. cholerae LPS 
Crude cholerae LPS from Ogawa NIH 41 and Inaba 35 A3 were
used as inhibitors as described in Section 2.3.3.2. Each value 
represents the mean of three assays.
I I  ^ I 04A6 competed with Ogawa LPS
03D1 competed with Ogawa LPS
^  04D2 competed with Ogawa LPS
m i____m  04A6 competed with Inaba LPS
^ 0 3 D 1  competed with Inaba LPS 
04D2 competed with Inaba LPS 
—  —  —  —  —. Background reaction
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Fig. 5.1 c Competition ELISA with crude V. cholerae LPS 
Crude V. cholerae LPS from Ogawa NIH 41 and Inaba 35 A3 were used 
as inhibitors as described in Section 2.3.3.2. Each value plotted 
represents the mean obtained three assays.
IlAl competed with Ogawa LPS
/ \  I4B1 competed with Ogawa LPS
I I I4C3 competed with Ogawa LPS
IlAl competed with Inaba LPS
I4B1 competed with Inaba LPS
^ 0  I4C3 competed with Inaba LPS
—  _  —  —  Background reaction
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250 50062.50.97 3.95 15.75
Nanogram LPS
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vibrios and the IlAl, I4B1 and I4C3 to the Inaba vibrios could be 
completely blocked with the homologous LPS. On the other hand 
even high quantities of heterologous LPS did not inhibit the 
binding of either the Ogawa or the Inaba series of MCAbs to their 
specific serotypes. The similarity of Inaba 569B LPS and Inaba 
35 A3 LPS was illustrated by the fact that both were capable of 
inhibiting the Inaba positive MCAbs from binding to the Inaba 
35 A3 vibrios.
5.2 Analysis of MCAb specificity by indirect immunofluorescence 
( IF ) assay
IF assays were similar to ELISA assays with two exceptions. 
First, the organisms were fixed on to the slides with alcohol, 
second Tween 20 was not included in the wash buffer ( Section 
2 . 3 . 3.3 ) .
MCAbs 04A6, 03D1 and 04D2 reacted very strongly with the 
Ogawa organisms ( Fig. 5.2 ) and did not react at all with the 
Inaba organisms ( Table 5.1 ). MCAbs IlAl, I4B1 and I4C3 
exhibited a different trend in their reactivities towards the 
vibrios. Each one of them reacted strongly with the Inaba vibrios 
but also reacted with the Ogawa organisms with about half the 
homologous signal strength ( Table 5.1 ).
The cross-reaction of the three Inaba positive MCAbs in 
the IF assay contrasted with the high degree of specificity which 
they exhibited in the ELISA and the Western blots ( Section 3.6 
and 4.8 ).
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Fig. 5.2 Ogawa vibrios detected by Immunofluorescent staining 
Ogawa vibrios were reacted with MCAb 0AA6 followed by anti-rat 
IgG fluorescein conjugate.
Table 5.1 Quantitation of indirect immunofluorescence assay with 
MCAbs
Quantitation of immunofluorescence signal was carried out on a 
LKB photometer ( Section 2.3.3.3 ). The background was obtained 
from a mean of ten separate readings. The fluorescence obtained 
by the MCAb reaction was a mean of 25 readings. Background values 
were deducted from each set of reading for obtaining the mean 
values.
I4l
Monoclonal Antibody Quantitation of IF
Ogawa Inaba
Background 1.87 1.87
04A6 38.00 ± 17 0.16 i 0.4
04D2 37.00 ±  17 0.15 t  0.16
03D1 35.00 ±. 18 0.14 + 0.1
IlAl 6.00 + 4 14.00 + 3.6
I4B1 5.60 + 2.5 14.00 +3.4
I4C3 4.5 ± 1.3 9.70 ±. 2.4
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5.3 ELISA with varying washing procedures
The fact that IlAl, I4B1 and I4C3 cross-reacted 
significantly with the Ogawa vibrios in the indirect IF assay 
while they were apparently totally serotype specific on ELISA, 
competition ELISA and immunoblotting, was of considerable 
interest. While there are several differences in the protocols 
such as the labelled second antibody, the nature of the solid 
support, and the detection system, two factors seemed the most 
relevant and simple to test. The first was fixation. Fixation of 
antigens with formaldehyde is known to cause covalent chemical 
changes in the epitopes which can lead to alterations in 
specificity profile ( Milstein ^  1983 ) and this could
potentially have been the reason for the cross-reaction observed. 
However, only alcohol, a mild fixative reagent was used to fix 
the vibrios and the much more drastic chemical procedures 
involved in LPS purification and immunoblotting had yielded an 
antigen which reacted with absolute serotype specificity. To test 
the second major possibility, that differential washing was 
responsible for the discrepancy in cross-reaction with assay, the 
ELISA wash buffer was modified to contain no Tween-20. The normal 
ELISA wash buffer ( Section 2.3.3.1 ) was also used and the the 
number of times a plate was washed after each incubation was 
varied. If the Inaba series of antibodies were capable of cross 
reaction with lower affinity sites on Ogawa, it seemed likely 
that this might be detected by differential washing procedures, 
particularly in the presence or absence of the detergent.
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The assay was carried with the MCAb I4C3. The different 
washes included, two washes with only PBS, two washes with 
PBS-Tween and six washes with PBS-Tween. The increase or decrease 
in the binding of the I4C3 antibody to Ogawa or Inaba under the 
modified protocols were primarily due to the changes in the 
background values. The background value steadily decreased as the 
washing procedure was made more stringent. The PBS wash had a
background value of 0.2 which decreased to a value of 0.06 with
six washes of PBS-Tween. The ratio of the Ogawa to Inaba binding 
did not change significantly with the alterations in the wash 
protocols and Tween-20 had no significant effect on relative
affinity ( Table 5.2; Fig 5.3 ). Consequently, it seemed likely
that this approach was of limited value in the analysis of
differential cross reactions.
5.4 Agglutination assays
Agglutination tests involved the use of high
concentrations of antigen and antibody. In this study the 
agglutinating property of the MCAbs were tested under different 
conditions.
5.4.1 Slide agglutination tests
The ammonium sulphate concentrated MCAbs ( Section
2.3.4.3 ) or ascitic fluid were added to equal volumes of 
suspensions of gram-negative bacteria on a slide. The results 
obtained are presented in the Table 5.3. The three MCAbs that 
were positive to Inaba on ELISA ( Section 3.6 ) agglutinated
Fig. 5.3 Effect of more and less stringent washing on ELISA 
signal
MCAb I4C3 was reacted with Ogawa or Inaba vibrios on ELISA and 
was subjected to varying wash protocols.
A ELISA plates washed with PBS, two times
B ELISA plates washed with PBS-Tween, two times
C ELISA plates washed with PBS-Tween, six times
Bk ELISA plates coated with no antigen
0 ELISA plates coated with Ogawa
1 ELISA plates coated with Inaba
1 .4 - ,
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C
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Wash Buffer No. of washes Absorbance at 492nm Ratio of 
Oqawa/InabaOgawa Inaba
PBS 2 0.29 1.01 0.29
PBS-Tween 2 0.24 1.16 0.21
PBS-Tween 6 0.23 0.93 0.25
Table. 3.2 Effect of washing on background reaction of ELISA 
I4C3 antibody was reacted with Inaba vibrios and the ELISA plate 
was washed by different methods.
Table 5.3 Slide agRlutlnation with MCAbs
Agglutination tests were performed as described in Section 
2.3.3.4.2.
+++ Formation of large clumps within a minute
++ Formation of small clumps within a minute
+ Formation of small clumps in two minutes
No agglutination
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Bactecla Score of 
Monoclonal Antibodies
Score of 
Ascitic fluid
IlAl I4B1 I4C3 04A6 0402 0301 04A6 I4B1
Ogawa 
Inaba 
B.abortus 
B.melitensis 
E.coli 
ï.enterocolotica
+++ +++ +++
+++
+++
+++ +++
+++ +++
+++
+++
+++
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Ogawa vibrios and Brucella abortus organisms with the same 
efficiency as they agglutinated the Inaba vibrios. 03D1, showed 
a slight reaction with Inaba vibrios and no other agglutination 
characteristics.
5.4.2 Agglutination in V-bottom plates
The agglutination tests performed on the slides were not 
quantitated to give an indication of the relative affinity of the 
antibodies for the variety of antigens used. For the easy 
quantitation of the agglutination data the tests were carried out 
in V-bottom plates as described in ( Section 2.3.3.4.3 ).
5.4.2.1 Primary agglutination test
The MCAbs were sequentially double diluted starting 
with the 20 times concentrated antibody. Each dilution of the 
antibody was added to an equal volume of either Ogawa or Inaba 
vibrios in to the V-bottom wells. The agglutination was scored as 
in Table 5.4.
The MCAbs raised against the Ogawa serotype did not 
exhibit good agglutinating properties. The agglutination produced 
by 03D1 was weak but it indicated a definite preference for the 
Inaba serotype in all tests with different batches of antibody 
and antigen. The antl-Inaba MCAbs, on the other hand, 
agglutinated both the serotypes of cholerae. The strength of 
the agglutinating properties of the antibodies were estimated by 
the lowest ,dilution of the antibody ( titre ) capable of 
producing agglutination. All three Inaba positive MCAbs ( ELISA )
Table 5.4 Scores of primary agglutination
Agglutinations were performed as described in Section 2.3.3.4.3 
and the intensity of agglutination was scored visually by the 
area of the mat formed. MCAbs were sequentially double diluted 
starting with a concentration of 20 times neat culture 
supernatant.
+++ Large mat 
++ Medium mat 
+ Small mat 
+ Small mat and a pellet 
- only a pellet, no agglutination
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Monoclonal 
Antibody
Score and endpoint titre against Ratio of endpoint 
titre Inaba/OqawaOgawa Inaba
04A6 4. 5
- n.a
04D2 + 20 - n.a
03D1 + 5 + 2.5 1/2
IlAl +++ 2.5 +++ 1.25 1/2
I4B1 +++ 1.25 +++ 0.6 1/2
I4C3 +++ 1.25 +++ 0.3 1/2
Fig. 5.4 Secondary Agglutination in V-Bottom plates
9
All the odd numbered wells contained 5x10 Ogawa vibrios, lOul of 
1 in 10 rabbit anti-rat IgG and different MCAbs. All the even
9
numbered wells contained 5x10 Inaba vibrios, lOul of 1 in 10 
rabbit anti-rat IgG and different MCAbs.
Columns 1-2 MCAb 03D1 
Columns 3-4 MCAb 04A6 
Columns 5-6 MCAb 04D2 
Columns 7-8 MCAb IlAl 
Columns 9-10 MCAb I4B1 
Columns 11—12 MCAb I4C3
Row A-G Doubling dilution of each MCAb starting with 20 times 
concentrated antibody
Row H Control, MCAb substituted with equal volume of PBS
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had a higher titre for the Inaba serotype than for the Ogawa 
serotype, as did 03D1. These data confirmed the cross reactivity 
detected by the IF assay and produced a new cross reaction in 
that of 03D1 which had been entirely serotype specific in other 
assays.
5.4.2.2 Secondary agglutination
In the secondary agglutination assay, a second antibody, 
the rabbit anti-rat antiserum was added to enhance the formation 
of a network for agglutination. Monoclonal antibodies, 
particularly IgG ones, can be anticipated to be highly variable 
reagents for cross linking organisms because their single epitope 
nature may have very precise geometric requirements which cannot 
be simulateneously satisfied by both organisms to be 
agglutinated. The addition of a second, polyclonal reagent 
directed against the first may therefore be expected to give 
better agglutination in general and, in a case such as this, 
potentially alter the specificity profile.
The addition of the anti-rat serum helped 04A6 but not 
04D2 to agglutinate the Ogawa vibrios ( Table 5.5 ). For the 
IlAl and 1461 antibodies, the preference for the Inaba serotype 
was increased as demonstrated by the ratio of the end point 
titres against the two serotypes while I4C3 remained unaffected 
( Table 5.5 ). Generally, the titres for the agglutination were 
increased in the presence of the second antibody. An interesting 
feature of the second antibody was that the preference for the 
heterologous serotype by 03D1 was not observed.
Table 5,5 Scores of secondary agalutlnatlon
MCAbs were tested for agglutination in presence of a second 
antibody, rabbit anti-rat IgG. The antibodies were sequentially 
double diluted starting with 20 times concentrated solution. 
Agglutinations were scored visually by the area of mat formed. 
Large mat 
H- Medium mat 
+ Small mat
+ Small mat and a pellet
Only a pellet, no agglutination
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Monoclonal
antibody
Score and endpoint titre Ratio of end point 
titre Inaba/OqawaOgawa Inaba
04A6 ++ 0.6 + 10 16.7
04D2 + 20 + 20 1
03D1 ++ 2.5 ++ 2.5 1
IlAl +++ 1.25 +++ 0,3 1/4
I4B1 +++ 1.25 +++ 0.3 1/4
I4C3 +++ 1.25 +++ 0.3 1/4
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5.4.3 Slide agglutination with staphylococcal protein A-adsorbed 
antibody
Many routine clinical serotyping assays involve the use of 
antibody adsorbed to Staphylococcus aureus as an agglutination 
test as the local concentration of antibody can be greatly 
increased by binding to the surface of the S^ aureus. This 
technique is claimed to increase the sensitivity of agglutination 
assays and is generally employed with rabbit polyclonal antisera.
MCAbs were adsorbed to Staphylococcus aureus « strain 
Cowan I, as described by Kronvall ( 1973 ), ( Section
2.3.3.4.2 ). During the process of coating the staphylococci with 
the MCAbs it was observed that the staphylococci organisms 
themselves were agglutinated by the antibodies. Normal rat serum 
used as a control also agglutinated the organisms. The batch of 
staphylococci used had been stored for frozen for two years. A 
fresh batch of staphylococci was tried and yielded the same 
results.
The techniques employing S_^  aureus-coated antibodies were 
established for rabbit antibodies which bind well and 
specifically to the protein A of the organism. Rat antibodies 
bind poorly to the protein A of aureus ( Rousseaux et al, 
1981; Nilsson et a^, 1982 ) and hence may not be suited to the 
assay. The fact that normal serum from several rats also gave 
high controls made the assay of little value and this approach 
was taken no further.
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5.4.4 Primary Agglutination at altered pH values
Mossman et al. ( 1980 ) reported the alteration of the
specificity of MCAbs with a change in the pH of the buffer in 
which the assay was performed. As Ogawa LPS has been reported to 
have the additional sugar 4,amlno-arabinose and at least two of 
the originally defined Ogawa panel of MCAbs were totally 
specific, it was logical to see if pH could affect this 
specificity, and in particular, if the use of a high pH close to 
the expected pK of the specific sugar group, would alter the 
specificity profile of these antibodies. The high cross reaction 
of IlAl, I4B1 and the I4C3 and the mild cross reaction of the 
03D1 were therefore tested on vibrios in acidic and alkaline
buffers ( Section 2.3.3.4.3 ). In the process of washing the 
vibrios in an acid and an alkaline buffer the texture of the 
suspension changed and this made comparison of the agglutination 
data at different pH values difficult.
There was no change in the titres of 04A6 and 04D2
with respect to their weak ability to agglutinate the vibrios at 
the selected pH values ( Table 5.6 ). There was a drop in the
titre of 03D1, I4B1 and I4C3 for both the serotypes at both the
alkaline and the acidic pH values ( Table5.6 ). Thus significant 
changes in the specifity of the MCAbs were not observed at 
altered pH. At pH values below 6 the vibrios formed clumps which 
were difficult to disperse, and consequently, a lower pH was not 
used for the test.
Table 5.6 Agglutination at different pH
20 times concentrated MCAbs were tested for agglutination at 
different pH values as described in Section 2.3.3.4.4.
No agglutination
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Monoclonal Endpoint titre Endpoint titre
Antibody agglutination with agglutination with
Ogawa Inaba
pH 6 pH 7.6 pH 9.2 pH 6 pH 7.6 pH 9.2
04A6 10 5 — 20 - 20
04D2 20 20 20 - 20
03D1 20 5 10 2.5 10
IlAl 1.25 2.5 5 1.25 1.25 1.25
I4B1 1.25 1.25 2.5 1.25 1.25 2.5
I4C3 1.25 1.25 5 1.25 1.25 1.25
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5.5 The effect of high antigen concentration on the
specificity of the MCAbs on ELISA
The cross-reactivities of some of the MCAbs was clearly 
exhibited in the agglutination assays ( Section 5.4 ). The 
apparently Inaba specific MCAbs cross-reacted not only with the 
heterologous serotype but also Brucella abortus in the 
agglutination tests ( Table 5.3 ). The similarity between 
V. cholerae LPS and B_^  abortus LPS was reported earlier by Feeley 
( 1969 ) from agglutination studies conducted with rabbit 
antisera. The validity of the agglutination data obtained in 
Section 5.4 were checked on ELISA by coating the plates with a 
logarithmic increase in antigen concentration.
5.5.1 The specificities of the apparently Ogawa specific 
antibodies
04A6, 03D1 and 04D2 were reacted with increasing amounts 
of vibrios of either serotype. In cases where the absorption was 
beyond the scale of the spectrophotometer, the curve was 
extrapolated at a value of 2.0 O.D. units although the actual 
reading was immeasureably greater. It was observed that all three 
MCAbs had high activities against Ogawa when large numbers of the 
vibrios were coated onto the ELISA plates ( Fig. 5.5a ). However, 
the increase in the antigen—antibody binding levelled off at 10 
vibrios on the plate. This indicated that the antibody 
concentration was limiting beyond 10^ vibrios per well. The 
binding efficiency decreased by 50% with the fall in antigen
Fig.5.5 a Activity of MCAbs on increased antigen density 
Increasing number of Ogawa or Inaba vibrios were coated on ELISA 
plate and MCAbs were reacted with them. The values plotted are a 
mean obtained form three assays.
04A6 reacted with Ogawa vibrios 
04A6 reacted with Inaba vibrios
[~|----- 03D1 reacted with Ogawa vibrios
m  03D1 reacted with Inaba vibrios
/ \----- y\ 04D2 reacted with Ogawa vibrios
^ 0 4 D 2  reacted with Inaba vibrios
Background reaction was below 0.1 O.D.
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concentration from 10^ to 10^ vibrios per well.
When 04A6, 03D1 and 04D2 were reacted with increasing
amounts of Inaba vibrios, they exhibited a different pattern. At
9
the maximum concentration of the antigen coated on the plate, 10 
vibrios per well, no binding was observed. A weak positive 
reaction was detected at 10 vibrios per well. This dropped to 
half the value at 10^ per well, and disappeared below the 
background at 10^ per well. The highest binding activity of the 
MCAbs to Inaba was about one tenth of that of that towards Ogawa.
The MCAbs were also reacted with similar concentrations 
of ^  abortus. B. melitensis and ^  coli. There was no 
significant reaction of the antibodies against these bacteria 
( Fig. 5.5b ). The rabbit anti-rat conjugate ( Miles ) gave a 
relatively high background with the B_^  melitensis organisms.
5.5.2 The specificities of the anti-Inaba MCAbs
The anti-Inaba MCAbs, IlAl, I4B1 and I4C3 showed strong 
reaction with Inaba vibrios ( Fig. 5.5c ). This panel of 
antibodies showed concentration limitations at the same level as 
the Ogawa panel, i.e. 10^ per well. However, the activities at
vibrio concentration of 10^ were comparatively high.
9
At concentrations of 10 Ogawa vibrios per well, the 
anti-Inaba MCAbs had little activity. However, there was an 
increase in antibody binding at 10 per well which reached its 
maximum at 10^ per well. It then fell sharply to background 
values at 10^ per well ( Fig. 5.5c )• The activity of the
Fig.3.3 b Activity of MCAbs on increased antigen density 
Increasing number of various bacteria were coated on ELISA plate 
and MCAbs were reacted with them. The values plotted are a mean 
obtained form three assays.
Ç y . ..Q Mean activity of all six MCAbs on ^  abortus
I I_____I ] Mean activity of all six MCAbs on ^  melitensis
/ \ ----- 2^  Mean activity of all six MCAbs on E^ , coll
Background reaction was 0.13 O.D.
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Fig. 5.5c Activity of MCAbs on increased anti&en density 
Increasing number of Ogawa or Inaba vibrios were coated on ELISA 
plate and MCAbs were reacted with them. The values plotted are a 
mean obtained form three assays.
IlAl reacted with Ogawa vibrios 
IlAl reacted with Inaba vibrios
I I____I I I4B1 reacted with Ogawa vibrios
^0____m  I4B1 reacted with Inaba vibrios
I4C3 reacted with Ogawa vibrios 
I4C3 reacted with Inaba vibrios 
Background reaction was below 0.1 O.D.
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anti-Inaba MCAbs at its maximum against Ogawa was half of that 
against Inaba.
The reaction of the antibodies against abortus. 
B. melitensis and ^  coli( ML 308 ) were very similar to that of 
the anti-Ogawa MCAbs ( Fig. 5.5 b ).
5.6 Heterologous activity of concentrated 04A6 and 03D1 
antibodies
The earlier ELISA results, competition ELISA results and 
immunoblotting data clearly indicated that 04A6, 03D1 and 04D2
had negligible activity against the Inaba serotype vibrios. This 
was in agreement with the indirect IF assay and the agglutination 
assays with the exception of 03D1 which showed an unexpected 
preference for the heterologous serotype ( Section 5.6.4 ). If a 
low affinity interaction with the heterologous serotype by 
anti-Ogawa antibodies such as by 03D1 is a genuine observation 
( Section 5.4.1 ), then such a reaction might be enhanced at 
higher concentrations of the antibody. Consequently, large 
amounts of 03D1 and 04D2 obtained from ammonium sulphate 
precipitation were tested on increased quantities of antigen to 
detect any binding with Inaba vibrios on ELISA.
When large quantitites of 03DI and 04A6 were reacted with 
increasing numbers of Ogawa vibrios, the binding of the 
antibodies increased till it reached a maximum value at a much 
higher concentration of the antigen on the plate ( Fig. 5.6 ). 
This was in contrast to the results observed in Section 5.5.1 
where the antibody was limiting. Even at the high concentrations
Fig.5.6 Effect of increased antibody concentration on 
increasing antigen density 
Ten times concentrated MCAbs 0AA6 and 03D1 were reacted with 
increasing numbers of Ogawa and Inaba vibrios.
The values plotted are a mean of two assays.
[ [ I I  06A6 reacted with Ogawa vibrios
^ 0 4 A 6  reacted with Inaba vibrios 
03D1 reacted with Ogawa vibrios
\y4_____ 03D1 reacted with Inaba vibrios
Background reaction was below O.IO.D.
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of antibody used for the assay 06A6 did not react significantly 
with Inaba vibrios. 03D1 showed a different pattern, binding 
significantly to Inaba ( Fig.5.6 ), and demonstrating significant 
cross-reaction. Since only 03D1 reacted at high concentrations 
with the Inaba it was clear that the other anti-Ogawa antibody 
did not have demonstrable anti-Inaba activities on this assay.
The skewed distribution in the ELISA reaction of the 
MCAbs to increasing amounts of heterologous antigen was again 
observed with 03D1 ( Fig. 5.6 ).
5.7 Variation in ELISA activity at increasing amounts of antigen 
The skewed distribution of activity on ELISA of IlAl, I4B1 
and I4C3 against Ogawa vibrios ( Fig. 5.5 c ) and ten times 03D1 
against Inaba vibrios ( Fig. 5.6 ) may be due to various factors. 
The leaching effect of the antigen at very high concentrations 
may result in some primary antibody being washed off the plate 
with antigen ( Frankel and Gerhard, 1979 ). However, one would 
also expect to observe this with homologous vibrios. It is 
possible that such an effect is occurring with the homologous 
virbrios but is poorly resolved at high optical density readings. 
Optical density is measured on a logarithmic scale and the 
measurements are poorly resolved above values of 1.5 so that 
printouts in this range from the Titretrek Multiskan may lead to 
data which is of limited accuracy. It is however, very possible 
that the skewed effect is due to zone effects at high antigen 
concentrations with the enzyme labelled second antibody having 
limited access. In this context, it is interesting to note that
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in direct binding assays utilising labelled monoclonals, skewed 
distribution of this type was not detected over the same antigen 
concentration range ( Figure 5.13 ).
5.8 Complement fixation by anti—V. cholerae MCAbs
The ability of the panel of monoclonal antibodies to fix 
complement was tested for several reasons. Firstly, the 
micro-complement fixation assay of Wasserman and Levine, 1961 
could be carried out at more physiological concentrations of 
antibody and antigen than an agglutination assay which is 
conducted at artificially high concentrations and is consequently 
frequently suggested to be misleading due to "non-specific" 
interactions. Complement fixation is, however, also an assay that 
does not involve washing procedures and may therefore detect low 
affinity reactions, difficult to detect in ELISA and IF and so 
the general specificity profile of the panel on this assay could 
be expected to provide additional Information on the relative 
contribution of specificity and affinity to cross reactions 
among monoclonal antibodies. In addition, few rat monoclonal 
antibodies ( Clark et 1983) and no IgG2b rat monoclonal
antibodies, have been tested for their ability to activate the 
complement pathways. The ability of the anti-V. cholerae MCAbs 
raised in this study to fix complement against cholerae was 
tested with whole vibrios as described in Section 2.3.3.5. 
Fig. 5.7 illustrates the concentrations of the antibodies which 
could be demonstrated to fix complement against either serotype
Fig. 5.7 a and b Complement fixation activity of MCAbs 
^ A c t i v i t y  against Inaba vibrios 
Activity against Ogawa vibrios
a) CF activity of 04A6
b) CF activity of IlAl
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of cholerae. 04A6 and 0AD2 exhibited monospecificity towards 
the Ogawa serotype. 04D2 fixed 100% complement against Ogawa at a 
dilution of 0.5 and none against Inaba at the same dilution. 04A6 
was tested at five times its strength in culture medium. 
Complement was not fixed by the high amounts of the antibody
against Inaba and above 90% of complement was fixed against
Ogawa.
03D1, the antibody which showed unexpected cross
reaction on agglutination, was tested over a wide range of 
antibody concentrations against both Ogawa and Inaba vibrios. At 
five its strength in culture medium 03D1 was able to fix 100% 
complement against both Ogawa and Inaba. The percentage of 
complement fixed against Inaba dropped as the antibody was 
diluted. It could no longer fix any complement against the Inaba 
vibrios at the dilution of 0.63, however, there was 100% 
complement fixation at dilutions as low as 0.05 against the Ogawa 
vibrios. This confirms the qualitative result of the
agglutination assay although the quantitative results are 
different.
IlAl, I4B1 and I4C3 showed cross-reaction with Inaba and 
Ogawa to the same extent, though high amounts of antibody I4B1 
were required for the demonstration of complement fixation. The 
weak reaction of I4BI was interesting but may relate to the fact 
that the ELISA titre of this antibody in this particular assay 
was low.
The cross-reactivity of the anti-Inaba MCAbs with 
B. abortus on agglutination assays was confirmed on complement
Pig. 5.7 c and d Complement fixation activity of MCAbs 
Activity against Inaba vibrios 
(2^ Activity against Ogawa vibrios
a) CF activity of 04D2
b) CF activity of I4B1
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Fig. 5.7 e Complement fixation activity of MCAb 
CF activity of 03D1 
^ A c t i v i t y  against Inaba vibrios 
Q  Activity against Ogawa vibrios
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fixation assay with I4C3. The antibody fixed complement against 
B. abortus to a lesser extent than it did with Inaba or Ogawa 
vibrios ( Fig. 5.7 f )• IlAl and I4B1 were not tested in this 
assay.
Various gram negative bacteria or their LPS have been 
reported to fix complement by classical pathways in the absence 
of antibodies ( Grossman and Lelve, 1984; Joiner et a^, 1984;
Wilson and Morrison, 1982 ). However, no fixation was observed 
with the control tubes containing vibrios alone indicating that 
either cholerae LPS does not fix complement, or that the 
relevant chemical structures of the LPS were not accessible to 
the complement pathway on the whole vibrios.
5.9 Cross-reactivity of the MCAbs
The apparent serotype specificity of the MCAbs observed in 
the ELISA ( Section 3.6 ), the Western blots ( Section 4.8 ) and 
the competition ELISA ( Section 5.1 ) were thus not observed in 
all the other assays described in this chapter. The Inaba 
specific antibodies cross-reacted with the Ogawa vibrios, though 
they generally exhibited a preference for the Inaba antigen, and 
03D1 showed some cross reaction with Inaba vibrios. It was 
clearly of relevance to determine whether these antibodies 
detected identical epitopes or overlapping epitopes on the two 
serotypes or whether each antibody recognised a distinct region 
of the LPS.
Fig.5.7 f Complement fixation activity of MCAbs 
CF activity of I6C3 
Activity against Inaba 
Activity against Ogawa 
Activity against ^  abortus 
J I Activity against melitensis
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5.10 Detection of epitopes on V. cholerae LPS by ELISA
Friguet et ^  ( 1983 ) have described an additive ELISA
method by which it was possible to demonstrate that two separate
MCAbs detected two different epitopes on the same antigen. The
same principle was applied to investigate the epitopes recognised 
by the anti-Inaba antibodies on the Ogawa LPS. The Ogawa vibrios 
were preincubated with saturating amounts of either of the Ogawa 
specific antibodies to block the sites recognised by them and 
washed. The addition of either IlAl, I4B1 or I4C3 antibodies to 
the blocked vibrios should have increased the binding of the 
peroxidase conjugated anti-rat serum to the plate if any of the 
anti-Inaba antibodies had bound to any site which was distinct 
from that recognised by 04A6, 04D2 and 03D1. There was no
increase in the absorbance after the double incubations of 
various combinations of antibodies asjil lustra ted] in Fig. 5.8. 
Preincubations with 03D1 and 04D2 yielded very similar results. 
This indicated that the sites recognised by IlAl, I4B1 and I4C3 
on the Ogawa LPS were either identical to, or close to the 
binding sites of the Ogawa positive MCAbs.
5.11 Epitopes on V. cholerae LPS
The inhibition of binding of the apparent Inaba specific 
MCAbs to the Ogawa vibrios by 04A6, 03D1 and 0402, demonstrated 
in Section 5.10. indicated that all antibodies shared epitopes 
which were closely related in spatial terms. However,this assay 
system had a very limited range over which competition could be
Fig.5.8 Detection of epitopes on LPS molecules by ELISA 
Ogawa vibrios were preincubated with MCAb 04A6, washed and then 
reacted with other MCAbs. The bars represent a mean obtained from 
nine values.
I I Second Incubation with PBS 
Second Incubation with 04A6 
Second Incubation with 03D1 or 04D2 
Second Incubation with IlAl, I4C3 or I4B1 
Incubation with 03D1 alone 
Incubation with 04D2 alone
Incubation with either IlAl, I4C3 or I4B1 alone 
Background reaction
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tested. In addition, previous assay systems of the ELISA type had 
given an innaccurate picture of fine specificity. Direct binding 
competition studies with purified antibodies can obviously yield 
less equivocal data over a much wider range and consequently the 
antibodies were purified from tissue culture supernatant.
5.12 Purification of Monoclonal Antibodies
Antibodies may be purified on affinity columns coated with 
suitable antigens or on columns coated with protein A ( Coding,
J.W. 1978 ). The rat MCAbs raised against the cholerae LPS
were all of the IgC2b type which was reported to have a low
affinity towards protein A of ^  aureus ( Rousseaux e^ 1981;
Nilsson et 1982 ) and the preparation of antigen-coated
affinity column was not considered to be feasible. Consequently 
the techniques employed for the purification of the antibodies 
generated in this work were those involving ion exchange columns.
5.12.1 Purification of rat IgC on DEAE Affi-gel blue
Affi-gel blue and DEAE Affi-gel blue have been reported 
to separate IgC from serum albumin. MCAbs from mouse ascites were 
purified by Bruck e^ al. ( 1982 ) on DEAE Affi-gel blue. The 
purification of the rat MCAbs was attempted on DEAE Affi-gel blue 
as described in Section 2.3.4.4.
The fractions that were collected from each column were 
estimated for protein by measuring the absorbance at 280nm and 
antibody activity on ELISA at 492nm. About 50% of the total
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antibody activity co-eluted with albumin at a salt concentration 
of 1.4M ( Fig. 5.9 ). Higher ionic strength was used to elute
the non-Ig proteins from the column. The fractions containing the
least amount of protein and maximum antibody activity were
electrophoresed on 10% acrylamide-SDS gels and stained with 
coomassie blue. Every fraction showed contaminating albumin and 
no Ig bands were detectable. Very small amounts of tissue culture 
supernatant could be purified by this method and the net yield of 
Ig was not satisfactory for further use. This led to the 
investigation of other approaches for the purification of the 
antibodies from cell culture supernatant.
5.12.2 Purification of antibodies on a QAE sephadex column
QAE sephadex has been employed for the separation of 
rabbit IgG from serum albumin. At the pH the separation is
conducted, pH 6.5, the IgGs have almost no net charge and hence
are eluted in the void volume. For the purification of the MCAbs,
50ml of culture supernatant of each hybridoma were concentrated 
by the ammonium sulphate precipitation method to 1-1.5ml. The 
concentrated antibodies were then applied onto a QAE sephadex A50 
column ( Section 2.3.4.4.2 ) and the fractions collected. Each 
fraction was estimated for the protein content by absorption at 
280nm and for anti-V. cholerae activity by ELISA on the
appropriate serotype of vibrios by absorption at 492nm.
Two very distinct profiles of protein content and
anti-V. cholerae were obtained from the fractions collected for 
different antibodies. Fig. 5.10a is the picture of IlAl fractions
Fig.5.9 Purification of MCAbs on DEAE Affi-Rel Blue
MCAb IlAl was purified on DEAE Affi-gel Blue as described in
Section 2.3.4.4.1.
^ ^  ELISA activity on Inaba vibrios
_________  Protein content as measured by optical density at 280nro
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Fig. 5.10 a Purification of MCAb on QAE Sephadex A50 column 
MCAb IlAl was purified on QAE Sephadex column as described in 
Section 2.3.4.4.2.
X ----- K  ELISA activity on Inaba vibrios
Protein content as measured by optical density at 280nm
175
(a )
/ \
8 0.8-
X3
<c
0.6 J
0 . 4 -
X'X
0 .2 -
— I— I— I— I— I— I— I I — I— I— I— I— I— r
2 4 6 8 10 12 14 16 18 20 22 24 26 28 30 32 34
Number o f  f r a c t io n s  from  QAE sephadex A50
176
from the QAE column. I4C3 and I4B1 antibodies behaved in a very 
similar fashion. The protein content and the antibody activities 
of 03D1 have been illustrated in Fig. 5.10 b. 04A6 and 04D2 gave 
identical patterns when purified on the QAE sephadex column. 
Every antibody was purified at least twice and it was always 
observed that the Ogawa specific MCAbs yielded much lower amounts 
of immunoglobulins than the Inaba specific antibodies ( Table 
5.7 ). Since the . Ogawa specific antibodies had good ELISA 
activity before purification, it is presumed that the Ogawa
specific antibodies had a significantly higher affinity for the
QAE sephadex and were less suited to purification by this method, 
which is one originally developed for the isolation of bulk IgG 
from polyclonal antisera. The method, however, yielded adequate
amounts of of all six antibodies for further study.
5.12.3 Microheterogeneltv in anti-Inaba MCAb molecules
The anti-Inaba MCAbs eluted over a large number of
fractions and this was in contrast to the elution pattern 
obtained with anti-Ogawa MCAbs. The heterogeneity in the 
migration of the anti-Inaba antibodies on the column could have 
been due to partial binding by some population of the antibody 
molecules. If it is true, it suggests that the whole population 
of all three anti-Inaba MCAbs are not homogenous in their net 
charge.
Fig. 5.10 b Purification of MCAb on QAE Sephadex A50 column 
MCAb 03D1 was purified on QAE Sephadex column as described in 
Section 2.3.4.4.2.
X------X ELISA activity on Ogawa vibrios
Protein content as measured by optical density at 280nm
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1481(1/10) 2.5 0.33 0.23 5.75
03D1 1.8 0.36 0.25 0.45
04D2 1.3 0.27 0.19 0.25
Table. 5.7 Yield of Immunoglobulins on purification of MCAbs 
MCAbs concentrated from culture supernatant by ammonium sulphate 
precipitation were purified on QAE-Sephadex column.
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5.12.4 SDS-PAGE of purified immunoglobulins
The fractions collected from the QAE sephadex column of 
each antibody were pooled according to the activities exhibited 
on ELISA. The pooled fractions were lyophilised and then 
regenerated as described in ( Section 2.3.4.4.2 ). The 
regenerated antibodies were electrophoresed to test the purity of 
the immunoglobulins. Fig. 5.11 illustrates the purity of 04D2 and 
I4B1 after being stained with coomassie blue. The purified 
samples of the other antibodies also contained no detectable 
traces of albumin.
5.13 Affinity tests of MCAbs at equivalent protein 
concentrations
The purified and regenerated samples of 04D2, 03D1 and 
I4B1 were estimated for protein by measuring the absorption at 
280nm. The protein content of the three antibodies were adjusted 
to 0.19mg per ml and serial doubling dilutions were made 
starting with the stated concentration. Dilutions of the 
antibodies prepared were reacted with 10^ Ogawa or Inaba vibrios 
on ELISA. This led to the observation that at the same 
concentration of immunoglobulins, I4B1 had maximum activity 
against the Inaba vibrios and this was followed by the activity 
of 04D2 and 03D1 against the Ogawa vibrios. Some binding of the 
I4B1 to Ogawa was also detected ( Fig. 5.12 ). There was no 
binding of the 03D1 and 04D2 to the Inaba at the levels of 
antibody and antigen used.
Fig. 5.11 SDS-PAGE of purified MCAbs
MCAbs purified on QAE Sephadex column were analysed on SDS-PAGE 
for detection of contaminating proteins. The gel was stained with 
coomassie blue.
Lane 1 Protein molecular weight markers 
Lane 2 Purified 04D2 
Lane 3 Purified I4B1
180
57K
30K
32
Fig. 5.12 ELISA of purified MCAbs
Purified MCAbs were adjusted to an identical protein 
concentration ( 0.I9mg/ml ) and titred on vibrios.
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These data suggest that either I4B1 has higher affinity 
for Inaba vibrios than 03D1 and 04D2 for Ogawa vibrios or that 
there are more available epitopes on the Inaba organisms. 
However, it is also possible that some antibody activity was 
differentially lost during the purification procedures.
5.14 Radio—iodination of purified MCAbs
About Img of IlAl, I4B1 and I4C3 were iodinated with 
125SOOuCi of Na I and 500ug of 04A6, 04D2 and 03D1 were iodinated
125 7with 300uCi of Na I. 2-8x 10 cpm of labelled antibodies were 
obtained by this procedure. The process of purification and 
iodination of the antibodies was repeated twice for each MCAb.
5.15 Radioactive binding assays with iodinated immunoglobulins 
Direct binding and inhibition studies were carried out
using the labelled antibodies. This analysis removed doubts about 
possible discrepancies introduced by the second antibody, and 
made it possible to confirm that the epitopes of the antibodies 
overlapped sufficiently to preclude simultaneous binding of two 
types of antibody at the same time.
5.15.1 Determination of vibrio concentration required for 
studies with labelled antibodies
Constant amounts of labelled antibodies were tested on 
increasing numbers of vibrios to detect the appropriate 
concentration of vibrios to be used for binding studies. It was 
particularly necessary to use high amounts of antigen for the
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detection of the cross-reactivity of the anti-Inaba antibodies. 
The binding of IlAl increased linearly up to 10^ vibrios and then 
formed a plateau at higher concentrations of the vibrios ( Fig-
5.13 ). This is in contrast to Figure 5.5c where a biphasic 
binding curve was observed in the ELISA assay utilising a second 
antibody, and suggests that second antibody effects were indeed 
responsible for this phenomenon. However, both the total antibody 
concentration and the type of plate employed were other 
contributory variables.
5.15.2 Direct binding of antibody to a variety of gram-negative 
bacteria
Linbro flexible plates were coated with a variety of
9
bacteria at the concentration 10 organisms per well. The 
bacteria used for the test were the two serotypes of cholerae. 
B. abortus. B. melitensis and coli ( ML 308 ). The labelled 
immunoglobulins were applied to each sample of bacteria and 
allowed to react as described in ( Section 2.3.3.6 ) and the 
extent of the reaction of each MCAb with the various bacteria was 
measured. A direct comparison between each MCAb was not possible 
since the specific activity of the antibodies was not determined.
None of the six MCAbs produced in this study bound to B. 
abortus « B. melitensis or coli. 03D1, 04D2 and 04A6 did not 
bind to Inaba. An appreciable amount of IlAl, I4B1 and 1403 bound 
to the Inaba vibrios ( Table 5.8 a ) and 04A6, 04D2 and 03D1
demonstrated high binding to the Ogawa vibrios. Cross reactive 
binding of IlAl, I4B1 and I4C3 to Ogawa was significant but the
Fig.s.13 Reaction of labelled antibody on Increased antigen 
density
4x106 of labelled IlAl was reacted with different antigen
concentrations. The values plotted are a mean of two assays.
(2) ( 3  bound on Ogawa vibrios
cpm bound on Inaba vibrios
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Table 5.8 a Binding studies of radiolabelled MCAbs to various 
gram-negative bacteria
Each radiolabelled antibody was applied to various organisms and 
the amount of antibody bound to the bacteria was determined as 
described in Section 2.3.3.6.
B.A B.abortus
B.M B.melitensis
E.C E.coli
185
MCAb cpm applied No. of 
assays
Bk. c p m + S.D.
Inaba Ogawa B.A. B.M. E.C
lAl 2-5x10® 6 100 7500 1200 140 130 130
±250 +85 ±13 ±16 ±10
I4C3 1-2x10® 4 60 6200 510 50 70 70
±500 +25 ±5 ±10 +12
I4B1 1-4x10® 4 100 4700 1110 135 110 200
±335 ±55 +16 ±9 + 15
04D2 5-8x10® 4 50 200 3090 80 120 350
+250 ±10 +14 + 10
03D1 1-2x10® 4 60 290 5670 70 200 300
+19 +215 +5 +15 +17
04A6 2-3x10® 2 75 315 4800 95 115 210
+ 25 +300 +15 +9 + 10
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cross reaction of the three Ogawa antibodies,Including 03D1, with 
Inaba was very weak.
5.15.3 Inhibition assays with'radiolabelled antibody
The binding sites of the labelled antibodies to Ogawa or 
Inaba vibrios were inhibited by cold antibodies to investigate 
two possibilities. Firstly, it was necessary to determine whether 
the apparently specific epitopes on the two vibrios were 
independent or whether the two basic types of monoclonal 
antibodies could block each other. Secondly, it was of interest 
to determine whether cross reactions between serotypes could be 
abolished by the use of antibodies to the homologous serotype and 
whether cross reacting activity was distinct from homologous 
reaction. The data ( Table 5.8 b, c, d and e ) clearly indicated 
that IlAl, I681 and I6C3 had binding sites distinct from the O 
panel of antibodies on their own serotype but could be dislodged 
by the anti Ogawa antibodies when c r o s s  reacting with this 
heterologous serotype. 04A6, 03D1, and 06D2 were totally specific 
on their own serotype and unaffected by the presence of the 
anti-Inaba monoclonals. 03D1 showed no tendency to diverge from 
the other two members of the original O specific panel as it had 
on other assays such as agglutination or complement fixation.
5.16 Summary of assay results for the six monoclonal antibodies
5.16.1 MCAbs I1AI.I6B1 and I6C3
These antibodies reacted in a similar manner in all 
assays. Their relative reaction to the two serotypes is
Table 5.8 b Inhibition assay on Inaba vibrios
The vibrios were incubated with unlabelled MCAbs followed by 
labelled antibodies as described in Section 2.3.3.7.
^  Average cpm bound to Inaba vibrios
* Average cpm bound to Inaba vibrios after blocking with 
unlabelled MCAbs
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MCAb cpm
appld
No. of 
assays
cpm*+S.D. 
on Inaba
Inhibition by MCAbs to Inaba
*
cpm +S.D. percentage
IlAl I4B1 I4C3 IlAl X4B1 I4C3
IlAl 3x10® 6 7500 2100 2660 2250 72 65 70
±250 +100 ±200 +95
I4B1 2x10® 4 4700 2805 2919 2750 40 38 42
+335 +155 +200 +350
I4C3 2x10® 4 6200 2860 3100 3215 54 49 48
+500 +400 +155 ±205
Table 5.8 c Inhibition assay on Inaba vibrios
The vibrios were incubated with unlabelled MCAbs followed by 
labelled antibodies as described in Section 2.3.3.7.
^  Average cpm bound to Inaba vibrios
* Average cpm bound to Inaba vibrios after blocking with 
unlabelled MCAbs
No inhibition observed
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MCAb cpm
appld
No. of 
assays
A
cpm +S.D. 
on Inaba
Inhibition by MCAbs to Inaba
it
cpm + S.D. percentage
04A6 03D1 04D2 04A6 0301 0402
IlAl 3x10® 4 7500 7800 7120 7700 ^  ^  —
+ 250 +100 +125 +200
I4B1 2x10® 4 4700 5700 4900 4500 - - —
+335 +400 +150 ±260
I4C3 2x10® 4 6200 6100 6555 7005 -  —  -
+500 +100 +90 ±115
Table 5.8 d Inhibition assay on Ogawa vibrios
The vibrios were incubated with unlabelled MCAbs followed by 
labelled antibodies as described in Section 2.3.3.7.
^  Average cpm bound to Ogawa vibrios
* Average cpm bound to Ogawa vibrios after blocking with 
unlabelled MCAbs
No inhibition observed 
nd not determined
loy
MCAb cpm
appld
No..of 
assays
f
cpm +S.D. 
Ogawa
Inhibition by MCAbs to Ogawa
*
cpm + S.D. percentage
IlAl I4B1 I4C3 IlAl I4B1 I4C3
IlAl 3x10® 6 1200 660 775 820 45 35 32
+85 ±15 +20 +25
I4B1 2x10® 4 1110 nd nd nd nd nd nd
+55
I4C3 2x10® 4 510 455 340 290 10 33 43
+25 +20 +35 +20
04A6 2x10® 2 4800 4920 5125 4795 —  —  -
+300 + 125 +300 +250
03D1 2x10® 4 5670 6600 7230 7290 — — -
+215 +500 +215 +310
04D2 6x10® 4 3090 3140 3200 3300 - - -
+250 + 30 ± 2 7 + 8 5
Table 5.8 e Inhibition assay on Ogawa vibrios
The vibrios were incubated with unlabelled MCAbs followed by 
labelled antibodies as described in Section 2.3.3.7.
Average cpm bound to Ogawa vibrios 
* Average cpm bound to Ogawa vibrios after blocking with 
unlabelled MCAbs
190
MCAb cpm
appld
No. of 
assays
A
cpm +S.D. 
Ogawa
Inhibition by MCAbs to Ogawa
★
cpm + S D. percentage
04A6 03D1 04D2 04A6 03D1 04D2
IlAl 3x10® 6 1200 300 316 320 75 74 73
±85 +10 +11 ±15
I4B1 2x10® 4 1110 330 400 500 70 64 55
+55 +15 +21 ±17
I4C3 2x10® 4 510 170 160 120 67 59 92
+25 +15 +16 +19
04A6 2x10® 2 4800 3665 4110 3700 24 14 23
+300 +95 +105 +190
03D1 2x10® 4 5670 4600 4000 4275 19 29 25
+215 +100 + 95 + 65
04D2 6x10 4 3090 1145 900 2010 63 71 35
+100 +12 +56 +145
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summarised in Table 5.9 a. Thus, in general, the three "Inaba 
specific" MCAbs all showed a significant cross reaction with 
Ogawa vibrios and a weak but significant cross reaction with 
B. abortus
5.16.2 MCAbs 04A6 and 04D2
These MCAbs appeared to be totally specific on all assays. 
They did not agglutinate even homologous bacteria. They did, 
however, dislodge the cross reacting anti-Inaba monoclonal 
antibodies from their interaction, indicating that there was a 
close relationship between the epitopes of the two serotypes.
5.16.3 MCAb 03D1
03D1 behaved identically to the other 04A6 and C4D2 in
all assays except two. In the;agglutination assay, it weakly but 
persistently agglutinated Inaba ( though not Ogawa ) bacteria. In 
the complement fixation assay, it fixed complement in the 
presence of Inaba vibrios at a concentration 5-10 fold higher 
than that in which it gave activity with the homologous serotype. 
Such results are suggestive of a weak interaction with Inaba 
vibrios, significantly weaker than the interaction observed with 
the "Inaba specific" monoclonal antibodies with Ogawa vibrios.
Table 5.9 a Summary chart of MCAbs raised against Inaba 
N.D. not determined
N.S. not significant
ASSAYS CONDUCTED MONOCLONAL ANTIBODIES
IlAl I4B1 I4C3
1. Titres of antibodies on ELISA 
( Section 3.6 )
Ogawa no react. no react. no react.
Inaba 1 in 256 1 in 512 1 in 512
B.abortus no react. no react. no react.
B.melitensis no react. no react. no react.
E.coli no react. no react. no react.
2. Reaction on immunoblotting 
{ Section 4.17 )
Ogawa no react. no react. no react.
Inaba positive positive positive
B.abortus no react. no react. no react.
E.coli no react. no react. no react.
S.tvohimuriuTn no react. no react. no react.
3. Competition ELISA 
( Section 5.1 )
50% inhibition with Ogawa LPS no inhib. no inhib. no inhib.
50% inhibition with Inaba LPS 56ng 60ng 45ng
4. Quantitation of IP
( Section 5.2 ) 
Ogawa 6 5.6 4.5
Inaba 14 14 9.7
Inaba / Ogawa preference 2.3 2.5 2.1
IlAl I4B1 I4C3
5. Slide Agglutination 
( Section 5.4.1 ) 
Ogawa 
Inaba 
B.abortus 
B.melitensis 
Y.enterocolitica
+
6. Antibody titre on primary
agglutination ( Section 5.7 )
Ogawa 2.5
Inaba 1.25
Inaba/Ogawa preference 2
1.25
0.6
2
1.25
0.3
4
7. Antibody titre on secondary 
agglutination(Section 5.4.2.2)
Ogawa 1.25 1.25
Inaba 0.3 0.3
Inaba/Ogawa preference 4 4
1.25
0.3
4
8. Concentration of antibodies 
that fixed 50% complement 
{ Section 5.7 )
Ogawa 0.034 12.31
Inaba 0.009 3.19
abortus N.D N.D
Inaba/Ogawa preference 3.7 3.8
Inaba/Brucella preference N.D N.D
Ogawa/brucella preference N.D N.D
0.044
0.014
0.8
3.2
57
18
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IlAl I4B1 I4C3
S>. Maximum activity on ELISA
7 A 
at 10 -10 bacteria
( Section 5.5.2 ) 
Ogawa 
Inaba 
B. abortus 
B.melitensis 
E.coli 
Inaba/Ogawa preference
0.9
2
N.S
N.S
N.S
2.2
0.91
2
N.S
N.S
N.S
2.19
0.64
1.68
N.S
N.S
N.S
2.63
10. Direct binding assay (cpm)
( Section 5.14.2 )
Ogawa 1200 1110 510
Inaba 7500 4700 6200
E.coli N.S N.S N.S
B.abortus N.S N.S N.S
B.melitensis N.S N.S N.S
Table 5.9 b Summary chart of MCAbs raised against Ogawa
N.S. not significant
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ASSAYS CONDUCTED
1. Titres of antibodies on ELISA 
( Section 3.6 )
MONOCLONAL ANTIBODIES 
04A6 04D2 03D1
Ogawa lin 512 1 in 512 1 in 512
Inaba no react. no react. no react.
B.abortus no react. no react. no react.
B.melitensis no react. no react. no react.
E.coli no react. no react. no react.
2. Reaction on immunoblotting 
( Section 4.17 )
Ogawa 
Inaba 
B.abortus 
E.coli
S.tvphimurium
positive positive positive 
no react, no react, no react,
no react, no react, no react,
no react, no react, no react,
no react, no react# no react.
3. Competition ELISA 
( Section 5.1 )
50% inhibition with Ogawa LPS 
50% inhibition with Inaba LPS
25ng 62.5ng 65ng
no inhib. no inhib, no inhib,
4. Quantitation of IF 
( Section 5.2 )
Ogawa
Inaba
38 37 35
no react, no react, no react.
5. Slide Agglutination 
( Section 5.4.1 )
Ogawa 
Inaba 
B.abortus 
B.abortus
04A6
Y.enterocolitica -
03D1
196
04D2
6. Antibody titre on primary
agglutination (Section 5.4.2.1) 
Ogawa 
Inaba
Ogawa/Inaba preference
20 5
2.5
1/2
7. Antibody titre on secondary
agglutination (Section 5.4.2.2)
Ogawa 0.6 20
Inaba 10 20
Ogawa/Inaba preference 16 1
2.5
2.5 
1
8. Concentration of antibodies 
that fixed 50% complement 
( Section 5.7 )
Ogawa
Inaba
Ogawa/Inaba preferrence
v.dil. 0.19 0.0038
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04A6 04D2 03D1.
9. Maximum activity on ELISA 
at 10 -10 bacteria
( Section 5.5.2 )
Ogawa 
Inaba 
B.abortus
B.melitensis 
E.coli 
Ogawa/ Inaba preference
1,8
N.S.
N.S.
N.S.
N.S.
2
N.S.
N.S.
N.S.
N.S.
1.65
0.65
N.S.
N.S.
N.S.
2.5
10. Direct binding assay (cpm) 
( Section 5.14.2 )
Ogawa 4800 3090 5670
Inaba N.S. N.S. N.S.
E.coli N.S. N.S. N.S.
B.abortus N.S. N.S. N.S.
B.melitensis N.S. N.S. N.S.
GENERAL DISCUSSION
6.1 The immune response to V.cholerae
Clinical infections of cholerae give rise to both 
antibacterial and anti-toxin antibodies ( Majumdar and Chose, 
1982; Holmgren and Svennerholm, 1973 ), although antibacterial 
antibodies have been found to be more effective in vibriocidal 
activity ( Levine et al. 1979 ). Cryz e^ ( 1982 ) have shown 
that absorption with LPS of antisera from animals immunised with 
viable vibrios leads to a decrease in the vibriocidal activity. 
They estimated that approximately 75% of the vibriocidal activity 
was directed against the LPS and the rest against non-LPS surface 
antigens. The type specific antigens of cholerae have been 
serologically defined by absorption studies ( Kauffmann, 1950; 
Gardner and Venkatraman, 1935 > and Gustafsson and Holme ( 1983 ) 
have produced MCAbs with specificities conforming to the 
classically defined A, B and C antigens. However, no 
immunological data relating to the structural inter-relationships 
among these antigens has yet been reported. In this study, the 
fine specificity of the MCAbs raised against the LPS of Inaba and
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Ogawa serotypes has been used to investigate the stuctural 
homologies among the epitopes on the complex LPS molecules of 
the two serotypes.
6.2 Factors leading to the preferential selection of MCAbs 
reactive with LPS
The fact that the six monoclonal antibodies in this study 
were all reactive with the bacterial LPS may be chance or due to 
the immunisation and selection procedures. The animals used for 
the production of the MCAbs were immunised with heat killed whole 
cells of either Ogawa or Inaba serotype ( Section 2.3.1.1 ). As 
the ‘ LPS represents several percent of the dry weight of 
gram-negative bacteria and accounts for many of their antigenic 
properties, a strong response against the V_j_ cholerae LPS would 
therefore be anticipated. However, immunisation with cells could 
have also led to the production of antibody directed against 
membrane proteins of the bacteria. Kabir ( 1980 ) and Stevenson 
et al. ( 1985 ) have reported the presence of immunogenic 
proteins in the outer membrane of cholerae. Outer membrane 
proteins have been used by other workers (Sciortiono et 1985)
for raising MCAbs to cholerae membrane proteins. Anti-protein 
activities of vibriocidal antibodies have also been demonstrated 
by Neoh and Rowley ( 1970; 1971 ). In this study, rat
anti-V. cholerae antiserum reacted with Western blots of cell 
sonicates showing staining of a wide range of proteins ( data not 
shown ). The MCAbs established from the immunised rats, however, 
reacted with only the LPS component of the bacteria.
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6.2.1 Final boosting of experimental animals
The final boost, 4 days prior to fusion, is generally 
agreed to be vital to the production of a large number of MCAbs 
( Stahli et al, 1980 ). It is possible to suggest that the LPS 
molecules on the outer surface of the bacteria dominate this 
procedure as they are effectively seen first by the immune 
system, with the other antigens only being able to elicit a 
response after the bacterium has been further degraded, possibly 
by antigen presenting cells with the subsequent involvement of T 
lymphocyte help ( see Section 6.2.3 ).
6.2.2 Selection of hybridomas by assay
V. cholerae cells were used in this study for the screening 
of hybridoma supernatants from emerging clones. As LPS is 
localised almost exclusively on the outer surface of the outer 
membrane it would have been readily accessible at high density to 
the antibodies from the emerging hybdridomas during selection. 
The membrane proteins on the other hand may have been less 
accessible for interaction with the antibodies. Thus either 
accessibility, or sheer epitope density, may have favoured MCAbs 
to LPS at this stage with the clones giving a lower signal for 
membrane proteins being rejected as only weak positives.
6.2.3 The polyclonal effect of bacterial LPS on B-cells 
Bacterial cell wall LPS is well known for its ability to
induce a Thymus Independent (TI) polyclonal activation of
201
B-cells( Andersson et 1972 ) in addition to many striking
pathophysiological effects on mammalian organisms ( Morrison and 
Ryan, 1970 ). Although the exact mechanism of activation of LPS 
on the proliferation and maturation of B-cells is not defined, 
considerable progress has been made in sorting out the multiple 
effects of LPS on B lymphocytes ( Section 1.16 ). The correlation 
between antigenic activity of the three originally classified 
anti-Inaba antibodies with other bacteria expressing 
mannopyranosyl sugars is of particular interest and may suggest 
that these play a significant role as adjuvants, comparable with 
that of the mannose associated 0 chains ( Section 1.16 ).
6.2.4 Specific effects of V.cholerae LPS as antigen
In this study cholerae organisms have been used as 
immunogens and have resulted in antibodies against LPS. The Lipid 
A moiety of coli LPS can induce B-cells to proliferate and
mature into antibody producing cells ( Raetz et al, 1983 ) and
it may therefore have been possible for Lipid A alone to have 
Induced the B-cells into producing increased amounts of 
antibodies against the immunodominant 0-region.
6.3. Antigenic components of the core LPS
The inner core region of the LPS is considered to be of 
great biomedical importance since it contains immunogenic 
structures that are common to many pathogenic gram-negative 
bacteria ( Luderitz et, 1966 ) ( Section 1.14 ).
The MCAbs established in this study do not react strongly
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with any of the core components of cholerae LPS as seen in the 
Western blots ( Section 4.8 ). This does not exclude the 
possibility of the existence of weak interactions of the 
antibodies with the core which were not detected in the Western 
blots because of the limited sensitivity of the method in 
comparison to the two non-washing methods employed. Some of the 
cross-reactions observed between the Inaba and the Ogawa 
serotypes and between Inaba and abortus may be due to the 
recognition of the core components. However, the core portions of 
the LPS of most gram-negative bacteria are thought from 
conventional serology, to be very similar and to share antigenic 
determinants. Consequently, the cross-reactive anti-Inaba MCAbs 
or the 03D1 anti-Ogawa antibody would have been expected to react 
to some extent with more of the other gram-negative bacteria 
tested. Thus the cross-reactive MCAbs appeared to detect only 
similarities between the 0-antigens of the different bacteria 
tested. Steric factors in both parts of the LPS may also affect 
the access of a single monoclonal antibody where they do not 
significantly affect the reaction of polyclonal antiserum.
Immunisation and selection protocols may have played a 
part in the stimulation and detection of the antibodies to 0 
regions in the same way as they may have influenced the selection 
of LPS as major antigen ( Section 6.2 ). The majority of 
anti-core antibodies have been obtained either by immunisation 
with mutant rough type organisms or by selection of the 
hybridomas against the purified LPS of the immunising organism. 
In both cases, the core may be better exposed in vivo to the
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immune system or in vitro to the selection system. The latter 
possibility is particularly logical since it seems likely that 
the core is more accessible to the antibodies in the purified 
form of the LPS rather than on the complex bacterial surface 
where it may remain embedded under the immuno-dominant 0-side 
chains. This conclusion is supported by the results of Perez 
et al, (1985) who from their studies with antisera raised against 
rough, intermediate and smooth types of Campylobacter have 
proposed two hypotheses. Firstly, the core structure on smooth 
type organisms is hidden by the 0-polysaccharides so that the
immune system does not see it. Secondly, the lack of response to
core antigens of smooth-type LPS may be caused by the
immunodominant 0-determinants that may preempt the entire immune 
response. The authors are in favour of the first hypothesis 
because they were able to produce anti-core and anti-0 antibodies 
from immunising rabbits with intermediate type organisms. 
However, such an interpretation is in contrast to the
observations of Nelles and Niswander ( 1984 ) who observed that 
the anti-core antibodies do not bind to LPS derived from the 
parental smooth-type bacteria but are able to bind to the 
bacteria itself.
6.4 Analysis of the IgG subclass of the MCAbs
All six of the rat MCAbs against cholerae LPS 
generated in this work were of the IgG2b type. Statistically, 
since this is a minor serum subclass, such a grouping is 
unlikely. Mouse MCAbs established by others against bacterial LPS
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have been predominantly of the isotypes IgM or IgG3 ( Quinn
et al, 1984; Gustafsson and Holme, 1983; Lind e^ a^, 1985 ). This
suggests a preferential LPS or carbohydrate association of the 
IgG3 isotype of MCAbs with antigens of this chemical constitution 
in the mouse. The rat equivalent, by analogy, would appear to be 
lgG2b. Isotype switching is not readily observed by cloned cells 
in culture but bulk culture of uncloned murine B lymphocytes 
responding to secondary LPS has been shown to generate additional 
IgG3 production from cultures previously producing IgM alone. 
( Jones et 1983; Vitetta et 1984; Bjorklund and Coutinho,
1983 ). Similar evidence has also shown that additional 
T-cell—derived factors are necessary for the expression of
isotypes other than IgG3.
The heavy chain locus for IgG3 in mouse DNA is the one
nearest to the delta chain coding region, albeit 55Kb downstream 
( Marcu, 1982; Shimizu and Honjo, 1984 ). It will be of interest 
to note, when the rat heavy chain genes are sequenced, if rat 
IgG2b genomic coding sequences occupy a similar and comparatively 
close position or whether the location is incidental.
6.5 Effect of phenol on LPS preparations
Aqueous phenol has been used for many years as a general 
method for the isolation of LPS from bacterial cells ( Westphal 
and Jann, 1965 ). The deproteinizing action of hot aqueous phenol 
is known to cause cleavage at the point of attachment of lipid A 
to the protein moiety on the membrane. However, Tsang e£ al,
205
( 1974 )have reported that that the action of phenol is at a 
phenol-sensitive linkage within the lipid A moiety. Hydrolysis of 
the 0-specific chain and fatty acids of the core were also 
reported to occur but only in negligible amounts.
V. cholerae LPS used for this study was extracted by hot 
aqueous phenol from the vibrios several times and no difference 
between the preparations was observed on SDS-PAGE analysis. The 
unextracted LPS in the sonicated vibrios and the crude LPS
obtained by hot aqueous phenol extraction exhibited identical 
mobilities, and hence the hot aqueous phenol was not considered
to have affected the 0-antigen or the lipid A core complex
significantly during the process of extraction.
6.6 Analysis of V.cholerae LPS on SDS-PAGE
6.6.1 0-side chain microheterogeneity in V.cholerae LPS
V. cholerae LPS has much greater size homogeneity than 
other LPS molecules previously analysed such as those from
E. coli and S_j_ typhymurium ( Palva and Makela, 1980; Goldman and 
Leive, 1980 ). In this work the apparently homogenous LPS of 
V. cholerae has been shown to possess microheterogeneity which 
could be resolved only after high resolution electrophoresis. The 
complete 0-chain of the LPS migrated as a single but diffuse band 
when electrophoresed under normal conditions. The existence of 
more than ten bands in the 0-region was demonstrated on final 
resolution of the LPS ( Section 4.14.2 and 4.14.3 ). It was, 
however, noticed that a background stain interspersed with the 
0-chain bands. This could mean that there were some glycans in
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the LPS which did not migrate as sharp bands but formed a 
continuous smear.
V. cholerae LPS Is a homopolysaccharide composed of
perosaminyl residues, the amino groups of which are acylated by
3-deoxy-glycero-tetronic acid ( Section 1.13.2 ). Very small
differences in the mobilities of the bands forming the ladder
suggest that the increments between them are also very small. The
most obvious addition to each of the lower bands would be that of
a perosamine residue. The repeat unit for the 0-chain of the
V. cholerae LPS would thus consist of only perosamine residues.
The number of residues forming a repeat unit has not yet been
defined. The mean chain length of the 0-chain has also not been
reported. The close spacing between the bands, however, indicates
that the repeat unit is likely to be one perosamine residue only.
An attempt to verify the suggestion was made by estimating the
molecular weights of the 0-chains from a calibration graph of
mobility versus molecular weight of LPS molecules with known
molecular structures, such as of coli Dili B4 and
S. typhimurium. The results indicated that the 0-region of the
V. cholerae consisting of more than ten bands was concentrated
within M of 1400. In such a case the difference between each 
r
band would be about 140 which falls short of the molecular weight 
of an acylated perosamine residue which is 247. However, this 
method of molecular weight estimation, which is routinely used 
for proteins with reference to protein standards, may have 
limited applicability to LPS molecules both for the determination 
of the overall molecular weight of the core plus 0 antigen and
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the molecular weight increment between two molecules with 
different numbers of 0 antigens. Where most proteins bind SDS in 
a uniform manner, the association of SDS with LPS involves only 
the hydrophobic lipid A moiety (Jann et 1975). The diversity
that exists in the 0-region of gram-negative bacterial LPS 
molecules may give rise to unique migration patterns on gel 
electrophoresis because of the variation in charge and chemical 
composition of the sugar residues. Even with proteins, which do 
bind SDS, mobility in gels can be shown to depend on 
conformational factors and also charge so that for example, the 
highly charged histones migrate abnormally slowly, as do 
glycoproteins ( Hames and Rickwood, 1981 ). Consequently, the use 
of LPS of different charge and chemical composition as a standard
for the analysis of LPS from another source has limited validity.
Redmond's ( 1979 ) observation of a molecular weight of
about 10,000 for 60 perosamine residues is consistent with the
small band difference obtained here.
An unequal distribution of the repeat units has been 
observed for ^  coll 0111 B4, S^ typhimurium and Citrobacter
strain 396 LPS ( Palva and Makela, 1980; Goldman and Leive, 
1980 ). Each organism showed a preferred range of repeat units 
for the expression of the 0-side chains. In contrast, the 
V. cholerae LPS extracted from the Ogawa NIH 41 and Inaba 35 A3 
serotypes did not exhibit such wide variation in the 0-side chain 
lengths, though the longer chains were in most abundance as seen 
in Figure 4.9. The presence of more than one diffuse band of 
0-antigen in the LPS of Inaba ( 569 B ) could be a characteristic
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of that strain or it may be a result of aggregation of the low
molecular weight bands ( Section 6.7.1 ). Since the length of
0-side chain most abundantly expressed by Inaba 569 B coincided 
with the lengths expressed by Ogawa NIH 41 and Inaba 35 A3 it may 
be that this particular length of side chain is the range 
preferred by the cholerae organisms.
The increment in molecular weight between the bands was 
observed to be the same for Ogawa and Inaba serotypes. This is 
Interesting because only the Ogawa polysaccharides has been
reported to contain the sugar 4—amino-deoxy-arabinose ( Redmond,
1978 ) and its position in the LPS has not been identified.
6.6.2 Mobilities of the core and the lipid A
The lipid A and the core of the cholerae LPS had
identical mobilities to that of the coli 0127 B8
( Figure.4.7 ) and this is consistent with the findings that the 
core-lipid A complexes of gram-negative bacterial LPS are 
conserved. However, the doublet of the core—lipid A obtained in 
short gels ( Figure. 4.2 a and b ) was resolved into three bands 
with high resolution electrophoresis { Figure. 4.9 ). The topmost 
band of the three, which was stained very faintly could either 
indicate the presence of a complete core with the addition of one 
perosamine residue or heterogeneity in the lipid A region as
reported by Rosner e^ al, ( 1979 ) in coli K12 LPS. The
heterogeneity in the lipid A was reported by these authors to be 
caused by differences in phosphate groups which introduce a 
change in charge and hence a slight alteration in the mobility.
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6.6.3 Sensitivity of silver stain for Identification of LPS 
The small quantities of V\ cholerae LPS used for analysis on 
SDS-PAGE by silver staining Is not inconsistent with the lower 
limit of carbohydrate content required for this detection system 
as estimated by Dubray and Bezard, (1982). It must be noted that 
Tsai and Frasch (1982) also reported their inability to stain 
free lipid A as was experienced in this study (Section 6.18 and 
6.19).
6.7 Aaere&ation of LPS
6.7.1 AgRreaation of LPS during electrophoresis
Migration of LPS has been shown to be affected by the 
formation of multimers in SDS-PAGE by Peterson and McGroarty 
( 1985 ). The authors found that the banding patterns of LPS in 
SDS-PAGE were influenced by both the LPS and SDS concentrations 
used. Nanogram quantities of E_^  coli LPS were reported to form 
noncovalently associated multimers in gels run in 0.1% SDS. The 
multimers migrated more slowly than their monomeric substituents, 
causing anamolous bands either to appear in between, or to 
overlap with thus darken, longer 0-antigen monomer bands. The 
multimers were moderately stable since they migrated as distinct 
bands and not as smears. Hitchcock ( 1983 ) has also described 
the dissociation of slow-migrating bands into faster migrating 
ones as well as fast migratng bands apparently dissociating to 
form slower-migrating bands. He, however, concluded that the 
phenomenon was caused by the dissociation of SDS from LPS during
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electrophoresis. Peterson and McGroarty ( 1985 ) in their studies 
of the migration rates of the multimers concluded that the LPS 
multimers were either formed immediately before or during the 
electrophoresis. Logan and Trust ( 1984 ) have also reported 
aggregation of LPS which could be reversed by resolubilisation in 
SDS.
0-antigens of Ogawa NIH 41 and Inaba 35 A3 exhibited only 
a limited variation in migration rate. Consequently, an aggregate 
of the fastest moving band would be likely to appear well behind 
the slowest moving band of the main LPS pattern and aggregation 
is unlikely to have affected the work described here. Moreover, 
the process of aggregation is enhanced by high concentrations of 
LPS or low concentrations of SDS. The low concentrations of LPS 
used for the resolution studies in this work are unlikely to have 
favoured the formation of aggregates.
Consequently, the high molecular weight bands exhibited 
by the Inaba 569 B LPS may have been a genuinely unique 
structural feature or a result of aggregation as described by 
Peterson and McGroarty ( 1985 ) or a spontaneous aggregation 
( Section 6.7.2 ).
6.7.2 Aggregation of LPS on storage
Aggregation of LPS was observed in this study when 
solutions of It in distilled water were stored for long periods 
of time at 4^C. Tsai and Frasch ( 1980 ) have also reported 
aggregation of LPS on long storage. Shands and Chun ( 1980 ) have 
shown that large aggregates of LPS are formed spontaneously and
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can be partially dissociated by detergent. The aggregate size is 
dependent on both the detergent concentration and the type of 
detergent used. Hurlbert and Hurlbert ( 1977 ) have demonstrated 
the dissociation of LPS into subunits following treatment with 
detergents. The re-aggregation of the subunits was then achieved 
by removing the dispersing agent followed by freezing and 
thawing.
6.8 Immunoblotting of LPS
Bacterial LPS molecules from various organisms have been 
immunoblotted with polyclonal and monoclonal antibodies ( Perez 
et al, 1985; Poxton e^ a^, 1985; Sidberry et 1985; Ogasawara
et a^, 1985 ) and it has been observed that some LPS molecules
have very characteristic profiles of migration in SDS-PAGE and 
Western blotting. A typical immunoblot of LPS would consist of a 
ladder shape as obtained by Sidberry et a^ ( 1985 ) with coll 
and Pseudomonas LPS. LPS from cholerae did not conform with 
the ladder shape exhibited by the 0-antigens. Unresolved 
0-antigens of cholerae appeared as smears on immunoblotting 
( Fig. 4.3a and b ). Since the MCAbs reacted with the whole 
region of the unresolved 0-antigen this indicates that even if 
heterogeneity does exist in the antigen the MCAbs did not 
differentiate it. Immunoblots similar to that of cholerae LPS 
were obtained by Ogasawara e^ a^, ( 1985 ) with
Yersinia enterocolitica 0:3 and by Bundle et ( 1984 ) with
Y. enterocolitica 0:9 and ^  abortus 0-antigens. The confluent 
pattern of the immunoblots was attributed to the chemical nature
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of the 0-antigens«hich were thought to be homopolysaccharides 
with no microheterogeneity. The 0-side chains of abortus. 
Y. enterocolitica 0:9 and cholerae have been proved to be 
polymers of monosaccharides ( Section 1.18 ). Hence the feature 
of microheterogeneity in the LPS may be characteristic only of 
apparenthomopolymers, i.e. molecules with small differences in 
their 0 side chains.
The resolved LPS of cholerae also failed to exhibit 
periodic bands in an immunoblot because of problems with the 
detection systems. Basically, the enzyme detection system 
( Section 4.15.1 ) had the potential to differentiate between the 
bands but was not sensitive enough for the low concentrations 
necessary to resolve them. The Protein A system ( Section
4.15.2 ) on the other hand, had the sensitivity to cope with the 
nanogram concentrations but gave blurred autoradiographs due to 
the long pathlength of the gamma rays emitted by the isotope. 
The experimental problem was further exacerbated by the lack of a 
sensitive stain for LPS which could be applied to nitrocellulose 
paper so that the fidelity of transfer of the closely knit bands 
from the gels could be assessed. After numerous experiments with 
the two detection systems, bands in the immunoblot, reminiscent 
of, but more diffuse than those in the original silver stain 
were demonstrable ( Fig 4.10.b ).
A common feature of the immunoblots of resolved LPS was the 
presence of differentially reacting regions. The fact that it 
appeared in both systems of detection ruled out the possibility 
of a methodological artefact. The extent of reaction of the
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0-antigen did not decrease as it might be expected to have done 
with a decrease in the number of side chains, i.e. molecular 
weight ( Fig. 4.9 ), and instead there was an apparently 
biphasic reaction with both the high and low molecular weight 
regions of the band reacting more than the median. Such a 
phenomenon could not be explained from the molecular structure of 
the 0 antigen. The alternative could be a selectively inefficient 
electrophoretic transfer of the resolved LPS which does not 
correlate with molecular weight or charge but depends on some 
other physicochemical factor operating during transfer.
There is only one report of immunoblotting of cholerae 
LPS in the literature and this is a recent paper from Sciortino 
et al ( 1985 ) who have produced 66 stable monoclonal antibodies
from a single fusion, screened by immunoblotting. Those of their
clones which reacted with LPS also did not show the typical 
ladder shape but resembled the immunoblot obtained in this study 
with Inaba 569 B. The diffused bands the authors presented 
clearly expressed heterogeneity in them. The widely spaced smears 
the authors obtained may have been due to LPS aggregates (Section 
6.7).
Poxton et al, ( 1985 ) produced evidence of outer
membrane protein linked LPS complexes in Pseudomonas aeroginosa. 
The MCAbs reactive with them recognised both the protein and LPS 
suggesting that the antibodies interacted with both. Protein 
antigens have been reported in cholerae outer membranes but
they have not been associated with the LPS. The studies conducted 
here with V». cholerae LPS did not have any protein contaminants
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as detected by coomassie blue or silver stain on the gel itself, 
or amido black on the blot. None of the six MCAbs reacted 
detectably with any protein in the vibrio outer membrane thus 
apparently ruling out the possibility of involvement of proteins 
in antibody-antigen interaction.However, in view of the fact 
that low affinity cross—reactions have been detected with 
heterologous LPS molecules ( Section 6.10.7 ), a minor 
contribution of LPS-protein interactions cannot be ruled out in 
this study. Since it has not effectively been tested.
6.9 Other biological methods of analysis of V. cholerae LPS
While this study has been concentrated on immunological 
methods of detection of LPS antigens, other well established 
methods of analysis were tested and did not yield immediate 
useful information.
6.9.1 Lectin studies.
In this study, wheat germ agglutinin and concanavalin A 
did not show any binding with the cholerae LPS when assessed 
by either direct gel blotting or nitrocellulose blotting 
respectively ( Section 4.12 ). However, Kabir ( 1982 ) reported 
precipitation of alkali treated LPS with con A and acetylated LPS 
with WGA ( Section 4.13 ). The concentrations of LPS and lectins 
used for the assays were high and no negative controls were 
included in the data and so it seems very possible that the high 
concentrations of lectins and LPS could have led to non-specific 
precipitation. It is, however, also possible that the
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interactions between the lectins and the LPS may have been weak 
and hence not suitable for detection by immunoblotting method 
employed in this study.
6.9.2 Enzyme studies
Sen et al^ , ( 1980 ) reported the presence of both alpha— 
and beta- anomeric configurations of the sugar residues in 
V. cholerae LPS. The enzymological studies undertaken here to 
investigate the nature of linkages of the sugar residues 
contained in the LPS ( Section 4.11 ) were not successful due to 
the interference of the enzymes in the assessment of the 
migration of the LPS. In addition, the purity of the enzymes used 
for the study was suspect. All the enzymes employed were 
exoglycosidases and so might not have been expected to dissect 
the molecule internally but rather to trim the edges and sharpen 
the electrophoretic profile and this was clearly not possible.
6-10 Assay methods and the detection of MCAb cross-reactivity
Cross reactions among polyclonal antisera raised against 
bacterial antigens are common. They are, however, difficult to 
evaluate in terms of fine specificity because of the 
heterogeneity of the antibody population. In hybridoma 
technology, cross reactions may be expected to be simplified. 
Where the antibody reacts with identical epitopes on two 
populations of antigen, the cross reaction is likely to be more 
extensive than with conventional serum. Where the antibody reacts
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with a unique epitope, cross reaction may be expected to be 
negligible. Conversely, however, when the whole antigen rather 
than a single epitope is considered, all the antibodies in 
polyclonal antisera have this target in common and a mature 
immune response should statistically favour the major immunising 
antigen. A homogeneous population of a single monoclonal antibody 
may be actually more able to make significant contact with 
antigens other than the immunising one and lead to equally 
complex cross reactions. The situation is further complicated in 
cases like this when the cross reacting antigens bear strong 
structural similarities.
The MCAbs raised in this study against cholerae organisms 
show varying degrees of cross-reactivity against different 
strains of bacteria. This anomalous behaviour of the MCAbs is 
dependent on the type of assay employed
6.10.1 ELISA
ELISA is the most widely used test system for the 
screening of emerging hybridomas. Firstly, it is a convenient 
assay for screening a large number of clones rapidly. Secondly, 
it is considered to be a sensitive test and yet involves the use 
of comparatively low amounts of antigen and antibody. ELISA has 
been modified by various workers to be used for inhibition 
studies of MCAbs with polyclonal or monoclonal reagents from a 
second species, for epitope detection of the antigen < Friguet 
et 1983 ) and for the quantitation of antibodies ( Engvall
et al. 1971 ). In this study ELISA has been mainly used for the
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screening of hybridomas. Other studies such as competitive 
inhibition with LPS and the effect of antigen-antibody 
concentrations on specifities were also conducted on ELISA.
Initial screening of the MCAbs on ELISA as hybridoma 
supernatant on optimum antigen concentrations revealed that the 
established clones were either totally specific towards the Inaba 
or the Ogawa serotype. Conventional serology would classify the 
antibodies as anti-B or anti-C antibodies.
Competition ELISA was undertaken to verify the respective 
serotype specifities of the MCAbs by using LPS as the competing 
antigen ( Section 5.1 ). However, even very high concentrations 
of heterologous LPS did not inhibit the MCAbs from binding to the 
vibrios of the homologous serotypes and the original 
classification of all six antibodies was confirmed by this 
procedure.
Once it had been established by other methods that some of 
the MCAbs were in fact cross-reactive under certain conditions, 
the six MCAbs were tested on ELISA with very large amounts of 
antigen coated on the plates. High concentrations of antigen 
changed the pattern of reactivity of three antibodies. IlAl, I6B1 
and I4C3 clearly demonstrated their ability to bind to Ogawa 
vibrios, though the activity was always much lower than against 
Inaba vibrios. The detection of cross-reactivity on ELISA at only 
high concentrations of the Ogawa vibrios indicated that the 
binding between Ogawa vibrio and the Inaba series of antibodies 
was of a comparatively low affinity. 03D1 was the only antibody 
of the Ogawa series to cross react weakly and it required very
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large amounts of not only the antigen, but also the antibody to 
do so, indicating that it had an even lower affinity for the 
heterologous serotype than the Inaba series of MCAbs.
The increase in antigen concentration which is necessary 
for the demonstration of cross reactivity can be simply 
interpreted ( ignoring antibody bivalence temporarily ) as 
pushing the equation
Ab + Ag — > AbAg 
to the right. In molecular terms, when an antibody dissociates 
from an antigen and there are many other antigenic epitopes in 
the vicinity, it has a greater opportunity for reassociating with 
one of these. With histocompatability antigens, which provide an 
analogous, although not identical situation, the elegant work of 
Ways and Parham ( 1983 ) and Parham ( 1984 ) has divided such low 
affinity cross reacting antibodies into two classes which 
emphasise that bivalence cannot,in practice, be ignored:- 
( 1 ) Those antibodies in which the prime reason for low 
affinity is a rapid rate of dissociation
( 2 > Those antibodies in which the prime reason for low affinity 
is a lowfratelof association and where the rate of dissociation is 
also reasonably low.
In model 1 the antibody bivalence is of critical importance and 
avidity is much greater than affinity. In model two, there is 
very little difference between the two fragments. These studies 
were not conducted. However, the results of the competition ELISA 
would suggest that model 1 was a more likely interpretation for 
all four of the six cross reactive antibodies since in this
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scheme it is possible to envisage antibodies weakly bound to the 
heterologous competing LPS able to dissociate rapidly and make a 
more stable contact with the plate bound homologous material, 
thus obliterating measurement of the valid but weak competition.
The main conclusions from the ELISA and competition ELISA 
results are therefore that, while all of the original six MCAbs 
may be made to appear totally serotype specific, four of them, 
namely the Inaba series and 03D1 ( very weakly ) may be shown to 
cross react with the heterologous cholerae serotype if the 
assay conditions are suitably manipulated. None can be shown to 
cross react with the other gram-negative bacteria tested 
including abortus. at the the highest practicable antigen 
concentrations.
6.10.2 Immunoblotting
Immunoblotting may be considered similar to ELISA as 
an assay procedure, especially where an enzyme blot is employed 
and may be expected to give a similar pattern of cross reactions. 
However, the antigen has been dissected on SDS-PAGE and such a 
procedure may alter both its structure and its relative 
concentration to an unknown extent. The concentrations employed 
in this study were necessarily low in order to achieve fine 
resolution of the bands ( Section 4.14.2 ) and the specificity 
profiles of all six antibodies fitted their original Inaba 
specific or Ogawa specific classification with no cross reactions 
being detectable. The MCAbs showed no tendency to blot with 
protein components of the bacteria. The main value of the
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experiment was therefore to confirm that the major epitopes of 
all six antibodies were present on the LPS molecule alone. 
Immunoblotting has also been used by Sciortino et ^  ( 1985 ) and 
Ogasawara et ^  ( 1985 ) for the determination of the specificity 
of MCAbs raised against bacterial LPS.
6.10.3 Radiolabelled immunoglobulin binding assays
125MCAbs were labelled with Na I in order to measure 
primary antibody-antigen interactions without the involvement of 
a second antibody. This removes potential complications which 
could have been introduced by variation in quality or labelling 
of the second antibody in ELISA or Immunofluorescence and also 
zone effects which can be observed with bacteria when the binding 
of the first antibody is so close as to impede the interaction of 
the second. Direct binding assays with labelled antibodies also 
detected high affinity attachments only and did not reveal the 
extent of cross-reaction taking place as observed in, say,
agglutination tests. The anti-Inaba antibodies bound very weakly 
to the Ogawa vibrios. However, the inhibition assays with cold 
anti-Ogawa antibodies confirmed that the binding was to a similar 
or neighbouring epitope. In the inhibition studies complete
displacement of any labelled antibody by cold antibody was not 
achieved and this may be because saturating amounts of cold
antibody were not used. This assay confirmed the ELISA data with 
respect to cross reactivity of the Inaba series of MCAbs with 
Ogawa vibrios.
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6.10.4 Indirect Immunofluorescence Assay
This assay could again be expected to yield a similar 
pattern of cross reactivity to the ELISA assay. It is however 
possible to measure the extent to which binding is uniform within 
and among organisms in the population under test or whether, for 
example, binding is cooperative. Cross-reaction of the
anti-Inaba antibodies with the Ogawa vibrios was, clearly 
demonstrated in the indirect i m m u n o f l u o r e s c e n c e  a s s a y  although 
washing was included In the protocol as for ELISA and direct 
binding assays. Several factors may have influenced the results 
obtained in this test system. Firstly, the commercial preparation 
and label of the second antibody was different from that used in 
ELISA or Immunoblotting. Secondly, the antigens were fixed with 
alcohol thus minimising leaching, and possibly altering epitope 
availability. Thirdly, greater amounts of antigen were presented 
to the antibodies ( Section 2.3.3.3 ) than in ELISA assays 
( Section 2.3.3.1 ),so that the assay was more equivalent to the 
ELISA Involving high antigen concentrations. Finally, PBS as 
wash buffer may not have exerted as strong a dissociating force 
as PBS-Tween in the weak interactions between antigen and 
antibody. The very weak activity of 03D1 against Inaba was not 
detected in this test. The higher reactivity of the Ogawa 
positive MCAbs against homologous organisms compared to that of 
Inaba positive MCAbs against homologous organisms was 
consistently observed and may relate to the ease of accessibility 
of the primary or secondary antibody.
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6.10.5 Agglutination tests
Agglutination is the most frequently employed test for 
the identification of strains of micro-organisms with standard 
polyclonal antibodies or, conversely for the determination of the 
specificity of polyclonal antibodies using known strains of 
bacteria. In order to determine the specifltles of MCAbs by 
agglutination, ascitic fluid or ammonium sulphate concentrated 
antibodies are generally used. The quantities of antigen required 
for agglutination are also higher than for any other 
immunological assay, and hence low affinity interactions may play 
a role in agglutination tests. In spite of the drawbacks it is 
still the most widely used assay because of its simplicity.
Agglutination tests are less easy to analyse than ELISA 
type assays. The antibody must not only bind to the bacterium, 
but also bind in a manner which makes it geometrically possible 
to form a bridge between two neighbouring bacteria with enough 
free energy to counteract diffusion forces. Factors such as 
epitope position and density and cooperativity of binding thus 
determine the extent to which a single MCAb can agglutinate a 
population of bacteria.
The activity of the anti-Inaba antibodies against 
B. abortus organisms and 03D1 against Inaba were observed only in 
this test and the complement fixation. 03D1 did not agglutinate 
Ogawa vibrios on its own but could agglutinate Inaba vibrios. 
04A6 and 04D2 were not capable of agglutinating either the 
homologous or the heterologous serotypes of bacteria despite
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their high ELISA titres. Bundle et aJ, ( 1984 ) also reported 
negative agglutination properties of a MCAb of isotype IgM 
although it exhibited a high ELISA titre.
Agglutination tests proved to be valuable in this study
for revealing weak antlgen-antibody interactions not detected in
other assays. Results from this study suggest that agglutination 
tests can detect both high and low affinity interactions. This is 
presumably because the antigen remains suspended in a solution of 
antibody without washing procedures to remove unbound material, 
and also because of the very high concentration of each of the 
two components.
The nonagglutinating properties of 04D2 and 04A6 despite 
their high reactivity towards the Ogawa vibrios may reflect the 
position of the binding site rather than the affinity of the 
antibody which binds strongly in all other tests.
6.10.6 Complement fixation assay
The complement fixation a s s a y  i s  a n o t h e r  o n e  in which 
washing is not involved and where low affinity interactions may 
therefore be detected. However, it is carried out at much lower 
concentrations of antibody and antigen than the agglutination 
assay. The detection system does not require that the antibody 
cross links two bacteria but instead, requires that the antibody 
be of a class which fixes complement. In addition, it is often 
suggested that two IgG molecules must bind in close proximity in 
order to fix complement ( Roitt et 1985 ) and so the cross 
reaction pattern might well be expected to be different. In
224
practice, the two non-washing assays were similar except that all 
the Ogawa series of antibodies, which failed to agglutinate the 
homologous vibrios, fixed complement with homologous antigen as 
well as displaying the cross reactions observed on agglutination. 
The interaction of the anti-Inaba antibodies with Ogawa vibrios 
and ^  abortus organisms were clearly demonstrated, and it was 
interesting to observe the activity of I4C3 gradually decrease as 
it was simultaneously tested against different strains of 
bacteria. The preference for Inaba was about three times than 
that for Ogawa and around 60 times that for ^  abortus ( Table 
5.9a ). 03D1 showed reaction with Inaba only at 80 fold the
concentration where it reacted with homologous antigen ( Table 
5.9b ) and yet it preferentially agglutinated the Inaba vibrios 
in primary agglutination. Observations of this type were reported 
by Bundle et a^, ( 1984 ). One of their anti-Y. enterocolitica 
MCAbs of isotype IgG2a agglutinated abortus but not 
Y. enterocolitica.
6.10.7 Classification of the six anti-V.cholerae antibodies
The variety of immunological assays conducted in this study 
revealed fine differences in the panel of antibodies raised 
against the two serotypes of cholerae. The behaviour of the 
antibodies throughout the study led to their classification into 
three separate groups, determined by the ratio of reactivity 
between the two serotypes in any particular assay, since in most 
cases tissue culture supernatant rather than pure antibody was 
used for the test and the immunoglobulin content could vary from
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batch to batch.
Group one antibodies comprised IlAl, I4B1 and I4C3, 
generated from animals immunised with the Inaba serotype, shown 
by initial screening to be ispeciTic|to the Inaba serotype but 
subsequently shown to cross react with the Ogawa serotype at a 
ratio of 1/2-1/4 of homologous activities on other assays. All of 
this group showed cross reactivity with Brucella abortus on 
agglutination and the only one tested on complement fixation 
( I4C3 ) showed cross reaction with ^  abortus. All three are 
therefore taken to be similarly cross reactive for the purposes 
of discussion, although further analysis with Bj^  abortus and 
other gram-negative bacteria may subdivide this group.
Group two consisted of 04D2 and 04A6, generated from 
animals immunised with the Ogawa serotype and shown by initial 
screening to be specific to the Ogawa serotype. In secondary 
antibody tests, it was very strongly positive while in direct 
labelled antibody tests, it showed less binding than the group 1 
antibodies, this could relate to the loss of antibodies or 
antibody activity during the multiple purification steps. These 
antibodies were non-agglutinating on all organisms tested.
Group three is the single antibody, 03D1 which was generated 
from animals imunlsed with the Ogawa serotype and originally 
classified as Ogawa specific. It could be shown, by the two 
non-washing assays to cross react with Inaba vibrios, but not any 
other organism tested. One feature of interest of this antibody, 
is that it agglutinates Inaba but not Ogawa vibrios although its 
reaction with Inaba vibrios is much weaker.
2 2 6
To this list, must be added the MCAbs of Gustafsson and 
Holme ( 1983 ) which were studied by exchange. In the two tests 
performed on these, ELISA and agglutination, the three antibodies 
generated by Gustafsson and Holme, behaved exactly as expected 
for antibodies reacting with the classical A, B and C antigens. 
It was of particular interest to note that all three agglutinated 
the appropriate |serotypesj at a concentration of ascites fluid 
which gave a much lower ELISA titre than was determined with the 
antibodies used in this study. However, even their A specific 
antibody was not equally reactive with both serotypes as 
undertaken in this study. Thus, the classical antigens of 
V. cholerae can, with minor caveats, also be demonstrated by 
hybridoma technology.
6.11 Dissection of V.cholerae antigens with MCAbs of three 
different idiotvpes
Detailed studies of the relationship between an antibody 
making a high affinity contact with a complex antigen have not 
been available until the advent of hybridoma technology. The 
earlier X-ray crystallographic data on interactions and cross 
reactions ( Richards et ^,1975 ) show that contact points may be 
made between an antibody of a myeloma cell line and two or more 
shelf selected antigens, each of totally different structure. 
When hybridoma technology was developed, the early detailed 
studies of selected interactions were with small haptens and it 
soon became apparent that the antibodies raised could see much
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deeper into the immunising mixture beyond the hapten structure 
and into the carrier material ( Rodwell e^ al, 1983 )• A detailed 
crystallographic study of the reaction of an antibody with an 
antigen is that of Amit et al, ( 1985 ) who analysed the 
interaction of a MCAb generated and selected against hen egg 
white lysosyme with its antigen. There are many contact points 
beyond the areas previously envisaged.
Chemical analyses have shown that Inaba and Ogawa LPS 
molecules are very similar with the possible exception of one 
sugar residue. The Ogawa serotype has been reported to contain 
the sugar 4-amino-4-deoxy-arablnose and the Inaba LPS to lack it 
( Redmond, 1978 ). Kenne e^ al, ( 1982 ) suggested that the 
polymer of amino acylated perosamine residues common to both 
serotypes probably represents the 01 antigen of cholerae LPS. 
The precise nature of Ogawa or Inaba specific antigens is still 
obscure and the contribution of 4-amino-4-deoxy-arabinose towards 
the type Specific antigen of Ogawa vibrios remains speculative. 
However, the data obtained from SDS-PAGE suggests that this sugar 
may not be a regular feature of the repeating 0 antigen in the 
Ogawa strain alone since the ladder pattern does not accommodate 
such a hypothesis. ( Section 6.6.1 ).
The idiotypes of the MCAbs established in this study do not 
conform to the A, B and C antigens defined for cholerae 
organisms by classical serology. Group one antibodies, specific 
against the Inaba serotype in certain assays ( Section 5.1 ) bind 
to Ogawa vibrios as well but with a lower affinity and thus 
cannot be classified as anti-A or anti-C antibodies. It is clear
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that these antibodies see a similar epitope on the Ogawa vibrio. 
A similar but not identical epitope may well attract an antibody 
as long as some contacts can be made ( Amit et 1985 ).
The Ogawa and Inaba LPS molecules share not only similar 
0-chains but also a common core ( Hisatsune and Kondo, 1980; 
Brade, 1985 ). The outer membrane proteins of the two serotypes 
have also been shown to be similar ( Kabir, 1980; Manning and 
Haynes, 1984 ). Hence, the common epitopes recognised by IlAl, 
I4B1 or I4C3 may involve interactions with the core and/or 
membrane protein antigens. The region linking of the 0-side 
chain to the core has been identified as an epitope recognised by 
two anti-Y. enterocolitica MCAbs established by Bundle e^ al, 
( 1984 ).
The data obtained from the six MCAbs in this panel cannot 
be easily interpreted in terms of subtle fine structural 
differences in the LPS of the two strains for a variety of 
reasons. Firstly, the structure of the LPS is not known ( Section
1.13.2 ), secondly, the cross reactive panel represents only 
three basic types of specificity and more antibodies with yet 
further specificity profiles would probably be required to obtain 
more data from the antibodies alone. Thirdly, the size of the 
repeat region in cholerae is small as shown by the 
microheterogeniety studies on gels. Thus, when interpreting 
interactions it is necessary to consider the possibility that the 
idiotype of any antibody may encompass more than one repeating 
unit in non integral fashion. Finally, all the cross reactions 
demonstrated were shown on whole vibrios and as such may involve
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proteins as well as core components of the LPS. The antigen and 
the potential contribution of proteins cannot be ruled out until 
tests utilising LPS alone have also demonstrated c r o s s  
reactivity. The involvement of the core LPS in the 
cross-reactions seem likely because the group one antibodies can 
agglutinate abortus but not ^  enterocolitica organisms and 
these two organisms differ only in the core structure of their 
LPS.
Some attempt may be made to discuss the types of 
interactions which may be involved between antibody and bacterial 
LPS antigen. Schalch ^  ( 1979 ) and Cisar e^ al, ( 1975 )
have demonstrated that the ability of antibodies to precipitate 
polysaccharides is associated with the multivalency of the 
antigens. A linear streptococcal polysaccharide was shown to bind 
to one type of antibody ( which was an agglutinating antibody )  
in the ratio of 1:4 due to the presence of several binding sites 
on the linear portion of the polymeric molecule. A second type of 
antibody bound in the ratio of 1:1 and did not agglutinate and 
was assigned to interaction with the terminal reducing end of the 
polysaccharide ( Schalch et 1979 ).
A similar situation could be envisaged In this case. IlAl, 
I4B1 and I4C3 could correspond to the agglutinating type of 
antibody. The vibrio LPS molecule is effectively a 
homopolysaccharide and by analogy may offer binding sites along 
the linear extension of the molecule. As discussed above, 
( Section 6.6.1 ) the chain length of cholerae LPS is not 
known but from SDS-PAGE studies It Is clear that the mean chain
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length is much above one repeat unit and the molecule thus 
possesses several potential antibody binding sites. The 
multivalent binding could thus precipitate the organisms. 
Conversely, the group two antibodies, 04D2 and 04A6, could 
exhibit chain end specifities because they are nonprecipitating 
antibodies. Cisar et ^  ( 1975 ) have shown that the interaction 
of mouse myeloma proteins with dextrans emphasises the 
immunodominancy of terminal nonreducing -linked glycosyl residue 
of linear homopolysaccharides. Since 04D2 and 04A6 do not bind to 
Inaba as was established by several assays, this would imply 
differences in the terminal groups of the two serotypes.
This interpretation of the group one antibodies binding 
to internal regions along the length of the LPS while group two 
bind to the chain ends, is simple and attractive. However, it 
becomes hard to sustain this hypothesis when the group three 
antibody, 03D1 is considered. One would then have to suggest that 
this antibody binds to terminal residues on Ogawa but internal 
ones on Inaba. Moreover, the displacement of group one antibody's 
cross-reaction by group two and three antibodies ( Section
5.14.3 ) cannot be easily explained by this theory. Thus the 
interpretation of Schalch et ( 1979 ) cannot be readily
applied to this situation.
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6.12 The significance of cross reactive antibodies in applied 
and commercial situations
6.12.1 In vivo applications ( i ) Applications for cholera 
therapy
The use of the antibodies produced in this study in vivo 
would present several complications. Not only are they foreign to 
man and liable to rejection if employed over a long period of 
time, but they are also basically required in the intestinal 
tract and the access of such antibodies after intravenous 
injection may well be highly limited since IgA antibodies with 
their own complex transport pathway through the intestinal 
epithelium, may be the only major class of antibody to be 
effective in this particular disease.
6.12.2 In vivo applications ( ii ) Implications of cross 
reactions for general therapy
Monoclonal antibodies are considered as possible agents 
for therapy of both tumours and autoimmune conditions. Where ^  
vivo use is contemplated, the antibody cannot be screened by a 
method equivalent to its final application and consequently 
screening is generally effected by ELISA or immunocytochemical 
assays on isolated tumour cells. Such assays will only detect the 
higher affinity contacts described in this work, and the actual 
environment in which the antibody is expected to operate is 
poorly understood. Thus, any antibody employed in therapy against 
an apparently specific tumour antigen, may have considerable
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cross reactive potential.
6.12.3 Implications for In vitro applications. Diagnostic tests 
In monoclonal antibody technology, the importance of 
selecting the emerging hybridoma by the assay in which the 
monoclonal antibody will be finally employed is well known. For 
diagnostic tests, the type of assay which has been popular for 
many antigens has been an ELISA -like one which involves the use 
of two monoclonal antibodies. One is fixed on a solid phase 
support such as a stick or filter and is reacted with the fluid 
which may contain the antigen. The second is labelled with an 
enzyme and used to detect the binding of antigen to the first 
monoclonal. With protein molecules, the two monoclonals need to 
have different epitopes whereas with bacteria, this is a less 
stringent requirement because of antigen multivalence. In such 
assays, the monoclonal antibodies generated in this study should 
perform with true serotype specific fidelity as suitable 
diagnostic reagents. However, tests of this type are still 
comparatively costly and there is also considerable pressure for 
the production of monoclonal antibodies which may be used in 
simple agglutination tests in the field in the third world with 
clinical samples with variable concentrations of antigen. 
Monoclonal antibodies to the major blood group antigens are 
screened in this way because they will be used in this way for 
testing ( Fraser et al, 1984 ) and such antibodies have proved to 
be highly successful, possibly in part because of the high 
antigen density in an easily obtained sample of red blood cells.
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None of the antibodies produced in this study would have 
shown cross reaction on screening but if used as concentrate for 
field testing, would have produced exceedingly confusing results. 
Much commercial pressure is directed towards sensitivity which is 
readily achieved in ELISA and much also towards convenience and 
cost which favour agglutination type assays.
Cross reactions are usually regared as a negative feature 
of monoclonal antibodies. However, as Mossman ^  a^, ( 1980 ) 
point out, they may also be adapted so that a single monoclonal 
antibody may be used for many applications. Thus the group one 
series of antibodies in this study could be used as either 
V. cholerae 01 or Inaba specific reagent according to assay 
conditions. Similarly, 03D1 could be used as Ogawa specific on 
ELISA and Inaba specific on agglutination tests. Thus, assay 
dependent cross reactivity, properly understood can not only be 
employed to analyse antigenic determinants on complex bacterial 
surfaces but also to provide versatile diagnostic reagents.
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